<SEC-DOCUMENT>0000355019-16-000049.txt : 20160510
<SEC-HEADER>0000355019-16-000049.hdr.sgml : 20160510
<ACCEPTANCE-DATETIME>20160510154242
ACCESSION NUMBER:		0000355019-16-000049
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		56
CONFORMED PERIOD OF REPORT:	20160331
FILED AS OF DATE:		20160510
DATE AS OF CHANGE:		20160510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FONAR CORP
		CENTRAL INDEX KEY:			0000355019
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				112464137
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-10248
		FILM NUMBER:		161635538

	BUSINESS ADDRESS:	
		STREET 1:		110 MARCUS DR
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6316942929

	MAIL ADDRESS:	
		STREET 1:		110 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>fonar_f2016-q3.htm
<DESCRIPTION>FONAR CORPORATION 3RD QUARTER 10-Q
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font-size: 11pt"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>FORM 10-Q</B></FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 31.5pt; text-align: center; text-indent: -0.5in">[X] QUARTERLY
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 31.5pt; text-align: center; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">For the quarterly period ended <FONT STYLE="font-size: 12pt"><B><U>MARCH
31, 2016</U></B></FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 22.5pt; text-align: center; text-indent: -22.5pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 22.5pt; text-align: center; text-indent: -22.5pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><U>Commission file number 0-10248</U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 14pt"><B><U>FONAR CORPORATION</U></B></FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">(Exact name of registrant as specified in its
charter)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-size: 11pt">
    <TD STYLE="vertical-align: bottom; width: 48%; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">DELAWARE</FONT></TD>
    <TD STYLE="vertical-align: top; width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 26%; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">11-2464137</FONT></TD></TR>
<TR STYLE="font-size: 11pt">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 11pt">
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>(State or other jurisdiction of</B></P>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>incorporation or organization)</B></P></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 11pt">
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>(I.R.S. Employer</B></P>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size: 11pt">
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">110 Marcus Drive&nbsp;&nbsp;Melville, New York</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">11747</FONT></TD></TR>
<TR STYLE="font-size: 11pt">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">(Address of principal executive offices)</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">(Zip Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><U>Registrant's telephone number, including area
code: (631) 694-2929</U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. YES <U> X </U> NO <U>___</U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant
has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted
and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for shorter period
that the registrant was required to submit and post such files. YES <U> X </U> NO <U>___</U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of
accelerated filer, large accelerated filer or smaller reporting company in Rule 12b-2 of the Exchange Act.(Check one): Large accelerated
filer___ Accelerated filer<U> X </U> Non-accelerated filer <U>___</U> Smaller reporting company <U>___</U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act). YES ___<U> </U> NO <U>_X__</U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Indicate the number of shares outstanding of
each of the issuer's classes of common stock, as of the close of the latest practicable date.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.2in 0 0; text-align: justify">Indicate the number of shares outstanding
of each of the issuer's classes of common stock, as of the close of the latest practicable date.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="padding-left: 5.4pt; border-bottom: Black 1pt solid; font-size: 11pt">Class</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid; font-size: 11pt">Outstanding
                                         at April 30, 2016</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="width: 45%; padding-left: 5.4pt; font-size: 11pt">Common Stock, par value $.0001</TD><TD STYLE="width: 20%; font-size: 11pt"></TD>
    <TD STYLE="width: 0%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 35%; text-align: right; font-size: 11pt">6,050,840</TD><TD STYLE="width: 0%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Class B Common Stock, par value $.0001</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">146</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Class C Common Stock, par value $.0001</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">382,513</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Class A Preferred Stock, par value $.0001</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">313,438</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"> </TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: center"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: center">INDEX</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.2in 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; background-color: transparent; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">PART I - FINANCIAL INFORMATION</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Page No.</FONT></TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Item 1.&nbsp;&nbsp;Financial Statements</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent; font-size: 11pt">
    <TD STYLE="width: 84%; text-align: left; text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Condensed Consolidated Balance Sheets - March 31, 2016 (Unaudited) and June 30, 2015</TD><TD STYLE="width: 6%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 0%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 10%; text-align: right; font-size: 11pt">3</TD><TD STYLE="width: 0%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Condensed Consolidated Statements of Income for the Three Months Ended March 31, 2016 and March 31, 2015 (Unaudited)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">6</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent; font-size: 11pt">
    <TD STYLE="text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Condensed Consolidated Statements of Income for the Nine Months Ended &nbsp;March 31, 2016 and March 31, 2015 (Unaudited)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">7</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Condensed Consolidated Statements of Cash Flows for the Nine Months Ended March 31, 2016 and March 31, 2015 (Unaudited)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">8</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Notes to Condensed Consolidated Financial Statements (Unaudited)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">9</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Item 2. Management's Discussion and Analysis of Financial Condition and &nbsp;Results of Operations</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">21</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Item 3. Quantitative and Qualitative Disclosures About Market Risk</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">29</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Item 4. Controls and Procedures</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">29</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">PART II - OTHER INFORMATION</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">29</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Item 1. Legal Proceedings</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">29</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Item 1A. Risk Factors</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">29</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">31</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Item 3. Defaults Upon Senior Securities</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">31</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Item 4. Mine Safety Disclosures</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">31</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Item 5. Other Information</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">32</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Item 6. Exhibits</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">32</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent; font-size: 11pt">
    <TD STYLE="text-indent: -17.1pt; padding-left: 17.1pt; font-size: 11pt">Signatures</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">32</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: center"></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">CONDENSED CONSOLIDATED BALANCE SHEETS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">ASSETS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"><P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt">March
31,<BR>2016</P></TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"><P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt">June
30,&nbsp;<BR>2015 *</P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; width: 64%; font-size: 11pt">Cash and cash equivalents</TD><TD STYLE="width: 4%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">13,147</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 4%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">9,449</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; font-size: 11pt">Accounts receivable &ndash; net</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">4,326</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">3,791</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; font-size: 11pt">Accounts receivable - related party</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">30</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; font-size: 11pt">Medical receivable &ndash; net</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">10,097</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">9,082</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; font-size: 11pt">Management and other fees receivable &ndash; net</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">15,901</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">14,058</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; font-size: 11pt">Management and other fees receivable &ndash; related medical practices &ndash; net</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">4,059</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">3,507</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; font-size: 11pt">Costs and estimated earnings in excess of billing on uncompleted contracts</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">279</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">682</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; font-size: 11pt">Inventories</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">2,234</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">2,192</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; font-size: 11pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">834</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">860</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; font-size: 11pt">Total Current Assets</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">50,907</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">43,621</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; font-size: 11pt">Deferred income tax asset</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">8,423</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">8,423</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; font-size: 11pt">Property and equipment &ndash; net</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">11,877</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">12,901</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; font-size: 11pt">Goodwill</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">1,767</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">1,767</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; font-size: 11pt">Other intangible assets &ndash; net</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">8,066</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">8,950</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; font-size: 11pt">Other assets</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">972</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">830</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9.6pt; padding-left: 9.6pt; font-size: 11pt">Total Assets</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">82,012</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">76,492</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">*Condensed from audited financial statements.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">See accompanying notes to condensed consolidated financial
statements.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: center"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">CONDENSED CONSOLIDATED BALANCE SHEETS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">LIABILITIES AND STOCKHOLDERS' EQUITY</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"><P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt">March
31,<BR>2016</P></TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">June 30, <BR>2015 *</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Current Liabilities:</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="width: 64%; text-align: left; text-indent: -9pt; padding-left: 18.6pt; font-size: 11pt">Current portion of long-term debt and capital leases</TD><TD STYLE="width: 4%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">2,455</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 4%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">2,490</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 18.6pt; font-size: 11pt">Accounts payable</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">1,345</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">1,783</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 18.6pt; font-size: 11pt">Other current liabilities</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">8,638</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">8,253</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 18.6pt; font-size: 11pt">Unearned revenue on service contracts</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">4,350</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">4,187</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 18.6pt; font-size: 11pt">Unearned revenue on service contracts - related party</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">28</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 18.6pt; font-size: 11pt">Customer advances</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">1,511</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">1,938</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.6pt; font-size: 11pt">Billings in excess of costs and estimated earnings on uncompleted contracts</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">255</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">142</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: 27pt; padding-left: 18.6pt; font-size: 11pt">Total Current Liabilities</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">18,582</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">18,793</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -0.25in; padding-left: 18.6pt; font-size: 11pt">Long-Term Liabilities:</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 18.6pt; font-size: 11pt">Deferred income tax liability</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">510</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">510</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 18.6pt; font-size: 11pt">Due to related medical practices</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">237</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">237</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 18.6pt; font-size: 11pt">Long-term debt and capital leases, less current <BR>portion</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">3,863</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">5,699</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.6pt; font-size: 11pt">Other liabilities</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">718</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">469</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 27pt; padding-left: 18.6pt; font-size: 11pt">Total Long-Term Liabilities</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">5,328</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">6,915</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 27pt; padding-left: 18.6pt; font-size: 11pt">Total Liabilities</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">23,910</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">25,708</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">*Condensed from audited financial statements.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">See accompanying notes to condensed consolidated financial
statements.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">CONDENSED CONSOLIDATED BALANCE SHEETS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center; text-indent: 0.5in">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">LIABILITIES AND STOCKHOLDERS' EQUITY (Continued)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; font-size: 11pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt">March 31,</P>
                                               <P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt">2016</P></TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; font-size: 11pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt">June 30,</P>
                                               <P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt">2015 *</P></TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">STOCKHOLDERS' EQUITY:</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: right; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9.6pt; font-size: 11pt">Class A non-voting preferred stock $.0001 par value; 453 shares authorized at March 31, 2016 and June 30, 2015, 313 issued and outstanding at March 31, 2016 and June 30, 2015</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9.6pt; font-size: 11pt">Preferred stock $.001 par value; 567 shares authorized at March 31, 2016 and June 30, 2015, issued and outstanding &ndash; none</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="width: 64%; text-indent: -9pt; padding-left: 9.6pt; font-size: 11pt">Common Stock $.0001 par value; 8,500 shares authorized at March 31, 2016 and June 30, 2015, 6,062 issued at March 31, 2016 and June 30, 2015; 6,051 outstanding at March 31, 2016 and June 30, 2015</TD><TD STYLE="width: 4%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">1</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 4%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">1</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-indent: -9pt; padding-left: 9.6pt; font-size: 11pt">Class B Common Stock (10 votes per share) $ .0001 par value; 227 shares authorized at March 31, 2016 and June 30, 2015, .146 issued and outstanding at March 31, 2016 and June 30, 2015</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-indent: -9pt; padding-left: 9.6pt; font-size: 11pt">Class C Common Stock (25 votes per share) $.0001 par value; 567 shares authorized at March 31, 2016 and June 30, 2015, 383 issued and outstanding at March 31, 2016 and June 30, 2015</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-indent: -9pt; padding-left: 9.6pt; font-size: 11pt">Paid-in capital in excess of par value</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">175,448</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">175,448</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9.6pt; font-size: 11pt">Accumulated deficit</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(126,989</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(136,349</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9.6pt; font-size: 11pt">Notes receivable from employee stockholders</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(26</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(32</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9.6pt; font-size: 11pt">Treasury stock, at cost - 12 shares of common stock at March 31, 2016 and June 30, 2015</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(675</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(675</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9.6pt; font-size: 11pt">Total Fonar Corporation Stockholder Equity</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">47,759</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">38,393</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9.6pt; font-size: 11pt">Noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">10,343</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">12,391</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9.6pt; font-size: 11pt">Total Stockholders' Equity</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">58,102</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">50,784</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9.6pt; font-size: 11pt">Total Liabilities and Stockholders' Equity</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">82,012</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">76,492</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">*Condensed from audited financial statements.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">See accompanying notes to condensed consolidated financial
statements.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: center"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">CONDENSED CONSOLIDATED STATEMENTS
OF INCOME</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">&nbsp;(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"><P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">FOR THE THREE MONTHS</FONT></P>
                                                                               <P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P> <P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"> ENDED MARCH 31</FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">REVENUES</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2015</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="width: 72%; text-align: left; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Product sales &ndash; net</TD><TD STYLE="width: 2%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 10%; text-align: right; font-size: 11pt">20</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 2%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 10%; text-align: right; font-size: 11pt">160</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Service and repair fees &ndash; net</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">2,406</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">2,299</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Service and repair fees &ndash; related parties - net</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">27</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">27</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Patient fee revenue, net of contractual allowances and discounts</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">8,695</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">7,284</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Provision for bad debts for patient fee</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(3,830</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(3,201</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Management and other fees &ndash; net</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">9,394</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">8,653</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Management and other fees &ndash; related medical practices &ndash; net</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1,907</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1,874</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 36.6pt; padding-left: 5.4pt; font-size: 11pt">Total Revenues &ndash; Net</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">18,619</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">17,096</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">COSTS AND EXPENSES</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Costs related to product sales</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">263</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">352</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Costs related to service and repair fees</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">552</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">630</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Costs related to service and repair fees &ndash; related parties</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">6</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">7</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Costs related to patient fee revenue</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">2,549</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">2,044</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Costs related to management and other fees</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">5,649</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">5,285</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Costs related to management and other fees &ndash; related medical practices</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">1,045</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">1,284</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Research and development</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">395</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">360</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Selling, general and administrative</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">4,533</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">3,706</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -13.5pt; padding-left: 27.6pt; font-size: 11pt">Provision for bad debts</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(470</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">762</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 36.6pt; padding-left: 5.4pt; font-size: 11pt">Total Costs and Expenses</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">14,522</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">14,430</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Income From Operations</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">4,097</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">2,666</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Interest Expense</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(127</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(169</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Investment Income</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">56</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">52</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Income Before Provision for Income Taxes and Noncontrolling Interests</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">4,026</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">2,549</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Provision for Income Taxes</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">145</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">30</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Net Income</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">3,881</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">2,519</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Net Income - Noncontrolling Interests</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(876</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(500</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Net Income - Controlling Interests</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">3,005</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,019</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Net Income Available to Common Stockholders</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,810</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1,888</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Net Income Available to Class A Non-Voting Preferred Stockholders</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">145</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">98</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Net Income Available to Class C Common Stockholders</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">50</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">33</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Basic Net Income Per Common Share Available to Common Stockholders</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.46</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Diluted Net Income Per Common Share Available to Common Stockholders</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.45</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Basic and Diluted Income Per Share-Class C Common</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.13</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.09</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted Average Basic Shares Outstanding-Common Stockholders</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted Average Diluted Shares Outstanding &ndash; Common Stockholders</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted Average Basic Shares Outstanding &ndash; Class C Common</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted Average Diluted Shares Outstanding &ndash; Class C Common</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">See accompanying notes to condensed consolidated financial
statements.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">CONDENSED CONSOLIDATED STATEMENTS
OF INCOME</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center; text-indent: 0.5in">(UNAUDITED)</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"><P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt">FOR THE NINE MONTHS</P>
                                                                               <P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt">ENDED MARCH 31,</P></TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">REVENUES</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2015</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="width: 72%; text-align: left; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Product sales &ndash; net</TD><TD STYLE="width: 2%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 10%; text-align: right; font-size: 11pt">780</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 2%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 10%; text-align: right; font-size: 11pt">1,806</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Service and repair fees &ndash; net</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">6,970</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">7,288</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Service and repair fees &ndash; related parties - net</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">83</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">83</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Patient fee revenue, net of contractual allowances and discounts</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">24,596</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">20,700</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Provision for bad debts for patient fee</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(10,608</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(9,244</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Management and other fees &ndash; net</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">27,180</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">26,004</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Management and other fees &ndash; related medical practices &ndash; net</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">5,598</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">5,536</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 36.6pt; padding-left: 5.4pt; font-size: 11pt">Total Revenues &ndash; Net</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">54,599</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">52,173</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">&nbsp;COSTS AND EXPENSES</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Costs related to product sales</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">939</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">1,674</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Costs related to service and repair fees</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">1,542</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">1,611</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Costs related to service and repair fees - related parties</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">18</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">18</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Costs related to patient fee revenue</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">7,015</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">5,845</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Costs related to management and other fees</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">16,664</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">15,665</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Costs related to management and other fees &ndash;&nbsp;&nbsp;related medical practices</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">3,116</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">3,893</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Research and development</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">1,243</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">1,116</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Selling, general and administrative</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">12,425</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">11,108</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 27.6pt; font-size: 11pt">Provision for bad debts</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(300</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1,540</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 36.6pt; padding-left: 5.4pt; font-size: 11pt">Total Costs and Expenses</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">42,662</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">42,470</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Income From Operations</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">11,937</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">9,703</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Interest Expense</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(416</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(545</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Investment Income</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">164</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">173</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Other Income (Expense)</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(2</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Income Before Provision for Income Taxes and Noncontrolling Interests</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">11,686</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">9,329</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Provision for Income Taxes</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">235</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">99</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Net Income</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">11,451</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">9,230</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Net Income - Noncontrolling Interests</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(2,091</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(2,018</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Net Income - Controlling Interests</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">9,360</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">7,212</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Net Income Available to Common Stockholders</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,752</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,743</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Net Income Available to Class A Non-voting Preferred Stockholders</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">453</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">350</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Net Income Available to Class C Common Stockholders</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">155</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">119</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Basic Net Income Per Common Share Available to Common Stockholders</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.45</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.11</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Diluted Net Income Per Common Share Available to Common Stockholders</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.42</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.09</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Basic and Diluted Income Per Share-Class C Common</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.40</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted Average Basic Shares Outstanding &ndash; Common Stockholders</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted Average Diluted Shares Outstanding &ndash; Common Stockholders</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted Average Basic Shares Outstanding &ndash; Class C Common</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted Average Diluted Shares Outstanding &ndash; Class C Common</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">See accompanying notes to condensed consolidated financial
statements.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">CONDENSED CONSOLIDATED STATEMENTS
OF CASH FLOWS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center; text-indent: 0.5in">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"><P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt">FOR THE NINE MONTHS</P>
                                                                               <P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt">ENDED MARCH 31,</P></TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2015</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; font-size: 11pt">Cash Flows from Operating Activities:</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="width: 72%; text-align: left; text-indent: -13.5pt; padding-left: 18.6pt; font-size: 11pt">Net income</TD><TD STYLE="width: 2%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 10%; text-align: right; font-size: 11pt">11,451</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 2%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 10%; text-align: right; font-size: 11pt">9,230</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -4.5pt; padding-left: 9.6pt; font-size: 11pt">Adjustments to reconcile net income to net cash provided by operating activities:</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Depreciation and amortization</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">2,507</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">2,665</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Provision for bad debts</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(300</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">1,540</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Stock issued for costs and expenses</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">76</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Compensatory element of stock issuances</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">53</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -36.6pt; padding-left: 36.6pt; font-size: 11pt">(Increase) decrease in operating assets, net:</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Accounts, medical and management fee receivable(s)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(3,674</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(4,310</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Notes receivable</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">17</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">118</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Costs and estimated earnings in excess of billings on uncompleted contracts</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">403</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">79</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Inventories</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(43</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">158</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Prepaid expenses and other current assets</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">9</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">89</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Other assets</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(143</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">18</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -3.9pt; padding-left: 5.4pt; font-size: 11pt">Increase (decrease) in operating liabilities, net:</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Accounts payable</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(437</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(178</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Other current liabilities</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">576</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(501</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Customer advances</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(427</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(259</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Billings in excess of costs and
    estimated earnings on uncompleted  contracts</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">112</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Other liabilities</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">249</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(230</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Due to related medical practices</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(2</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; font-size: 11pt">Net cash provided by operating activities</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">10,300</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">8,546</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; font-size: 11pt">Cash Flows from Investing Activities:</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Purchases of property and equipment</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(534</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(125</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Cost of patents</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(65</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(108</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; font-size: 11pt">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(599</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(233</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">&nbsp;Cash Flows from Financing Activities:</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Repayment of borrowings and capital lease obligations</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(1,871</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(2,166</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Distributions to noncontrolling interests</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(4,138</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(3,306</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Buyout of noncontrolling interests</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(4,971</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 27.6pt; font-size: 11pt">Repayment of notes receivable from employee stockholders</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">6</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">6</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; font-size: 11pt">Net cash used in financing activities</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(6,003</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(10,437</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; font-size: 11pt">Net Increase (Decrease) in Cash and Cash Equivalents</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">3,698</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">(2,124</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; font-size: 11pt">Cash and Cash Equivalents &ndash; Beginning of Period</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">9,449</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">9,952</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; font-size: 11pt">Cash and Cash Equivalents - End of Period</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">13,147</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">7,828</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">See accompanying notes to condensed consolidated financial
statements.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: center"></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 1 &ndash; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><U>Description of Business</U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Effective July 1, 2015, the Company restructured the corporate organization
of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate
the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized
in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation
of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest
in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM,
operating under the name &ldquo;Health Management Company of America&rdquo;.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><U>Basis of Presentation</U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The accompanying unaudited condensed consolidated
financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information
and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information
and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.
In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation
have been included. Operating results for the three and nine months ended March 31, 2016, are not necessarily indicative of the
results that may be expected for the fiscal year ending June 30, 2016. For further information, refer to the consolidated financial
statements and footnotes thereto included in the Company's Annual Report on Form 10-K filed on September 29, 2015 for the fiscal
year ended June 30, 2015.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><U>Principles of Consolidation</U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The unaudited condensed consolidated financial statements include
the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships (collectively the &ldquo;Company&rdquo;).
All significant intercompany accounts and transactions have been eliminated in consolidation.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><U>Earnings Per Share</U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Basic earnings per share (&ldquo;EPS&rdquo;)
is computed based on weighted average number of shares common stock and stock equivalents outstanding, net of common stock. In
accordance with ASC topic 260-10, &ldquo;Participating Securities and the Two-Class method&rdquo;, the Company used the Two-Class
method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for
the three and nine months ended March 31, 2016 and March 31, 2015.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-decoration: none"><U></U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"><U>Earnings Per Share</U> (Continued)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">Diluted EPS reflects the potential dilution
from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares
outstanding during the period. For the three and nine months ended March 31, 2016 and March 31, 2015, diluted EPS for common shareholders
includes 128 shares upon conversion of Class C Common.&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="11" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Three months ended <BR>March 31, 2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="11" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Three months ended <BR>March 31, 2015</TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt"><U></U></TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="font-size: 11pt"><P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt"><U>Basic</U></P>
        <P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt"><U>Numerator:</U></P></TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; width: 33%; font-size: 11pt">Net income available to&nbsp;common stockholders</TD><TD STYLE="width: 3%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">3,005</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,810</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">50</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,019</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1,888</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">33</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"><U>Denominator:</U></TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Basic income per common share</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.50</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.46</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.13</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"><P STYLE="margin-top: 0; margin-bottom: 0"></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">0.33</P></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.09</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="font-size: 11pt"></TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="font-size: 11pt"><P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt"><U>Diluted</U></P>
        <P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt"><U>Denominator:</U></P></TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">6,050</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">383</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">6,050</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">383</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Convertible Class C Stock</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Total denominator for diluted earnings per share</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Diluted income per common share</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.45</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.13</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.09</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"><U>Earnings Per Share</U> (Continued)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="11" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Nine months ended <BR>March 31, 2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="11" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Nine months ended <BR>March 31, 2015</TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt"><U></U></TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="font-size: 11pt"><P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt"><U>Basic</U></P>
        <P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt"><U>Numerator:</U></P></TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; width: 33%; font-size: 11pt">Net income available to&nbsp;common stockholders</TD><TD STYLE="width: 3%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">9,360</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,752</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">155</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">7,212</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,743</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">119</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"><U>Denominator:</U></TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Basic income per common share</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.55</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.45</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.40</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.19</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.11</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="font-size: 11pt"></TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="font-size: 11pt"><P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt"><U>Diluted</U></P>
        <P STYLE="margin-top: 0; margin-bottom: 0; font-size: 11pt"><U>Denominator:</U></P></TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">6,050</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">383</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">6,050</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">383</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Convertible Class C Stock</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Total denominator for diluted earnings per share</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Diluted income per common share</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.42</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.40</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.09</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><U>Recent Accounting Pronouncements </U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In March 2016, the FASB issued ASU No. 2016-09,
&ldquo;Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting&rdquo;. This update
includes provisions intended to simplify various aspects of accounting for share-based compensation. ASU No. 2016-09 will take
effect for public companies for the annual periods beginning after December 15, 2016. The Company is currently assessing the potential
impact of ASU No. 2016-09 on the Company&rsquo;s consolidated condensed financial statements.</P>


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(Continued)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><U>Recent Accounting Pronouncements </U>(Continued)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In November 2015, the FASB issued ASU No. 2015-17,
Balance Sheet Classification of Deferred Taxes, which will require entities to present deferred tax assets and deferred tax liabilities
as non-current in a classified balance sheet. The ASU simplified the current guidance, which requires entities to separately present
deferred tax assets and deferred tax liabilities as current and non-current in a classified balance sheet. This standard is effective
for annual periods and interim periods within those fiscal years, beginning after December 15, 2016 but permits entities to early
adopt at the beginning of any interim or annual period. During the quarter ended December 31, 2015, the Company elected to early
adopt ASU 2015-17 and applied the change retrospectively to all periods present. As a result, the Company presented all deferred
assets and liabilities as non-current in its consolidated balance sheet. The adoption of this ASU did not result in a reclassification
of the Company&rsquo;s net deferred tax assets and liabilities as of June 30, 2015. As of March 31, 2016, there was no impact on
the Company&rsquo;s results of operations as a result of the adoption of ASU No. 2015-17</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The FASB has issued ASU No. 2014-09, <I>Revenue
from Contracts with Customers</I>. This ASU supercedes the revenue recognition requirements in Accounting Standards Codification
605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity
recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the company expects to be entitled in exchange for those goods or services. This ASU is effective for annual reporting
periods beginning after December 15, 2017, as deferred including interim periods within the reporting period and should be applied
retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the
ASU recognized at the date of initial application. The Company is currently evaluating the effect that this ASU will have on its
condensed consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has
it determined the effect of the standard on it ongoing financial reporting.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In July 2015, the FASB issued Accounting Standards
Update No. 2015-11, &ldquo;<I>Simplifying the Measurement of Inventory</I>&rdquo; (&ldquo;ASU 2015-11&rdquo;). ASU 2015-11 requires
an entity to measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices
in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement
is unchanged for inventory measured using last-in, first-out (&ldquo;LIFO&rdquo;) or the retail inventory method. It is effective
for annual reporting periods beginning after December 15, 2016. The amendments should be applied prospectively with earlier application
permitted as of the beginning of an interim or annual reporting period.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FASB, the Emerging Issues Task Force and the
SEC have issued certain other accounting standards, updates, and regulations as of March 31, 2016 that will become effective in
subsequent periods; however, management does not believe that any of those updates would have significantly affected our financial
accounting measures or disclosures had they been in effect during 2016 or 2015, and it does not believe that any of those pronouncements
will have a significant impact on our condensed consolidated financial statements at the time they become effective.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><U>Reclassifications</U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Certain prior year amounts have been reclassified
to conform to the current year presentation. The reclassifications did not have any effect on reported consolidated net income
for any periods presented.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 3 &ndash; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT
AND OTHER FEES RECEIVABLE</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Receivables, net is comprised of the following
at March 31, 2016:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Gross <BR>Receivable</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Allowance for <BR>doubtful accounts</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Net</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Accounts receivable</TD><TD STYLE="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,614</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">288</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,326</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Accounts receivable - related party</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">30</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">30</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Medical receivable</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">36,164</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">26,067</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">10,097</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Management and other fees receivable</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">28,873</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">12,972</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">15,901</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Management and other fees receivable - related medical practices ("PC&rsquo;s")</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,462</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">403</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,059</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Receivables, net is comprised of the following
at June 30, 2015:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Gross <BR>Receivable</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Allowance for <BR>doubtful accounts</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Net</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Accounts receivable</TD><TD STYLE="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,153</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">362</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">3,791</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Accounts receivable - related party</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Medical receivable</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">24,541</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">15,459</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">9,082</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Management and other fees receivable</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">27,330</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">13,272</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">14,058</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Management and other fees receivable -&nbsp;&nbsp;related medical practices ("PC&rsquo;s")</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">3,910</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">403</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">3,507</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company's customers are concentrated in
the healthcare industry.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><U>Accounts Receivable</U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Credit risk with respect to the Company&rsquo;s
accounts receivable related to product sales and service and repair fees is limited due to the customer advances received prior
to the commencement of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair
fees are billed on a monthly or quarterly basis and the Company does not continue providing these services if accounts receivable
become past due. The Company controls credit risk with respect to accounts receivable from service and repair fees through its
credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs ongoing
credit authorizations before a product sales contract is entered into or service and repair fees are provided.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></P>


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 3 &ndash; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT
AND OTHER FEES RECEIVABLE (Continued)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><U>Medical Receivable</U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Medical receivables are due under fee-for-service
contracts from third party payors, such as hospitals, government sponsored healthcare programs, patient&rsquo;s legal counsel and
directly from patients. Substantially all the revenue relates to patients residing in Florida. The carrying amount of the medical
receivable is reduced by an allowance that reflects management&rsquo;s best estimate of the amounts that will not be collected.
The Company continuously monitors collections from its clients and maintains an allowance for bad debts based upon the Company&rsquo;s
historical collection experience. The Company determines allowances for contractual adjustments and uncollectible accounts based
on specific agings, specific payor collection issues that have been identified and based on payor classifications and historical
experience at each site.</P>


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><U>Management and Other Fees Receivable</U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><U></U></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company's receivables from the related and
non-related professional corporations (PC's) substantially consist of fees outstanding under management agreements. Payment of
the outstanding fees is dependent on collection by the PC's of fees from third party medical reimbursement organizations, principally
insurance companies and health management organizations.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Payment of the management fee receivables from
the PC&rsquo;s may be impaired by the inability of the PC&rsquo;s to collect in a timely manner their medical fees from the third
party payors, particularly insurance carriers covering automobile no-fault and workers compensation claims due to longer payment
cycles and rigorous informational requirements and certain other disallowed claims. Approximately 59% and 55% of the PCs&rsquo;
net revenues for the three months ended March 31, 2016 and 2015, respectively, were derived from no-fault and personal injury protection
claims. Approximately 60% and 54% of the PCs&rsquo; net revenues for the nine months ended March 31, 2016 and 2015, respectively,
were derived from no-fault and personal injury protection claims. The Company considers the aging of its accounts receivable in
determining the amount of allowance for doubtful accounts. The Company generally takes all legally available steps to collect its
receivables. Credit losses associated with the receivables are provided for in the condensed consolidated financial statements
and have historically been within management's expectations.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Net revenues from management and other fees
charged to the related PCs accounted for approximately 10.2% and 11% of the consolidated net revenues for the three months ended
March 31, 2016 and 2015, respectively. Net revenues from management and other fees charged to the related PCs accounted for approximately
10.3% and 10.6% of the consolidated net revenues for the nine months ended March 31, 2016 and 2015, respectively.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Tallahassee Magnetic Resonance Imaging, PA,
Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related medical practices) entered into a guaranty
agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which have arisen under
each individual management agreement.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 3 &ndash; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT
AND OTHER FEES RECEIVABLE (Continued)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&rsquo;s patient fee revenue, net
of contractual allowances and discounts less the provision for bad debts for the three and nine months ended March 31, 2016 and
2015 are summarized in the following tables.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="text-align: center; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">For the Three Months Ended <BR>March 31,</TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2015</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="width: 60%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Commercial Insurance/ Managed Care</TD><TD STYLE="width: 6%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 11%; text-align: right; font-size: 11pt">1,245</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 8%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 11%; text-align: right; font-size: 11pt">1,091</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Medicare/Medicaid</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">332</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">292</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Workers' Compensation/Personal Injury</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">5,453</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">4,513</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Other</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1,665</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1,388</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Patient Fee Revenue, net of contractual allowances and discounts</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">8,695</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">7,284</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Provision for Bad Debts</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(3,830</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(3,201</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Net Patient Fee for Revenue</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,865</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,083</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="text-align: center; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">For the Nine Months Ended <BR>March 31,</TD></TR>
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2015</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="width: 60%; text-align: left; padding-left: 0pt; font-size: 11pt">Commercial Insurance/ Managed Care</TD><TD STYLE="width: 6%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 11%; text-align: right; font-size: 11pt">3,438</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 8%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 11%; text-align: right; font-size: 11pt">3,245</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="padding-left: 0pt; font-size: 11pt">Medicare/Medicaid</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">874</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">896</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; font-size: 11pt">Workers' Compensation/Personal Injury</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">15,649</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">11,354</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="padding-bottom: 1pt; font-size: 11pt">Other</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">4,635</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">5,205</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Patient Fee Revenue, net of contractual allowances and discounts</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">24,596</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">20,700</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; font-size: 11pt">Provision for Bad Debts</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(10,608</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(9,244</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; font-size: 11pt">Net Patient Fee for Revenue</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">13,988</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">11,456</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 4 - INVENTORIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Inventories included in the accompanying condensed consolidated balance
sheet consist of the following:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="text-align: center; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">March 31, <BR>2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">June 30, <BR>2015</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="width: 56%; text-align: left; text-indent: -0.25in; padding-left: 0.25in; font-size: 11pt">Purchased parts, components and supplies</TD><TD STYLE="width: 8%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">2,033</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 8%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">2,043</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; font-size: 11pt">Work-in-process</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">201</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">149</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; font-size: 11pt">Total Inventories</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,234</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,192</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 5 &ndash; COSTS AND ESTIMATED EARNINGS
ON UNCOMPLETED CONTRACTS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left">Information relating
to uncompleted contracts is as follows:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">March 31, 2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">June 30, 2015</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="width: 56%; text-align: left; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Costs incurred on uncompleted contracts</TD><TD STYLE="width: 8%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">2,310</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 8%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">1,862</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Estimated earnings</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1,622</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1,371</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Subtotal</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">3,932</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">3,233</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Less: Billings to date</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">3,908</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">2,693</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Total Costs and estimated earnings in excess of billings on uncompleted contracts</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">24</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">540</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left">Included in the accompanying
condensed consolidated balance sheets under the following captions:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">March 31, 2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">June 30, 2015</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="width: 56%; text-align: left; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Costs and estimated earnings in excess of billings on uncompleted contracts</TD><TD STYLE="width: 8%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">279</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 8%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">682</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Less: Billings in excess of costs and estimated earnings on uncompleted contracts</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">255</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">142</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Total Costs and estimated earnings in excess of billings on uncompleted contracts</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">24</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">540</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 6 &ndash; OTHER INTANGIBLE ASSETS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Other intangible assets, net of accumulated
amortization, in the accompanying condensed consolidated balance sheet consist of the following:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; text-align: center; font-size: 11pt">March 31, 2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; text-align: center; font-size: 11pt">June 30, 2015</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="width: 56%; text-align: left; padding-left: 8.85pt; font-size: 11pt">Capitalized software development costs</TD><TD STYLE="width: 8%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">7,005</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 8%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">7,005</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 8.85pt; font-size: 11pt">Patents and copyrights</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">4,612</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">4,547</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="padding-left: 8.85pt; font-size: 11pt">Non-compete</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">4,100</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">4,100</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 8.85pt; font-size: 11pt">Customer relationships</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">3,800</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">3,800</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 8.85pt; font-size: 11pt">Gross Other intangible assets</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">19,517</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">19,452</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 8.85pt; font-size: 11pt">Less: Accumulated amortization</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">11,451</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">10,502</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 8.85pt; font-size: 11pt">Other Intangible Assets</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,066</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,950</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 6 &ndash; OTHER INTANGIBLE ASSETS (Continued)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of patents
and copyrights for the three months ended March 31, 2016 and 2015 amounted to $47 and $46, respectively.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of capitalized
software development costs for the three months ended March 31, 2016 and 2015 amounted to $65 and $81, respectively.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of non-compete
for the three months ended March 31, 2016 and 2015 amounted to $146 and $146, respectively.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of customer
relationships for the three months ended March 31, 2016 and 2015 amounted to $47 and $47, respectively.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of patents
and copyrights for the nine months ended March 31, 2016 and 2015 amounted to $141 and $137, respectively.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of capitalized
software development costs for the nine months ended March 31, 2016 and 2015 amounted to $227 and $246, respectively.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of non-compete
for the nine months ended March 31, 2016 and 2015 amounted to $439 and $439, respectively.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of customer
relationships for the nine months ended March 31, 2016 and 2015 amounted to $142 and $142, respectively.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;NOTE 7 &ndash; OTHER CURRENT LIABILITIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Other current liabilities in the accompanying
condensed consolidated balance sheet consist of the following:&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; font-size: 11pt">
    <TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">March 31, 2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">June 30, 2015</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="width: 56%; text-align: left; text-indent: -8.95pt; padding-left: 8.95pt; font-size: 11pt">Accrued salaries, commissions and payroll taxes</TD><TD STYLE="width: 8%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">903</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 8%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 12%; text-align: right; font-size: 11pt">992</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Accrued interest</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">117</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">117</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Litigation accruals</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">493</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">521</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Sales tax payable</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">2,565</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">2,539</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Legal and other professional fees</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">307</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">344</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Accounting fees</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">193</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">235</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Self-funded health insurance reserve</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">434</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">510</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Interest and penalty - sales tax</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">2,644</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">2,509</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="padding-bottom: 1pt; padding-left: 5.4pt; font-size: 11pt">Other</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">982</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">486</TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: right; padding-bottom: 2.5pt; padding-left: 5.4pt; font-size: 11pt">Total Other Current Liabilities</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,638</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,253</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&nbsp;&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 8 - SEGMENT AND RELATED INFORMATION</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company operates in two industry segments
- manufacturing and the servicing of medical equipment and management of diagnostic imaging centers.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The accounting policies of the segments are
the same as those described in the summary of significant accounting policies as disclosed in the Company&rsquo;s 10-K as of June
30, 2015. All inter-segment sales are market-based. The Company evaluates performance based on income or loss from operations.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Summarized financial information concerning
the Company's reportable segments is shown in the following table:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="padding-bottom: 1pt; padding-left: 5.4pt; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Medical</P> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Equipment</P></TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Management</P> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">of</P> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Diagnostic</P> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Imaging</P> <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Centers</P></TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: center; font-size: 11pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Totals</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 11pt"></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt">For the three months ended March 31, 2016</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="width: 46%; text-align: left; padding-left: 5.4pt; font-size: 11pt">Net revenues from external customers</TD><TD STYLE="width: 5%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 11%; text-align: right; font-size: 11pt">2,454</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 5%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 11%; text-align: right; font-size: 11pt">16,165</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="width: 5%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; font-size: 11pt">$</TD><TD STYLE="width: 11%; text-align: right; font-size: 11pt">18,619</TD><TD STYLE="width: 1%; text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Inter-segment net revenues</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">546</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">546</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">(Loss) income from operations</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">(207</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">4,304</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">4,097</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Depreciation and amortization</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">79</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">751</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">830</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Capital expenditures</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">31</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">117</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">148</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="padding-left: 5.4pt; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt">For the three months ended March 31, 2015</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Net revenues from external customers</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">2,486</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">14,610</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">17,096</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Inter-segment net revenues</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">502</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">502</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">(Loss) income from operations</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">(367</TD><TD STYLE="text-align: left; font-size: 11pt">)</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">3,033</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">2,666</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Depreciation and amortization</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">78</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">811</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">889</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Capital expenditures</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">111</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">111</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="padding-left: 5.4pt; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt">For the nine months ended March 31, 2016</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Net revenues from external customers</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">7,833</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">46,766</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">54,599</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Inter-segment net revenues</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">1,594</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">1,594</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Income from operations</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">18</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">11,919</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">11,937</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Depreciation and amortization</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">242</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">2,265</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">2,507</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Capital expenditures</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">390</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">209</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">599</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="padding-left: 5.4pt; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt">For the nine months ended March 31, 2015</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: right; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Net revenues from external customers</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">9,177</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">42,996</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">52,173</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Inter-segment net revenues</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">1,504</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">1,504</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Income from operations</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">457</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">9,246</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">9,703</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Depreciation and amortization</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">229</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">2,436</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">2,665</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <TD STYLE="text-align: left; padding-left: 5.4pt; font-size: 11pt">Capital expenditures</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">178</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">55</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 11pt">$</TD><TD STYLE="text-align: right; font-size: 11pt">233</TD><TD STYLE="text-align: left; font-size: 11pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 9&ndash; SUPPLEMENTAL CASH FLOW INFORMATION</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During the nine months ended March 31, 2016
and March 31, 2015, the Company paid $280 and $406 for interest, respectively.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During the nine months ended March 31, 2016
and March 31, 2015, the Company paid $235 and $99 for income taxes, respectively.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 10 &ndash; COMMITMENTS AND CONTINGENCIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><U>Litigation</U></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company is subject to legal proceedings
and claims arising from the ordinary course of its business, including personal injury, customer contract and employment claims.
In the opinion of management, the aggregate liability, if any, with respect to such actions, will not have a material adverse effect
on the consolidated financial position or results of operations of the Company.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">There were no material changes in litigation
from that reported in our Form 10-K for the fiscal year ended June 30, 2015 with the exception of the case with Dr. Shapiro. The
case was settled for $258,400 plus interest on February 18. 2016.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><U>Other Matters</U></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company is also delinquent in filing sales
tax returns for certain states, for which the Company has transacted business. As of March 31, 2016, the Company has recorded tax
obligations of approximately $2,565 plus interest and penalties of approximately $2,644. The Company is in the process of determining
the regulatory requirements in order to become compliant.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company maintains a self-funded health insurance
program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims
to $100 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company
considers historical and projected medical utilization data when estimating its health insurance program liability and related
expense. As of March 31, 2016 and June 30, 2015, the Company had approximately $434 and $510, respectively, in reserve for its
self-funded health insurance programs. The reserves are included in &ldquo;Other current liabilities&rdquo; in the condensed consolidated
balance sheets.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company regularly analyzes its reserves
for incurred but not reported claims, and for reported but not paid claims related to its reinsurance and self-funded insurance
programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing these reserves
such as assessing historical paid claims, average lags between the claims&rsquo; incurred date, reported dates and paid dates,
and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded
in the periods covered by this report.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In March 2016, the Company signed a  2nd
amendment with Signature Bank to extend the terms of the revolving loan to September 2018. As of March 31, 2016, the Company
has not been advanced any money under this revolving loan.</P>



<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0">NOTE 11 - INCOME TAXES</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">ASC topic 740 prescribes a recognition threshold
and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken
in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon
examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit
recognized and measured pursuant to the interpretation are referred to as &ldquo;unrecognized benefits&rdquo;. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it
represents an enterprise&rsquo;s potential future obligation to the taxing authority for a tax position that was not recognized
as a result of applying the provisions of ASC topic 740.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In accordance with ASC topic 740, interest costs
related to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &ldquo;Interest expense,
net&rdquo;. Penalties if incurred would be recognized as a component of &ldquo;Selling, general and administrative&rdquo; expenses.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company files corporate income tax returns
in the United States (federal) and in various state and local jurisdictions. In most instances, the Company is no longer subject
to federal, state and local income tax examinations by tax authorities for years prior to 2009.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company recorded a deferred tax asset of
$8,423 and a deferred tax liability of $510 as of March 31, 2016, primarily relating to net operating loss carryforwards of approximately
$122,926 available to offset future taxable income through 2034. The net operating losses begin to expire in 2019 for federal tax
purposes and in 2015 for state income tax purposes.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The ultimate realization of deferred tax assets
is dependent on the generation of future taxable income during the periods in which those temporary differences become deductible.
The Company considers projected future taxable income and tax planning strategies in making this assessment. At present, the Company
does have a sufficient history of income and anticipates profitability in the coming years and has concluded that it is more-likely-than-not
that the Company will be able to realize a portion of its tax benefits in the near future and therefore a valuation allowance was
established for the partial value of the deferred tax asset.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A valuation allowance will be maintained until
sufficient positive evidence exists to support the reversal of the remainder of the valuation. Should the Company continue to remain
profitable in future periods with supportable trends, the valuation allowance will be reversed accordingly.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 12- SUBSEQUENT EVENTS</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On May 2, 2016, the Company repaid the balance
of the Class A Stockholders capital contribution in the amount of $1,125. As a result, the Company&rsquo;s subsidiary, HMCA, owns
a 100% interest in Imperial Management Services.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify">Item 2.&#9;MANAGEMENT&rsquo;S DISCUSSION
AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">For the nine
month period ended March 31, 2016, we reported a net income of $11.5 million on revenues of $54.6 million as compared to net income
of $9.2 million on revenues of $52.2 million for the nine month period ended March 31, 2016. Operating income increased 23.0% from
$9.7 million for the nine month period ended March 31, 2015 to $11.9 million for the six month period ended March 31, 2016.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">For the three
month period ended March 31, 2016, we reported net income of $3.9 million on revenues of $18.6 million as compared to net income
of $2.5 million of revenues of $17.1 million for the three month period ended December 31, 2015.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">The revenue
increase of 4.6%, from $52.2 million for the first nine months of fiscal 2015 to $54.6 million for the first nine months of fiscal
2016, was primarily due to an increase in patient fee revenue (net of contractual allowances and discounts) from $11.5 million
for the first nine months of fiscal 2015 to $14.0 million for the first nine months of fiscal 2016. There were also increases in
net management fees of $1.2 million, from $31.6 million for the first nine months of fiscal 2015 to $32.8 million for the first
nine months of fiscal 2016.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Offsetting
these increases, however, net product sales decreased by 56.8% to $780,000 for the first nine months of fiscal 2016 from $1.8 million
for the first nine months of fiscal 2015. Service and repair fees also decreased by 4.3% to $7.1 million for the first nine months
of fiscal 2016 from $7.4 million for the first nine months of fiscal 2015.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">The increase
in the amount of our revenues was higher than the increase in the amount of our costs and expenses, and as a result, our operating
income of $11.9 million for the nine months ended March 31, 2016 was higher than our operating income of $9.7 million for the nine
months ended March 31, 2015. In terms of percentages, costs and expenses increased 0.5% from $42.5 million in the first nine months
of fiscal 2015 to $42.7 million in the first nine months of fiscal 2016, while revenues increased 4.6%, from $52.2 million in the
first nine months of fiscal 2015 to $54.6 million in the first nine months of fiscal 2016.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Fonar&rsquo;s
wholly-owned subsidiary, Health Management Corporation of America (&ldquo;HMCA&rdquo;), is the controlling, but not sole owner
of two limited liability companies, Imperial Management Services, LLC (&ldquo;Imperial&rdquo;) and Health Diagnostics Management,
LLC (&ldquo;HDM&rdquo;). Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic
imaging centers segment of the business. The reorganization was structured to more completely integrate the operations of HMCA
and HDM. Imperial Management Services LLC contributed all of its assets (which had been utilized in the business of HMCA) to HDM
and received a 24.2% interest in HDM. HMCA retained a direct ownership interest of 45.8% in HDM, and the original investors in
HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of the diagnostic imaging centers business
segment is now being conducted by HDM, operating under the name &ldquo;Health Management Company of America&rdquo;. For the sake
of simplicity, HMCA, Imperial and HDM are referred to as &ldquo;HMCA&rdquo;, unless otherwise indicated.</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin-top: 0; text-align: center; margin-bottom: 10pt">&nbsp;FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify">Forward Looking Statements</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Certain statements
made in this Quarterly Report on Form 10-Q are &quot;forward-looking statements&quot; (within the meaning of the Private Securities
Litigation Reform Act of 1995) regarding the plans and objectives of Management for future operations. Such statements involve
known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially
different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking
statements included herein are based on current expectations that involve numerous risks and uncertainties. Our plans and objectives
are based, in part, on assumptions involving the expansion of business. Assumptions relating to the foregoing involve judgments
with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which
are difficult or impossible to predict accurately and many of which are beyond our control. Although we believe that our assumptions
underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can
be no assurance that the forward-looking statements included in this Report will prove to be accurate. In light of the significant
uncertainties inherent in the forward-looking statement included herein, the inclusion of such information should not be regarded
as a representation by us or any other person that our objectives and plans will be achieved.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Results of
Operations</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">We operate
in two industry segments: the manufacture and servicing of medical (MRI) equipment, our traditional business, which is conducted
directly by Fonar, and diagnostic facilities management services, which is conducted through HMCA and its subsidiaries.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Manufacturing
and Service of MRI Equipment</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Revenues from
MRI product sales decreased 56.8% to $780,000 for the first nine months of fiscal 2016 from $1.8 million for the first nine months
of fiscal 2015. Costs related to product sales also decreased, by 43.9%, from $1.7 million for the nine month period ended March
31, 2015 to $939,000 for the nine month period ended March 31, 2016. The decrease in sales revenues, when expressed as a percentage,
reflects the volatility resulting from low sales volume. During the first nine months of fiscal 2015 we sold two scanners; during
the first nine months of fiscal 2016 we sold one scanner. Continuing tight credit and economic uncertainty, together with lower
reimbursement rates for MRI scans, have depressed the market for our MRI scanner products.</P>

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in">Service revenues
decreased 4.3% from $7.4 million for the nine month period ended March 31, 2015 to $7.1 million for the nine month period ended
March 31, 2016. However, service revenues increased 4.6% from $2.3 million for the three month period ended March 31, 2015 to $2.4
million for the three month period ended March 31, 2016. Continuing lower sales volumes have been a factor ultimately contributing
to decreasing service revenues, as the number of older scanners being taken out of service has been greater than the number of
new scanners being placed under service agreements following the expiration of their warranties.<BR CLEAR="ALL">
</P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 10pt; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Costs relating
to providing service for the first nine months of fiscal 2016 decreased by 4.2% from $1.63 million in the first nine months of
fiscal 2015 to $1.56 million in the first nine months of fiscal 2016. Costs relating to providing service for the three month period
ended March 31, 2016 also decreased, by 12.4% to $558,000 from $637,000 for the three month period ending March 31, 2015. We believe
that an important factor in controlling our service costs is our ability to monitor the performance of customers&rsquo; scanners
from our facilities in Melville, New York on a daily basis, and to detect and repair any irregularities before more serious problems
result.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">There were
approximately $440,000 in foreign revenues for the first nine months of fiscal 2016 as compared to approximately $1.9 million in
foreign revenues for the first nine months of fiscal 2015, representing a decrease in foreign revenues of 76.8%. We do not regard
this as a material trend, but as part of a normal although sometimes volatile variation resulting from low volumes of foreign sales.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">We recognize
MRI scanner sales revenues on the &ldquo;percentage of completion&rdquo; basis, which means the revenues are recognized as the
scanner is manufactured. Revenues recognized in a particular quarter do not necessarily reflect new orders or progress payments
made by customers in that quarter. We build the scanner as the customer meets certain benchmarks in its site preparation in order
to minimize the time lag between incurring costs of manufacturing and our receipt of the cash progress payments from the customer
which are due upon delivery. Consequently, there can be a disparity between the revenues recognized in a fiscal period and the
number of product sales. Generally, the revenues from a scanner sale are recognized in a fiscal quarter or quarters following the
quarter in which the sale was made.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Revenues for
the medical equipment segment as a whole decreased by 14.6% to $7.8 million for the first nine months of fiscal 2016 from $9.2
million for the first nine months of fiscal 2015. Operating results for our medical equipment segment decreased to an operating
income of $18,000 for the first nine months of fiscal 2016 as compared to an operating income of $457,000 for the first nine months
of fiscal 2015. For the first nine months of fiscal 2016, our medical equipment segment recognized a net loss of $226,000, compared
to a net income of $377,000 in the same period of fiscal 2015.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Diagnostic
Facilities Management Services</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">HMCA revenues
increased in the first nine months of fiscal 2016 by 8.8% to $46.8 million from $43.0 million for the first nine months of fiscal
2015. The percentage of our revenues derived from our diagnostic facilities management segment relative to the percentage of our
revenues derived from our medical equipment segment increased to 85.7% for the first nine months of fiscal 2016, from 82.5% for
the first nine months of fiscal 2015).</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">The increase
in HMCA revenues is principally due to HMCA&rsquo;s success in marketing the scanning services of the facilities managed or owned
by HMCA, notwithstanding the decrease in reimbursement rates paid for MRI scans by insurers, Medicare and other government programs.
The reductions in reimbursement rates are not unique to HMCA or HMCA&rsquo;s clients but are being experienced by the industry
in general.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">HMCA&rsquo;s
efforts are countering the effects of lower reimbursement rates by increasing the scan volume of the facilities it owns or manages.</P>

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in">As a result
of our vigorous marketing efforts, the number of scans performed at our centers and at our client&rsquo;s centers increased from
106,259 in the first nine months of fiscal 2015 to 116,226 in the first nine months of fiscal 2016.<BR CLEAR="ALL">
</P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 10pt; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">We manage twenty-five
sites, twenty-four of which are equipped with Fonar Upright&reg; MRI scanners (our Upright&reg; MRI Scanners are also called Stand-Up&reg;
MRI Scanners). HMCA experienced an operating income of $11.9 million for the first nine months of fiscal 2016 compared to operating
income of $9.2 million for the first nine months of fiscal 2015.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">HMCA&rsquo;s
cost of revenues for the first nine months of fiscal 2016 as compared to the first nine months of fiscal 2015 increased by 5.5%
from $25.4 million to $26.8 million.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Consolidated</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">For the first
nine months of fiscal 2016, our consolidated net revenues increased by 4.6% to $54.6 million from $52.2 million for the first nine
months of fiscal 2015, and total costs and expenses increased by 0.5% to $42.7 million for the first nine months of fiscal 2016
from $42.5 million for the first nine months of fiscal 2015. As a result, our operating income increased 23.0% to $11.9 million
in the first six months of fiscal 2016 from $9.7 million in the first nine months of fiscal 2015.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Selling, general
and administrative expenses increased by 11.9% to $12.4 million in the first nine months of fiscal 2016 from $11.1 million in the
first nine months of fiscal 2015. The compensatory element of stock issuances, which is included in selling, general and administrative
expenses, decreased, by 100%, to $0 for the first nine months of fiscal 2016 from $53,200 for the first nine months of fiscal 2015.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Research and
development expenses increased by 11.4% to $1.2 million for the first nine months of fiscal 2016 from $1.1 million for the first
nine months of fiscal 2015.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Interest expense
in the first nine months of fiscal 2016 decreased by 23.7% to $416,000 from $545,000 in the first nine months of fiscal 2015. The
decrease was due to the repayment of debt incurred by Fonar in connection with the acquisition of HDM.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Inventories
remained constant at $2.2 million at March 31, 2016 and June 30, 2015. This represents our purchase of raw materials and components
in our business operations.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Net Management
fee and medical receivables increased by 12.8% to $30.1 million at March 31, 2016 from $26.6 million at June 30, 2015 as a result
of slower collections. The slower collections were primarily due to an increase in no-fault and workers&rsquo; compensation revenue,
which typically takes longer to collect.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">The results
of operations for the first nine months of fiscal 2016 reflect an increase in revenues from management, patient and other fees,
as compared to the first nine months of fiscal 2015 ($46.8 million for the first nine months of fiscal 2016 as compared to $43.0
million for the first nine months of fiscal 2015), and an decrease in MRI equipment segment revenues ($7.8 million as compared
to $9.2 million). Revenues were 14.3% from the MRI equipment segment as compared to 85.7% from HMCA, for the first nine months
of fiscal 2016, as compared to 17.6% from the MRI equipment segment and 82.4% from HMCA for the first nine months of fiscal 2015.</P>

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in">The implementation
of the Patient Protection and Affordable Care Act (PPACA) is having a profound impact on the healthcare industry. We are experiencing
some of the impact of the Act on our business in the reduction of reimbursement rates and fewer sales of our MRI equipment, but
are unable to predict the ultimate effect of the legislative mandates and regulations on our MRI equipment segment or HMCA segment
in the future.<BR CLEAR="ALL">
</P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 10pt; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">We are committed
to improving our operating results and dealing with the challenges posed by legislative and regulatory requirements. Nevertheless,
factors beyond our control, such as the timing and rate of market growth, economic conditions, the availability of credit and payor
reimbursement rates, or unexpected expenditures and the timing of such expenditures, make it difficult to forecast future operating
results.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">As mentioned,
one of the effects of the PPACA on our business has been the reduction in Medicare reimbursement rates for MRI scans. This also
has resulted in a reduction in the reimbursement rates by commercial insurers and government programs which tie their reimbursement
rates to the Medicare rates. Nevertheless, the increased patient volume of the scanning centers we manage or own has enabled us
to maintain a healthy profitability in spite of these challenges. We believe we are pursuing the correct policies to cope with
these problems and to improve the Company&rsquo;s operating results. However, our future revenues and results of operations may
be adversely impacted by future reductions in reimbursement rates.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Our Upright&reg;
MRI (also referred to as the Stand-Up&reg; MRI), together with our works-in-progress, are intended to significantly improve our
competitive position.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">The Upright&reg;
MRI scanner, which operates at 6000 gauss (.6 Tesla) field strength, allows patients to be scanned while standing, sitting, reclining
and in multiple flexion and extension positions. It is common in visualizing the spine that abnormalities are visualized in some
positions and not others. This enables surgical corrections that heretofore would be unaddressable for lack of visualizing the
symptom causing the pathology and therefore, in general enables the treating physician to achieve a better treatment outcome for
his patient. A floor-recessed elevator brings the patient to the height appropriate for the targeted image region. A custom-built
multi-position adjustable bed will allow patients to sit or lie on their backs, sides or stomachs at any angle. This allows the
MRI technologist to ask the patient to position himself/herself in the exact position that generates his/her pain so that images
of the patient in the position that explicitly generates the patient&rsquo;s pain can be nailed down. Full-range-of-motion studies
of the joints in virtually any direction are possible, a particularly promising feature for sports injuries.</P>

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in">In addition
FONAR has announced the publication of a new book &ldquo;THE CRANIOCERVICAL SYNDROME and MRI&rdquo; that highlights the unique
attributes of FONAR UPRIGHT&reg; MRI Imaging (S. Karger, A.G. based in Basel, Switzerland- www.karger.com/Book/Home/261956) which
has been published by S. Karger, a 125 year old company and an academic publisher of scientific and medical journals and books.
The seven chapter monograph examines the rapid advances in MRI made possible by the FONAR UPRIGHT&reg; Multi-Position MRI that
are transforming the treatment of patients suffering from the craniocervical syndrome (CCS). It is written by leading international
experts in the field to practitioners with a better understanding of the subtle anatomy and MRI appearances at the craniocervical
junction, along with insight into the clinical significance of cerebrospinal fluid (CSF) flow measurements and its potential role
in generating the devastating impairments of the neurodegenerative diseases: Alzheimer&rsquo;s (5.1 million patients in the United
States), childhood and adult Autism (3.0 million), Parkinson&rsquo;s (1.0 million), Multiple Sclerosis (250,000-350,000) and Amyotrophic
Lateral Sclerosis (ALS) (30,000). It calls attention to the revolutionary importance of FONAR&rsquo;s new UPRIGHT&reg; MRI imaging
technology and the prospect of significantly relieving the suffering of the above totaled 9.38 million patients afflicted with
these disorders.<BR CLEAR="ALL">
</P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 10pt; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Fonar also
announced a major diagnostic breakthrough in multiple sclerosis achieved with advanced Upright&reg; MRI. Medical researchers at
FONAR published a paper reporting a diagnostic breakthrough in multiple sclerosis (MS), based on observations made possible by
the Company&rsquo;s unique Upright&reg; Multi-Position&trade; MRI scanner. The findings reveal that the cause of multiple sclerosis
may be biomechanical and related to earlier trauma to the neck, which can result in obstruction of the flow of cerebrospinal fluid
(CSF), which is produced and stored in the central anatomic structures of the brain known as the ventricles. Since the ventricles
produce a large net volume of CSF each day (500 cc), the obstruction can result in a build up of pressure within the ventricles,
resulting in leakage of the CSF and the antigenic polypeptides it contains into the surrounding brain tissue. This leakage could
be responsible for generating the brain lesions of multiple sclerosis.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">The paper,
titled &ldquo;The Possible Role of Cranio-Cervical Trauma and Abnormal CSF Hydrodynamics in the Genesis of Multiple Sclerosis,&quot;
appears in the the Journal of Physiological Chemistry and Physics and Medical NMR (Sept. 20, 2011).</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">This capability
of the Fonar Upright&reg; technology has demonstrated its key value on patients with the Arnold-Chiari syndrome [Cerebellar Tonsil
Extopia (CTE)], which is believed to affect 200,000 to 500,000 Americans. In this syndrome, brain stem compression and subsequent
severe neurological symptoms occur in these patients, because the brain stem descends and is compressed at the base of the skull
in the foramen magnum, which is the circular bony opening at the base of the skull where the spinal cord exits the skull. Conventional
lie-down MRI scanners cannot make an adequate evaluation of this pathology since the patient's pathology is most visible and the
symptoms most acute when the patient is scanned in the upright fully weight-bearing position.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">A combined
study of 1,200 neck pain patients published in &ldquo;Brain Injury&rdquo; (July 2010) by eight university medical centers reported
that cerebellar tonsil ectopia (CTE) of 1mm or greater was found and visualized 2.5 times (250%) more frequently when patients
who had sustained automobile whiplash injuries were scanned upright rather than lying down.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">The Upright&reg;
MRI has also demonstrated its value for patients suffering from scoliosis. Scoliosis patients have been typically subjected to
routine x-ray exams for years and must be imaged upright for an adequate evaluation of their scoliosis. Because the patient must
be standing for a complete evaluation of the extent of the patient&rsquo;s scoliosis, an x-ray machine has been the only modality
that could provide that service. The Upright&reg; MRI is the only MRI scanner which allows the patient to stand during the MRI
exam. Fonar has developed an RF receiver and scanning protocol that for the first time allows scoliosis patients to obtain diagnostic
pictures of their spines without the risks of x-rays. A study by the National Cancer Institute (2000) of 5,466 women with scoliosis
reported a 70% increase in breast cancer resulting from 24.7 chest x-rays these patients received on the average in the course
of their scoliosis treatment. The Upright&reg; MRI examination of scoliosis enables the needed imaging evaluation of the degree
of spine scoliosis without exposing the patient to the risk of breast cancer from x-radiation. Currently scoliosis affects more
than 3,000,000 American women.</P>

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in">In addition,
the University of California, Los Angeles (UCLA) reported their results of their study of 1,302 patients utilizing the Fonar Upright&reg;
MRI at the 22nd Annual Meeting of the North American Spine Society on October 23, 2007. The UCLA study showed the superior ability
of the Fonar Upright&reg; MRI to detect spine pathology, including spondylolisthesis, disc herniations and disc degeneration, as
compared to visualizations of the spine produced by traditional single position static MRIs.<BR CLEAR="ALL">
</P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 10pt; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">The UCLA study
by MRI of 1,302 back pain patients when they were in the Fonar Upright&reg; MRI and examined in a full range of flexion and extension
positions made possible by Fonar&rsquo;s new Upright&reg; technology established that significant &ldquo;misses&rdquo; of pathology
were occurring with static single position MRI imaging. At L4-5, the vertebral level responsible for 49.8% of lumbar disc herniations,
35.1% of the spondylolistheses (vertebral instabilities) visualized by the Upright&reg; MRI, were being missed by static single
position MRI (510 patients). Since this vertebral segment is responsible for the majority of all disc herniations, the finding
may reveal a significant cause of failed back surgeries. The UCLA study further showed the &ldquo;miss-rate&rdquo; of vertebral
instabilities by static only MRI was even higher, 38.7%, at the L3-4 vertebral segment. Additionally, the UCLA study showed that
MRI examinations of the cervical spine that did not perform extension images of the neck &ldquo;missed&rdquo; disc bulges 23.75%
of the time (163 patients).</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">The UCLA study
further reported that they were able to quantitatively measure the dimensions of the central spinal canal with the &ldquo;highest
accuracy&rdquo; using the FONAR Upright&reg; MRI thereby enabling the extent of spinal canal stenosis that existed in patients
to be measured. Spinal canal stenosis gives rise to the symptom complex intermittent neurogenic claudication manifest as debilitating
pain in the back and lower extremities, weakness and difficulties in ambulation and leg paresthesias. Spinal canal stenosis is
a spinal compression syndrome separate and distinct from the more common nerve compression syndrome of the spinal nerves as they
exit the vertebral column through the bony neural foramen.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Fonar
Upright&reg; MRI can also be useful for MRI directed emergency neuro-surgical procedures as the surgeon would have unhindered access
to the patient&rsquo;s head when the patient is supine with no restrictions in the vertical direction. This easy-entry, mid-field-strength
scanner could prove ideal for trauma centers where a quick MRI-screening within the first critical hour of treatment will greatly
improve patients&rsquo; chances for survival and optimize the extent of recovery.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Liquidity and
Capital Resources</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Cash and cash
equivalents increased by 39.1% from $9.4 million at June 30, 2015 to $13.1 million at March 31, 2016, primarily as a result of
the increased profitability of HMCA.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Cash provided
by operating activities for the first nine months of fiscal 2016 was $10.3 million. Cash provided by operating activities was attributable
principally to net income of $11.5 million, an increase in other current liabilities of $576,000, and depreciation and amortization
of $2.5 million, offset by an increase in accounts, management fees and medical receivables of $3.7 million.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Cash used in
investing activities for the first nine months of fiscal 2016 was $599,000. The principal uses of cash used in investing activities
during the first nine months of fiscal 2016 consisted of patent costs of $65,000 and the purchase of property and equipment of
$534,000.</P>

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in">Cash used in
financing activities for the first nine months of fiscal 2016 was $6.0 million. The principal uses of cash in financing activities
during the first six months of fiscal 2016 were the repayment of principal on long-term debt and capital lease obligations of $1.9
million and distributions to non-controlling interests of $4.1 million.<BR CLEAR="ALL">
</P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 10pt; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Total liabilities
decreased by 7.0% to $23.9 million at March 31, 2016 from $25.7 million at June 30, 2015. &ldquo;Other&rdquo; current liabilities
increased by 4.7% to $8.6 million at March 31, 2016 from $8.3 million at June 30, 2015, offset by a decrease in long-term debt
and capital lease obligations from $5.7 million to $3.9 million. The current portion of our unearned revenue on service contracts
increased from $4.2 million to $4.4 million. Customer deposits decreased from $1.9 million at June 30, 2015 to $1.5 million at
March 31, 2016 as a result of reduced sales.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">As of March
31, 2016, the total of $8.8 million in &ldquo;other&rdquo; current liabilities included accrued salaries and payroll taxes of $903,000,
and sales taxes of $2.6 million plus accrued interest and penalties of $2.6 million.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Our working
capital increased to $32.3 million at March 31, 2016 from $24.8 million at June 30, 2015. This resulted from an increase in current
assets ($43.6 million at June 30, 2015 as compared to $50.9 million at March 31, 2016), and a smaller decrease in current liabilities
from $18.8 million at June 30, 2015 to $18.6 million at March 31, 2016.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">The ultimate
realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those temporary
differences become deductible. The Company considers projected future taxable income and tax planning strategies in making this
assessment. A valuation allowance will be maintained until sufficient positive evidence exists to support the reversal of any portion
or all of the valuation allowance. Should the Company continue to remain profitable in the future periods with supportable trends,
the valuation allowance will be reversed accordingly.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Fonar has not
committed to making any significant capital expenditures for the remainder of the 2016 fiscal year.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Critical to
our business plan are the improvement and expansion of the MRI facilities managed or owned by HMCA, and increasing the number of
scans performed at those facilities. In addition, our business plan calls for a continuing commitment to providing our customers
with enhanced equipment service and maintenance capabilities and delivering state-of-the-art, innovative and high quality equipment
and upgrades at competitive prices.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">In furtherance
of our business plan, HMCA began managing a twenty-fifth MRI scanning facility located in Great Neck, New York, in the last week
of December, 2015.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Management
is seeking to promote wider market recognition of Fonar&rsquo;s scanner products, and to increase demand for Upright&reg; scanning
at the facilities HMCA owns or manages. Given the liquidity and credit constraints in the markets, and the uncertainty resulting
for the Patient Protection and Affordable Care Act, the sale of medical equipment has and may continue to suffer.</P>

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in">The Company
believes that its business plan has been responsible for the past four consecutive fiscal years and past three fiscal quarters
of profitability (fiscal 2012, fiscal 2013, fiscal 2014, fiscal 2015 and the first nine months of fiscal 2016) and that its capital
resources will be adequate to support operations at current levels through at least March 31, 2017. In the past, the Company experienced
periods of working capital deficits and prior to fiscal 2011, losses. The future effects on our business of healthcare reform legislation,
the Deficit Reduction Act, the 2.3% excise tax on sales of medical equipment, reimbursement rates and the general economic and
business climate are not known at the present time. Nevertheless, there is a possibility of adverse consequences to our business
operations from these causes.<BR CLEAR="ALL">
</P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 10pt; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify">Item 3. Quantitative and Qualitative
Disclosures About Market Risk</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">The Company
maintains its funds in liquid accounts. None of our investments are in fixed rate instruments.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">All of our
revenue, expense and capital purchasing activities are transacted in United States dollars.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify">Item 4. Controls and Procedures</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">Evaluation
of Disclosure Controls and Procedures</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">The Company
maintains &ldquo;disclosure controls and procedures,&rdquo; as such term is defined under Rule 13a-15(e) of the Exchange Act, that
are designed to provide reasonable assurance that information required to be disclosed in the Company&rsquo;s Exchange Act reports
is recorded, processed, summarized and reported within the time periods specified in the SEC&rsquo;s rules and forms, and that
such information is accumulated and communicated to the Company&rsquo;s management, including its Principal Executive Officer and
Acting Principal Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating
the disclosure controls and procedures, management recognized that any control and procedures, no matter how well designed and
operated, can provide only reasonable assurance of achieving the desired control objective.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">As required
by SEC Rule 13a-15(b), the Company carried out an evaluation, under the supervision and with the participation of the Company&rsquo;s
management, including the Company&rsquo;s Principal Executive Officer and Acting Principal Financial Officer, of the effectiveness
of the design and operation of the Company&rsquo;s disclosure controls and procedures as of March 31, 2016. Based on this evaluation,
the Company&rsquo;s Principal Executive Officer and Acting Principal Financial Officer concluded that the Company&rsquo;s disclosure
controls and procedures were not effective as of March 31, 2016 because of the material weakness in our internal control over financial
reporting described in our Annual Report on Form 10-K. The Company&rsquo;s plan is to implement changes in information technology
general controls in order to improve controls over segregation of duties, restricted access to programs and data, and to change
management activities in order to address the previously reported internal control deficiencies in our Form 10-K. The Company is
engaging the services of independent consultants to assist in addressing and reviewing its internal controls, including information
technology general controls.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">Changes in Internal Control Over
Financial Reporting</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">There have
been no changes in the Company&rsquo;s internal control over financial reporting, during the fiscal quarter ended March 31, 2016,
that have materially affected, or are reasonably likely to materially affect, the Company&rsquo;s internal control over financial
reporting.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">PART II &ndash; OTHER INFORMATION</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify">Item 1 &ndash; Legal Proceedings:&#9;There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2015 and our Form
10-Q for the six months ended December 31, 2015.</P>

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">Item 1A &ndash; Risk Factors: An investment in the securities
of the Company is subject to various risks, the most significant of which are summarized below.<BR CLEAR="ALL">
</P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin-top: 0; text-align: center; margin-bottom: 10pt">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt 0.25in; text-align: justify">1. Reduced Reimbursement
Rates. Most of our revenues are derived from our scanning center business conducted by HMCA. Our scanning center clients and the
Florida facilities owned by HMCA are experiencing lower reimbursement rates from Medicare, other government programs and private
insurance companies. To date, the impact of these reductions has been countered by increasing scanning volume, thereby maintaining
profitability in this business segment. There is, however, no assurance that we will be able to continue to do so.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt 0.25in; text-align: justify">2. Demand for MRI Scanners.
The reduced reimbursement rates also affects our sales of MRI scanners negatively. With lower revenue projections, fewer prospective
customers will be able to operate and demand lower prices for scanners. Although the reduced reimbursements may not affect foreign
demand, a lower number of sales in the aggregate could reduce economies of scale and consequently, profit margins.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt 0.25in; text-align: justify">3. Manufacturing Competition.
Many if not most of our competing scanner manufacturers have significantly greater financial resources, production capacity, and
other resources than we do. Such competitors would include General Electric, Siemens, Hitachi and Phillips. Although Fonar is the
only company which can manufacture and sell the unique Stand-Up&reg; (Upright&reg;) MRI scanner, potential customers must be convinced
that the purchase of a Fonar scanner is their best choice. We believe that with time, that objective will be reached, particularly
with customers scanning patients having neck, back, knee and various orthopedic issues who would benefit from being scanned in
weight-bearing positions.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt 0.25in; text-align: justify">4. Dependence on Referrals.
HMCA derives substantially all of its revenue, directly or indirectly, from fees charged for the diagnostic imaging services performed
at the facilities. We depend on referrals of patients from unaffiliated physicians and other third parties to the facilities we
manage or own for the MRI scanning services performed. If these physicians and other third parties were to reduce the number of
patients they refer or discontinue referring patients, scan volumes could decrease, which would have the effect of reducing our
net revenue, from both management and scanning fees, and operating margins.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt 0.25in; text-align: justify">5. Pressure to Control
Healthcare Costs. One of the principal objectives of health maintenance organizations and preferred provider organizations is to
control the cost of healthcare services. Healthcare providers participating in managed care plans may be required to refer diagnostic
imaging tests to certain providers depending on the plan in which a covered patient is enrolled. In addition, managed care contracting
has become very competitive. The expansion of health maintenance organizations, preferred provider organizations and other managed
care organizations within New York or Florida could have a negative impact on the utilization and pricing of services performed
at the facilities HMCA manages or owns to the extent these organizations exert control over patients&rsquo; access to diagnostic
imaging services, selections of the provider of such services and reimbursement rates for those services.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt 0.25in; text-align: justify">6. Scanning Facility Competition.
The market for diagnostic imaging services is highly competitive. The facilities we manage or own compete for patients on the basis
of reputation, location and the quality of diagnostic imaging services. Groups of radiologists, established hospitals, clinics
and other independent organizations that own and operate imaging equipment are the principal competitors.<BR CLEAR="ALL">
</P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 10pt; text-align: center">FONAR CORPORATION AND
SUBSIDIARIES</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt 0.25in; text-align: justify">7. Changes to Insurance
Programs. Changes in the eligibility requirements for governmental programs such as the Medicaid program and state decisions on
whether to participate in the expansion of such programs could increase the number of patients who participate in such programs.
A shift in payor mix from managed care and other private payors to government payors could result in a reduction in the rates of
reimbursement with a corresponding decrease in our clients&rsquo; and HMCA&rsquo;s revenues. Even for patients in private insurance
plans, changes to their plans could increase patient financial responsibility, resulting in a greater risk of uncollectible receivables
for the scanning centers we manage or own. These factors could have a material adverse effect on our business.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt 0.25in; text-align: justify">8. Proposed Reduction of
New York Workers&rsquo; Compensation Benefits. A proposal was published by the New York State Workers&rsquo; Compensation Board
(&ldquo;NYSWCB&rdquo;) to change the fee schedule for Workers&rsquo; Compensation payments which would have reduced fees for the
most commonly billed radiology procedures. These reductions threatened to have a material adverse impact on the business of the
scanning centers we manage or own. After receiving many negative comments, the NYSWCB withdrew the proposal. We are presently waiting
for a new proposal to be published, but we do not have an indication as to when the NYSWCB may do so, or what such a proposal may
be.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt 0.25in; text-align: justify">9. Federal and state privacy
and information security laws. We must comply with numerous federal and state laws and regulations governing the collection, dissemination,
access, use, security and privacy of PHI, including HIPAA and its implementing privacy and security regulations, as amended by
the federal HITECH Act and collectively referred to as HIPAA. If we fail to comply with applicable privacy and security laws, regulations
and standards, properly maintain the integrity of our data, protect our proprietary rights to our systems, or defend against cybersecurity
attacks, our business, reputation, results of operations, financial position and cash flows could be materially and adversely affected.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt 0.25in; text-align: justify">Information security risks
have significantly increased in recent years in part because of the proliferation of new technologies, the use of the internet
and telecommunications technologies to conduct our operations, and the increased sophistication and activities of organized crime,
hackers, terrorists and other external parties, including foreign state agents. Our operations rely on the secure processing, transmission
and storage of confidential, proprietary and other information in our computer systems and networks.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt 0.25in; text-align: justify">10. Changes in Domestic
and Worldwide Economic Conditions. We are subject to risk arising from adverse changes in general domestic and global economic
conditions, including recession or economic slowdown and disruption of credit markets. Turbulence and uncertainty in the United
States and international markets and economies may adversely affect our liquidity, financial condition, revenues, profitability
and business operations generally.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt 0.5in; text-align: justify; text-indent: -0.5in">Item
2 &ndash; Unregistered Sales of Equity Securities and Use of Proceeds: The Company has not issued any unregistered shares of its
Common Stock during the first nine months of fiscal 2016.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify">Item 3 - Defaults Upon Senior
Securities: None</P>

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">Item 4 - Mine Safety Disclosure: Not Applicable<BR CLEAR="ALL">
</P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin-top: 0; text-align: center; margin-bottom: 10pt">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify">Item 5 - Other Information: &#9;None</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify">Item 6 - Exhibits and Reports
on Form 8-K:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">a)</TD><TD STYLE="text-align: justify">Exhibit 31.1 Certification. See Exhibits</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">b)</TD><TD STYLE="text-align: justify">Exhibit 32.1 Certification. See Exhibits</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">c)</TD><TD STYLE="text-align: justify">Report on Form 8-K filed on January 14, 2016, Item 2.02: Results of Operations and Financial Condition
for the fiscal quarter ended December 31, 2015.</TD></TR></TABLE>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: center">SIGNATURES</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in">Pursuant to
the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 3.5in">FONAR CORPORATION</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 3.5in">(Registrant)</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 3.5in">By: /s/ Timothy
Damadian</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 3.5in">Timothy Damadian</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 3.5in">President
and Principal Executive Officer</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 3.5in">&nbsp;</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 3.5in">/s/ Raymond
V. Damadian</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify; text-indent: 3.5in">Raymond V.
Damadian</P>

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt 3.75in; text-align: justify; text-indent: -0.25in">Chairman
of the Board, Treasurer and Acting Principal Financial Officer</P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">&nbsp;</P>



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>



<P STYLE="margin: 0; font-size: 11pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>2
<FILENAME>fonar_exhibit-31.htm
<DESCRIPTION>FONAR CORPORATION EXHIBIT 31 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify">Dated: May 10, 2016</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Exhibit 31.1</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center">CERTIFICATION</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Timothy Damadian, and Raymond V. Damadian each
certify that:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify">1.&#9;I have reviewed this report on Form
10-Q of Fonar Corporation;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify">2.&#9;Based on my knowledge, this report
does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,
in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
report;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify">3.&#9;Based on my knowledge, the financial
statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify">4.&#9;I am responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15(e)) and internal control
over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f) for the registrant and have:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.5in; text-align: justify">a)&#9;designed such disclosure controls
and procedures or caused such disclosure controls over procedures to be designed under my supervision to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.5in; text-align: justify">b)&#9;designed such internal control
over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.5in; text-align: justify">c)&#9;evaluated the effectiveness
of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions about the effectiveness
of the disclosure controls and procedures as of the end of the period covered by this report; and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.5in; text-align: justify">d)&#9;disclosed in this report any
change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent
fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or
is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify">5.&#9;I have disclosed, based on my most
recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the
registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.5in; text-align: justify">(a)&#9;all significant deficiencies
and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 0.5in; text-align: justify">(b)&#9;Any fraud, whether or not
material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over
financial reporting.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 2in; text-align: justify">Date: May10, 2016</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 2in; text-align: justify">/s/ Timothy Damadian</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 2in; text-align: justify">Timothy Damadian</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 2in; text-align: justify">President and Principal Executive Officer</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 2in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 2in; text-align: justify">/s/ Raymond V. Damadian</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 2in; text-align: justify">Raymond V. Damadian</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 2in; text-align: justify">Chairman of the Board, Treasurer and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 2in; text-align: justify">Acting Principal Financial Officer</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>3
<FILENAME>fonar_exhibit-32.htm
<DESCRIPTION>FONAR CORPORATION EXHIBIT 32 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Exhibit 32.1</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">CERTIFICATION PURSUANT TO</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">18 U.S.C. SECTION 1350,</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">AS ADOPTED PURSUANT TO</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">In connection with the Quarterly
Report of FONAR Corporation and Subsidiaries (the &ldquo;Company&rdquo;) on Form 10Q for the fiscal quarter ended March 31, 2016,
as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Timothy Damadian, President
and Chief Executive Officer, and I, Raymond V. Damadian, Chairman of the Board, Treasurer and Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Report fully complies
with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">The information contained
in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">/s/Timothy Damadian</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">----------------------------------</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Timothy Damadian</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">President and Chief Executive
Officer</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">/s/ Raymond V. Damadian</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">-----------------------------------</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Raymond V. Damadian</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Chairman of the Board, Treasurer
and</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Chief Financial Officer</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">May 10, 2016</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">A signed original of this
written statement required by Section 906 has been provided to Fonar Corporation and will be retained by Fonar Corporation and
furnished to the Securities and Exchange Commission or its staff upon request.</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>4
<FILENAME>fonr-20160331.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: XFR%2DMayQ%2Dfinal.xfr; Date: 2016%2D05%2D10T19:03:03Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:FONR="http://fonar.com/20160331">
    <link:schemaRef xlink:href="fonr-20160331.xsd" xlink:type="simple" />
    <xbrli:context id="AsOf2016-04-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-04-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-04-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-04-30_custom_PreferredStockClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:PreferredStockClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-03-31_custom_PreferredStockClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:PreferredStockClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_PreferredStockClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:PreferredStockClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-03-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_AllowanceForDoubtfulAccountsCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AllowanceForDoubtfulAccountsCurrentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-03-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-03-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-03-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-03-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-03-31_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-03-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-03-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_PreferredStockClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:PreferredStockClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-03-31_custom_PreferredStockClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:PreferredStockClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-03-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31_us-gaap_AllowanceForDoubtfulAccountsCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AllowanceForDoubtfulAccountsCurrentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-03-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-03-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-03-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-03-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-03-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-03-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-03-31_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">13147000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">9449000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">2234000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">2192000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">834000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">860000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">50907000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">43621000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">11877000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">12901000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssets contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">972000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">830000</us-gaap:OtherAssets>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">2455000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">2490000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">1345000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">1783000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">8638000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">8253000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">4350000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">4187000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:CustomerAdvancesCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">1511000</us-gaap:CustomerAdvancesCurrent>
    <us-gaap:CustomerAdvancesCurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">1938000</us-gaap:CustomerAdvancesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">18582000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">18793000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">3863000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">5699000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">5328000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">6915000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">23910000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">25708000</us-gaap:Liabilities>
    <us-gaap:OtherDeferredCreditsCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">28000</us-gaap:OtherDeferredCreditsCurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2016-03-31_custom_ClassANonVotingPreferredStockMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2015-06-30_custom_ClassANonVotingPreferredStockMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2016-03-31_us-gaap_PreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2015-06-30_us-gaap_PreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2015-06-30_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-03-31_us-gaap_CommonClassBMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2015-06-30_us-gaap_CommonClassBMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2015-06-30_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:Goodwill contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">1767000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">1767000</us-gaap:Goodwill>
    <us-gaap:AccountsPayableRelatedPartiesNoncurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">237000</us-gaap:AccountsPayableRelatedPartiesNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesNoncurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">237000</us-gaap:AccountsPayableRelatedPartiesNoncurrent>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">20000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">160000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">780000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">1806000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:MaintenanceRevenue contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">2406000</us-gaap:MaintenanceRevenue>
    <us-gaap:MaintenanceRevenue contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">2299000</us-gaap:MaintenanceRevenue>
    <us-gaap:MaintenanceRevenue contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">6970000</us-gaap:MaintenanceRevenue>
    <us-gaap:MaintenanceRevenue contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">7288000</us-gaap:MaintenanceRevenue>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">27000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">27000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">83000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">83000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <us-gaap:ManagementFeesRevenue contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">9394000</us-gaap:ManagementFeesRevenue>
    <us-gaap:ManagementFeesRevenue contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">8653000</us-gaap:ManagementFeesRevenue>
    <us-gaap:ManagementFeesRevenue contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">27180000</us-gaap:ManagementFeesRevenue>
    <us-gaap:ManagementFeesRevenue contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">26004000</us-gaap:ManagementFeesRevenue>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">1907000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">1874000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">5598000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">5536000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <us-gaap:CostOfGoodsSold contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">263000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">352000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">939000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">1674000</us-gaap:CostOfGoodsSold>
    <us-gaap:MaintenanceCosts contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">552000</us-gaap:MaintenanceCosts>
    <us-gaap:MaintenanceCosts contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">630000</us-gaap:MaintenanceCosts>
    <us-gaap:MaintenanceCosts contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">1542000</us-gaap:MaintenanceCosts>
    <us-gaap:MaintenanceCosts contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">1611000</us-gaap:MaintenanceCosts>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">6000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">7000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">18000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">18000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <us-gaap:ServiceManagementCosts contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">5649000</us-gaap:ServiceManagementCosts>
    <us-gaap:ServiceManagementCosts contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">5285000</us-gaap:ServiceManagementCosts>
    <us-gaap:ServiceManagementCosts contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">16664000</us-gaap:ServiceManagementCosts>
    <us-gaap:ServiceManagementCosts contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">15665000</us-gaap:ServiceManagementCosts>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">1045000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">1284000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">3116000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">3893000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">395000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">360000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">1243000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">1116000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">4533000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">3706000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">12425000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">11108000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">14522000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">14430000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">42662000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">42470000</us-gaap:CostsAndExpenses>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">-876000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">-500000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-2091000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-2018000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">3005000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">2019000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">2810000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-01-01to2015-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">1888000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-01-01to2015-03-31_custom_PreferredStockClassAMember" unitRef="USD" decimals="-3">98000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-03-31_custom_PreferredStockClassAMember" unitRef="USD" decimals="-3">145000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-01-01to2015-03-31_us-gaap_CommonClassCMember" unitRef="USD" decimals="-3">33000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="USD" decimals="-3">50000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">9360000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">7212000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">8752000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2014-07-01to2015-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">6743000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-03-31_custom_PreferredStockClassAMember" unitRef="USD" decimals="-3">453000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2014-07-01to2015-03-31_custom_PreferredStockClassAMember" unitRef="USD" decimals="-3">350000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="USD" decimals="-3">155000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2014-07-01to2015-03-31_us-gaap_CommonClassCMember" unitRef="USD" decimals="-3">119000</us-gaap:NetIncomeLoss>
    <us-gaap:AssetsNet contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">82012000</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">76492000</us-gaap:AssetsNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">18619000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">17096000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-01-01to2015-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">2486000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-01-01to2015-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">14610000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-01-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">2454000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-01-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">16165000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">54599000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">52173000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">7833000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">46766000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2014-07-01to2015-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">9177000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2014-07-01to2015-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">42996000</us-gaap:SalesRevenueNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">148000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">111000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2015-01-01to2015-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">111000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2016-01-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">31000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2016-01-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">117000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">599000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">233000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2015-07-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">390000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2015-07-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">209000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2014-07-01to2015-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">178000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2014-07-01to2015-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">55000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">830000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">889000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2015-01-01to2015-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">78000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2015-01-01to2015-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">811000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2016-01-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">79000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2016-01-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">751000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">2507000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">2665000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2015-07-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">242000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2015-07-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">2265000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2014-07-01to2015-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">229000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2014-07-01to2015-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">2436000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">4097000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">2666000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2015-01-01to2015-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">-367000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2015-01-01to2015-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">3033000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2016-01-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">-207000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2016-01-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">4304000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">11937000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">9703000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2015-07-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">18000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2015-07-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">11919000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2014-07-01to2015-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">457000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2014-07-01to2015-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">9246000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:Revenues contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">546000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">502000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2015-01-01to2015-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">502000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2016-01-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">546000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">1594000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">1504000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2015-07-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">1594000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2014-07-01to2015-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">1504000</us-gaap:Revenues>
    <us-gaap:ProfitLoss contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">3881000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">2519000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">11451000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">9230000</us-gaap:ProfitLoss>
    <us-gaap:CustomerAdvancesAndDeposits contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">3908000</us-gaap:CustomerAdvancesAndDeposits>
    <us-gaap:CustomerAdvancesAndDeposits contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">2693000</us-gaap:CustomerAdvancesAndDeposits>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">11451000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">10502000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">8066000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">8950000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">-470000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">762000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-300000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">1540000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:OtherCostOfOperatingRevenue contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">2549000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">2044000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">7015000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">5845000</us-gaap:OtherCostOfOperatingRevenue>
    <FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims contextRef="From2016-01-01to2016-03-31" unitRef="Pure" decimals="INF">0.59</FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims contextRef="From2015-01-01to2015-03-31" unitRef="Pure" decimals="INF">0.55</FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims contextRef="From2015-07-01to2016-03-31" unitRef="Pure" decimals="INF">0.6</FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims contextRef="From2014-07-01to2015-03-31" unitRef="Pure" decimals="INF">0.54</FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs contextRef="From2016-01-01to2016-03-31" unitRef="Pure" decimals="INF">-0.102</FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs>
    <FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs contextRef="From2015-01-01to2015-03-31" unitRef="Pure" decimals="INF">-0.11</FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs>
    <FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs contextRef="From2015-07-01to2016-03-31" unitRef="Pure" decimals="INF">-0.103</FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs>
    <FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs contextRef="From2014-07-01to2015-03-31" unitRef="Pure" decimals="INF">-0.106</FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">2565000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">2644000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">175448000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">175448000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">-126989000</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
    <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">-136349000</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">-26000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">-32000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:TreasuryStockValue contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">-675000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">-675000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityAttributableToParentNotAllowableForNetCapital contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">47759000</us-gaap:StockholdersEquityAttributableToParentNotAllowableForNetCapital>
    <us-gaap:StockholdersEquityAttributableToParentNotAllowableForNetCapital contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">38393000</us-gaap:StockholdersEquityAttributableToParentNotAllowableForNetCapital>
    <us-gaap:MinorityInterest contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">10343000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">12391000</us-gaap:MinorityInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">82012000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">76492000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2015-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-03-31_us-gaap_CommonClassBMember" unitRef="Shares" decimals="0">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2015-06-30_us-gaap_CommonClassBMember" unitRef="Shares" decimals="0">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2015-06-30_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6062000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2015-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6062000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-03-31_us-gaap_CommonClassBMember" unitRef="Shares" decimals="0">146</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2015-06-30_us-gaap_CommonClassBMember" unitRef="Shares" decimals="0">146</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2015-06-30_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6051000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2015-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6051000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-03-31_us-gaap_CommonClassBMember" unitRef="Shares" decimals="0">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2015-06-30_us-gaap_CommonClassBMember" unitRef="Shares" decimals="0">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2015-06-30_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2016-03-31_custom_ClassANonVotingPreferredStockMember" unitRef="Shares" decimals="0">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2015-06-30_custom_ClassANonVotingPreferredStockMember" unitRef="Shares" decimals="0">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2016-03-31_us-gaap_PreferredStockMember" unitRef="Shares" decimals="0">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2015-06-30_us-gaap_PreferredStockMember" unitRef="Shares" decimals="0">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2016-03-31_custom_ClassANonVotingPreferredStockMember" unitRef="Shares" decimals="0">313000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2015-06-30_custom_ClassANonVotingPreferredStockMember" unitRef="Shares" decimals="0">313000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2016-03-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2015-06-30_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2016-03-31_custom_ClassANonVotingPreferredStockMember" unitRef="Shares" decimals="0">313000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2015-06-30_custom_ClassANonVotingPreferredStockMember" unitRef="Shares" decimals="0">313000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2016-03-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2015-06-30_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2016-04-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6050840</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2016-04-30_us-gaap_CommonClassBMember" unitRef="Shares" decimals="0">146</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2016-04-30_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">382513</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2016-04-30_custom_PreferredStockClassAMember" unitRef="Shares" decimals="0">313438</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock contextRef="From2016-01-01to2016-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock contextRef="From2015-01-01to2015-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock contextRef="From2015-07-01to2016-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock contextRef="From2014-07-01to2015-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:InterestPaid contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">280000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">406000</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">235000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">99000</us-gaap:IncomeTaxesPaid>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">434000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">510000</us-gaap:SelfInsuranceReserve>
    <FONR:MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">100000</FONR:MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance>
    <us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">279000</us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms>
    <us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">682000</us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms>
    <FONR:MedicalReceivable contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">10097000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">9082000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2015-06-30_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">24541000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2015-06-30_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">15459000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2016-03-31_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">36164000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2016-03-31_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">26067000</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">15901000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">14058000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2015-06-30_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">27330000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2015-06-30_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">13272000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2016-03-31_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">28873000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2016-03-31_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">12972000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:AccountsReceivableNetRelatedParty contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">30000</FONR:AccountsReceivableNetRelatedParty>
    <FONR:AccountsReceivableNetRelatedParty contextRef="AsOf2016-03-31_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">30000</FONR:AccountsReceivableNetRelatedParty>
    <us-gaap:CommonStockValue contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">1000</us-gaap:CommonStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">58102000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">50784000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">8423000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">8423000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">510000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">510000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
    <us-gaap:BillingsInExcessOfCostCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">255000</us-gaap:BillingsInExcessOfCostCurrent>
    <us-gaap:BillingsInExcessOfCostCurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">142000</us-gaap:BillingsInExcessOfCostCurrent>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">8695000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">7284000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2015-01-01to2015-03-31_custom_CommercialInsuranceManagedCareMember" unitRef="USD" decimals="-3">1091000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2015-01-01to2015-03-31_custom_MedicareMedicaidMember" unitRef="USD" decimals="-3">292000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2015-01-01to2015-03-31_custom_WorkersCompensationPersonalInjuryMember" unitRef="USD" decimals="-3">4513000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2015-01-01to2015-03-31_custom_OtherRevenueSourceMember" unitRef="USD" decimals="-3">1388000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2016-01-01to2016-03-31_custom_CommercialInsuranceManagedCareMember" unitRef="USD" decimals="-3">1245000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2016-01-01to2016-03-31_custom_MedicareMedicaidMember" unitRef="USD" decimals="-3">332000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2016-01-01to2016-03-31_custom_WorkersCompensationPersonalInjuryMember" unitRef="USD" decimals="-3">5453000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2016-01-01to2016-03-31_custom_OtherRevenueSourceMember" unitRef="USD" decimals="-3">1665000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">24596000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">20700000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2015-07-01to2016-03-31_custom_CommercialInsuranceManagedCareMember" unitRef="USD" decimals="-3">3438000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2014-07-01to2015-03-31_custom_CommercialInsuranceManagedCareMember" unitRef="USD" decimals="-3">3245000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2015-07-01to2016-03-31_custom_MedicareMedicaidMember" unitRef="USD" decimals="-3">874000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2014-07-01to2015-03-31_custom_MedicareMedicaidMember" unitRef="USD" decimals="-3">896000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2015-07-01to2016-03-31_custom_WorkersCompensationPersonalInjuryMember" unitRef="USD" decimals="-3">15649000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2014-07-01to2015-03-31_custom_WorkersCompensationPersonalInjuryMember" unitRef="USD" decimals="-3">11354000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2015-07-01to2016-03-31_custom_OtherRevenueSourceMember" unitRef="USD" decimals="-3">4635000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2014-07-01to2015-03-31_custom_OtherRevenueSourceMember" unitRef="USD" decimals="-3">5205000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">145000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">30000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">235000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">99000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">3698000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-2124000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-6003000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-10437000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:RepaymentsOfOtherDebt contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">6000</us-gaap:RepaymentsOfOtherDebt>
    <us-gaap:RepaymentsOfOtherDebt contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">6000</us-gaap:RepaymentsOfOtherDebt>
    <us-gaap:PaymentsOfDividendsMinorityInterest contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-4138000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-3306000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-1871000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-2166000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-599000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-233000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-65000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-108000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-534000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-125000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-2000</us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">249000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-230000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInCustomerAdvances contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-427000</us-gaap:IncreaseDecreaseInCustomerAdvances>
    <us-gaap:IncreaseDecreaseInCustomerAdvances contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-259000</us-gaap:IncreaseDecreaseInCustomerAdvances>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">576000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-501000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-437000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-178000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-143000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">18000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">9000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">89000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-43000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">158000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInReceivables contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">17000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">118000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-3674000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-4310000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">53000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:DepreciationAndAmortization contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">2507000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">2665000</us-gaap:DepreciationAndAmortization>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-01-01to2016-03-31" unitRef="Shares" decimals="0">6050000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2015-01-01to2015-03-31" unitRef="Shares" decimals="0">6050000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-01-01to2016-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6050000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2015-01-01to2015-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6050000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2015-01-01to2015-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-01-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2015-07-01to2016-03-31" unitRef="Shares" decimals="0">6050000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2014-07-01to2015-03-31" unitRef="Shares" decimals="0">6050000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2015-07-01to2016-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6050000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2014-07-01to2015-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6050000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2015-07-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2014-07-01to2015-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <FONR:CostsIncurredOnUncompletedContracts contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">2310000</FONR:CostsIncurredOnUncompletedContracts>
    <FONR:CostsIncurredOnUncompletedContracts contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">1862000</FONR:CostsIncurredOnUncompletedContracts>
    <FONR:EstimatedEarnings contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">1622000</FONR:EstimatedEarnings>
    <FONR:EstimatedEarnings contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">1371000</FONR:EstimatedEarnings>
    <FONR:SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">3932000</FONR:SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts>
    <FONR:SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">3233000</FONR:SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">903000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">992000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">493000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">521000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">2565000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">2539000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">307000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">344000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">193000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">235000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">2644000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">2509000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">982000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">486000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">122926000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">-3830000</us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">-3201000</us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-10608000</us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-9244000</us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">4059000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">3507000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2015-06-30_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">3910000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2015-06-30_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">403000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2016-03-31_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">4462000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2016-03-31_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">403000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">24000</us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear>
    <us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">540000</us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear>
    <us-gaap:OtherLiabilities contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">718000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">469000</us-gaap:OtherLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">10300000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">8546000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">4326000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">3791000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2015-06-30_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">4153000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2015-06-30_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">362000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2016-03-31_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">4614000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2016-03-31_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">288000</FONR:AccountsReceivableServiceAndRepairFees>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-01-01to2016-03-31" unitRef="USDPShares" decimals="INF">0.50</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-01-01to2015-03-31" unitRef="USDPShares" decimals="INF">0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-01-01to2016-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">0.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-01-01to2015-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-01-01to2015-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-01-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-07-01to2016-03-31" unitRef="USDPShares" decimals="INF">1.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2014-07-01to2015-03-31" unitRef="USDPShares" decimals="INF">1.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-07-01to2016-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">1.45</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2014-07-01to2015-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">1.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-07-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2014-07-01to2015-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.31</us-gaap:EarningsPerShareBasic>
    <FONR:ProvisionForBadDebts contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-300000</FONR:ProvisionForBadDebts>
    <FONR:ProvisionForBadDebts contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">1540000</FONR:ProvisionForBadDebts>
    <FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent contextRef="AsOf2015-07-01" unitRef="Pure" decimals="INF">0.242</FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">4026000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">2549000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">11686000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">9329000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:InvestmentIncomeNet contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">56000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">52000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">164000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">173000</us-gaap:InvestmentIncomeNet>
    <us-gaap:EarningsPerShareDiluted contextRef="From2016-01-01to2016-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">0.45</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2015-01-01to2015-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2015-01-01to2015-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2016-01-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2015-07-01to2016-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">1.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2014-07-01to2015-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">1.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2015-07-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2014-07-01to2015-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">13147000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">9449000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2014-06-30" unitRef="USD" decimals="-3">9952000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2015-03-31" unitRef="USD" decimals="-3">7828000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">76000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2016-01-01to2016-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6178000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2015-01-01to2015-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6178000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2015-01-01to2015-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2016-01-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2015-07-01to2016-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6178000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2014-07-01to2015-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6178000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2015-07-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2014-07-01to2015-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">201000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">149000</us-gaap:InventoryWorkInProcess>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">2033000</us-gaap:OtherInventorySupplies>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">2043000</us-gaap:OtherInventorySupplies>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">19494000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">19452000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2015-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="USD" decimals="-3">7005000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2015-06-30_custom_PatentsAndCopyrightsMember" unitRef="USD" decimals="-3">4547000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2015-06-30_us-gaap_NoncompeteAgreementsMember" unitRef="USD" decimals="-3">4100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2015-06-30_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">3800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2016-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="USD" decimals="-3">7005000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2016-03-31_custom_PatentsAndCopyrightsMember" unitRef="USD" decimals="-3">4612000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2016-03-31_us-gaap_NoncompeteAgreementsMember" unitRef="USD" decimals="-3">4100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2016-03-31_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">3800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent contextRef="AsOf2015-07-01" unitRef="Pure" decimals="INF">.458</FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent>
    <FONR:OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent contextRef="AsOf2015-07-01" unitRef="Pure" decimals="INF">.3</FONR:OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2015-01-01to2015-03-31_custom_PatentsAndCopyrightsMember" unitRef="USD" decimals="-3">46000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2015-07-01to2016-03-31_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">142000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2014-07-01to2015-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="USD" decimals="-3">246000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2014-07-01to2015-03-31_us-gaap_NoncompeteAgreementsMember" unitRef="USD" decimals="-3">439000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2014-07-01to2015-03-31_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">142000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2016-01-01to2016-03-31_custom_PatentsAndCopyrightsMember" unitRef="USD" decimals="-3">47000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2015-07-01to2016-03-31_custom_PatentsAndCopyrightsMember" unitRef="USD" decimals="-3">141000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2014-07-01to2015-03-31_custom_PatentsAndCopyrightsMember" unitRef="USD" decimals="-3">137000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2016-01-01to2016-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="USD" decimals="-3">65000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2015-01-01to2015-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="USD" decimals="-3">81000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2016-01-01to2016-03-31_us-gaap_NoncompeteAgreementsMember" unitRef="USD" decimals="-3">146000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2015-01-01to2015-03-31_us-gaap_NoncompeteAgreementsMember" unitRef="USD" decimals="-3">146000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2016-01-01to2016-03-31_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">47000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2015-01-01to2015-03-31_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">47000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2015-07-01to2016-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="USD" decimals="-3">227000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2015-07-01to2016-03-31_us-gaap_NoncompeteAgreementsMember" unitRef="USD" decimals="-3">439000</us-gaap:AmortizationOfIntangibleAssets>
    <dei:EntityRegistrantName contextRef="From2015-07-01to2016-03-31">Fonar Corporation</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2015-07-01to2016-03-31">0000355019</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2015-07-01to2016-03-31">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2015-07-01to2016-03-31">2016-03-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2015-07-01to2016-03-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2015-07-01to2016-03-31">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2015-07-01to2016-03-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2015-07-01to2016-03-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2015-07-01to2016-03-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2015-07-01to2016-03-31">Accelerated Filer</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2015-07-01to2016-03-31">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2015-07-01to2016-03-31">2016</dei:DocumentFiscalYearFocus>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font-size: 12pt"&gt;FONAR CORPORATION&#13;AND SUBSIDIARIES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;MARCH 31, 2016 and 2015&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(Amounts and shares in thousands,&#13;except per share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;NOTE 1 &amp;#150; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;u&gt;Description of Business&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Effective July 1, 2015, the Company restructured the corporate organization&#13;of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate&#13;the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized&#13;in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation&#13;of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest&#13;in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM,&#13;operating under the name &amp;#147;Health Management Company of America&amp;#148;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;u&gt;Basis of Presentation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The accompanying unaudited condensed consolidated&#13;financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information&#13;and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information&#13;and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.&#13;In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation&#13;have been included. Operating results for the three and nine months ended March 31, 2016, are not necessarily indicative of the&#13;results that may be expected for the fiscal year ending June 30, 2016. For further information, refer to the consolidated financial&#13;statements and footnotes thereto included in the Company's Annual Report on Form 10-K filed on September 29, 2015 for the fiscal&#13;year ended June 30, 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font-size: 12pt"&gt;FONAR CORPORATION&#13;AND SUBSIDIARIES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;MARCH 31, 2016 and 2015&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(Amounts and shares in thousands,&#13;except per share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;u&gt;Principles of Consolidation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The unaudited condensed consolidated financial statements include&#13;the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships (collectively the &amp;#147;Company&amp;#148;).&#13;All significant intercompany accounts and transactions have been eliminated in consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;u&gt;Earnings Per Share&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Basic earnings per share (&amp;#147;EPS&amp;#148;)&#13;is computed based on weighted average number of shares common stock and stock equivalents outstanding, net of common stock. In&#13;accordance with ASC topic 260-10, &amp;#147;Participating Securities and the Two-Class method&amp;#148;, the Company used the Two-Class&#13;method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for&#13;the three and nine months ended March 31, 2016 and March 31, 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;Diluted EPS reflects the potential dilution&#13;from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares&#13;outstanding during the period. For the three and nine months ended March 31, 2016 and March 31, 2015, diluted EPS for common shareholders&#13;includes 128 shares upon conversion of Class C Common.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Three months ended &lt;br /&gt;March 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Three months ended &lt;br /&gt;March 31, 2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;u&gt;&lt;/u&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Basic&lt;/u&gt;&lt;/p&gt;&#13;        &lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Numerator:&lt;/u&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; width: 33%; font-size: 11pt"&gt;Net income available to&amp;#160;common stockholders&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;3,005&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;2,810&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;50&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;2,019&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1,888&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;33&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;&lt;u&gt;Denominator:&lt;/u&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.46&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&#13;                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;0.33&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.09&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Diluted&lt;/u&gt;&lt;/p&gt;&#13;        &lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Denominator:&lt;/u&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Convertible Class C Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Total denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.45&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.09&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Nine months ended &lt;br /&gt;March 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Nine months ended &lt;br /&gt;March 31, 2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;u&gt;&lt;/u&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Basic&lt;/u&gt;&lt;/p&gt;&#13;        &lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Numerator:&lt;/u&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; width: 33%; font-size: 11pt"&gt;Net income available to&amp;#160;common stockholders&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;9,360&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;8,752&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;155&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;7,212&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,743&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;119&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;&lt;u&gt;Denominator:&lt;/u&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.55&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.45&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.19&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.11&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Diluted&lt;/u&gt;&lt;/p&gt;&#13;        &lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Denominator:&lt;/u&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Convertible Class C Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Total denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.42&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.09&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Recent Accounting Pronouncements &lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;In March 2016, the FASB issued ASU No. 2016-09,&#13;&amp;#147;Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting&amp;#148;. This update&#13;includes provisions intended to simplify various aspects of accounting for share-based compensation. ASU No. 2016-09 will take&#13;effect for public companies for the annual periods beginning after December 15, 2016. The Company is currently assessing the potential&#13;impact of ASU No. 2016-09 on the Company&amp;#146;s consolidated condensed financial statements.&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;In November 2015, the FASB issued ASU No. 2015-17,&#13;Balance Sheet Classification of Deferred Taxes, which will require entities to present deferred tax assets and deferred tax liabilities&#13;as non-current in a classified balance sheet. The ASU simplified the current guidance, which requires entities to separately present&#13;deferred tax assets and deferred tax liabilities as current and non-current in a classified balance sheet. This standard is effective&#13;for annual periods and interim periods within those fiscal years, beginning after December 15, 2016 but permits entities to early&#13;adopt at the beginning of any interim or annual period. During the quarter ended December 31, 2015, the Company elected to early&#13;adopt ASU 2015-17 and applied the change retrospectively to all periods present. As a result, the Company presented all deferred&#13;assets and liabilities as non-current in its consolidated balance sheet. The adoption of this ASU did not result in a reclassification&#13;of the Company&amp;#146;s net deferred tax assets and liabilities as of June 30, 2015. As of March 31, 2016, there was no impact on&#13;the Company&amp;#146;s results of operations as a result of the adoption of ASU No. 2015-17&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The FASB has issued ASU No. 2014-09, &lt;i&gt;Revenue&#13;from Contracts with Customers&lt;/i&gt;. This ASU supercedes the revenue recognition requirements in Accounting Standards Codification&#13;605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity&#13;recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration&#13;to which the company expects to be entitled in exchange for those goods or services. This ASU is effective for annual reporting&#13;periods beginning after December 15, 2017, as deferred including interim periods within the reporting period and should be applied&#13;retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the&#13;ASU recognized at the date of initial application. The Company is currently evaluating the effect that this ASU will have on its&#13;condensed consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has&#13;it determined the effect of the standard on it ongoing financial reporting.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;In July 2015, the FASB issued Accounting Standards&#13;Update No. 2015-11, &amp;#147;&lt;i&gt;Simplifying the Measurement of Inventory&lt;/i&gt;&amp;#148; (&amp;#147;ASU 2015-11&amp;#148;). ASU 2015-11 requires&#13;an entity to measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices&#13;in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement&#13;is unchanged for inventory measured using last-in, first-out (&amp;#147;LIFO&amp;#148;) or the retail inventory method. It is effective&#13;for annual reporting periods beginning after December 15, 2016. The amendments should be applied prospectively with earlier application&#13;permitted as of the beginning of an interim or annual reporting period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;FASB, the Emerging Issues Task Force and the&#13;SEC have issued certain other accounting standards, updates, and regulations as of March 31, 2016 that will become effective in&#13;subsequent periods; however, management does not believe that any of those updates would have significantly affected our financial&#13;accounting measures or disclosures had they been in effect during 2016 or 2015, and it does not believe that any of those pronouncements&#13;will have a significant impact on our condensed consolidated financial statements at the time they become effective.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;u&gt;Reclassifications&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;u style="text-decoration: none"&gt;&amp;#160;&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Certain prior year amounts have been reclassified to conform&#13;to the current year presentation. The reclassifications did not have any effect on reported consolidated net income for any periods&#13;presented.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;FONAR CORPORATION AND SUBSIDIARIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;MARCH 31, 2016 and 2015&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(Amounts and shares in thousands,&#13;except per share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;NOTE 3 &amp;#150; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT&#13;AND OTHER FEES RECEIVABLE&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Receivables, net is comprised of the following&#13;at March 31, 2016:&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Gross &lt;br /&gt;Receivable&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Allowance for &lt;br /&gt;doubtful accounts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Net&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;4,614&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;288&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;4,326&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Accounts receivable - related party&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Medical receivable&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;36,164&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;26,067&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;10,097&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Management and other fees receivable&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;28,873&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;12,972&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;15,901&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Management and other fees receivable - related medical practices ("PC&amp;#146;s")&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;4,462&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;403&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;4,059&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Receivables, net is comprised of the following&#13;at June 30, 2015:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Gross &lt;br /&gt;Receivable&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Allowance for &lt;br /&gt;doubtful accounts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Net&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;4,153&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;362&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;3,791&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Accounts receivable - related party&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Medical receivable&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;24,541&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;15,459&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;9,082&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Management and other fees receivable&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;27,330&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;13,272&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;14,058&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Management and other fees receivable -&amp;#160;&amp;#160;related medical practices ("PC&amp;#146;s")&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;3,910&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;403&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;3,507&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company's customers are concentrated in&#13;the healthcare industry.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;u&gt;Accounts Receivable&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Credit risk with respect to the Company&amp;#146;s&#13;accounts receivable related to product sales and service and repair fees is limited due to the customer advances received prior&#13;to the commencement of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair&#13;fees are billed on a monthly or quarterly basis and the Company does not continue providing these services if accounts receivable&#13;become past due. The Company controls credit risk with respect to accounts receivable from service and repair fees through its&#13;credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs ongoing&#13;credit authorizations before a product sales contract is entered into or service and repair fees are provided.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;u&gt;Medical Receivable&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Medical receivables are due under fee-for-service&#13;contracts from third party payors, such as hospitals, government sponsored healthcare programs, patient&amp;#146;s legal counsel and&#13;directly from patients. Substantially all the revenue relates to patients residing in Florida. The carrying amount of the medical&#13;receivable is reduced by an allowance that reflects management&amp;#146;s best estimate of the amounts that will not be collected.&#13;The Company continuously monitors collections from its clients and maintains an allowance for bad debts based upon the Company&amp;#146;s&#13;historical collection experience. The Company determines allowances for contractual adjustments and uncollectible accounts based&#13;on specific agings, specific payor collection issues that have been identified and based on payor classifications and historical&#13;experience at each site.&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;u&gt;Management and Other Fees Receivable&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;u&gt;&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company's receivables from the related and&#13;non-related professional corporations (PC's) substantially consist of fees outstanding under management agreements. Payment of&#13;the outstanding fees is dependent on collection by the PC's of fees from third party medical reimbursement organizations, principally&#13;insurance companies and health management organizations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Payment of the management fee receivables from&#13;the PC&amp;#146;s may be impaired by the inability of the PC&amp;#146;s to collect in a timely manner their medical fees from the third&#13;party payors, particularly insurance carriers covering automobile no-fault and workers compensation claims due to longer payment&#13;cycles and rigorous informational requirements and certain other disallowed claims. Approximately 59% and 55% of the PCs&amp;#146;&#13;net revenues for the three months ended March 31, 2016 and 2015, respectively, were derived from no-fault and personal injury protection&#13;claims. Approximately 60% and 54% of the PCs&amp;#146; net revenues for the nine months ended March 31, 2016 and 2015, respectively,&#13;were derived from no-fault and personal injury protection claims. The Company considers the aging of its accounts receivable in&#13;determining the amount of allowance for doubtful accounts. The Company generally takes all legally available steps to collect its&#13;receivables. Credit losses associated with the receivables are provided for in the condensed consolidated financial statements&#13;and have historically been within management's expectations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Net revenues from management and other fees&#13;charged to the related PCs accounted for approximately 10.2% and 11% of the consolidated net revenues for the three months ended&#13;March 31, 2016 and 2015, respectively. Net revenues from management and other fees charged to the related PCs accounted for approximately&#13;10.3% and 10.6% of the consolidated net revenues for the nine months ended March 31, 2016 and 2015, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Tallahassee Magnetic Resonance Imaging, PA,&#13;Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp;#38; Diagnostic Center, PA (all related medical practices) entered into a guaranty&#13;agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which have arisen under&#13;each individual management agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company&amp;#146;s patient fee revenue, net&#13;of contractual allowances and discounts less the provision for bad debts for the three and nine months ended March 31, 2016 and&#13;2015 are summarized in the following tables.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: center; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;For the Three Months Ended &lt;br /&gt;March 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 60%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;&lt;td style="width: 6%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-size: 11pt"&gt;1,245&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-size: 11pt"&gt;1,091&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Medicare/Medicaid&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;332&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;292&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Workers' Compensation/Personal Injury&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;5,453&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;4,513&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;1,665&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;1,388&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Patient Fee Revenue, net of contractual allowances and discounts&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;8,695&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;7,284&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Provision for Bad Debts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;(3,830&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;(3,201&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Net Patient Fee for Revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;4,865&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;4,083&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: center; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;For the Nine Months Ended &lt;br /&gt;March 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 60%; text-align: left; padding-left: 0pt; font-size: 11pt"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;&lt;td style="width: 6%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-size: 11pt"&gt;3,438&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-size: 11pt"&gt;3,245&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 11pt"&gt;Medicare/Medicaid&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;874&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;896&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;Workers' Compensation/Personal Injury&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;15,649&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;11,354&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;4,635&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;5,205&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Patient Fee Revenue, net of contractual allowances and discounts&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;24,596&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;20,700&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; font-size: 11pt"&gt;Provision for Bad Debts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;(10,608&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;(9,244&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; font-size: 11pt"&gt;Net Patient Fee for Revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;13,988&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;11,456&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;FONAR CORPORATION AND SUBSIDIARIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;MARCH 31, 2016 and 2015&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(Amounts and shares in thousands,&#13;except per share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;NOTE 4 - INVENTORIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Inventories included in the accompanying condensed consolidated balance&#13;sheet consist of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: center; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;March 31, &lt;br /&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;June 30, &lt;br /&gt;2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 56%; text-align: left; text-indent: -0.25in; padding-left: 0.25in; font-size: 11pt"&gt;Purchased parts, components and supplies&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;2,033&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;2,043&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; font-size: 11pt"&gt;Work-in-process&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;201&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;149&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; font-size: 11pt"&gt;Total Inventories&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;2,234&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;2,192&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <FONR:CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;FONAR CORPORATION AND SUBSIDIARIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;MARCH 31, 2016 and 2015&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(Amounts and shares in thousands,&#13;except per share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 5 &amp;#150; COSTS AND ESTIMATED EARNINGS&#13;ON UNCOMPLETED CONTRACTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;Information relating&#13;to uncompleted contracts is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;March 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;June 30, 2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 56%; text-align: left; text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Costs incurred on uncompleted contracts&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;2,310&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;1,862&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Estimated earnings&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;1,622&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;1,371&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Subtotal&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;3,932&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;3,233&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Less: Billings to date&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;3,908&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;2,693&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Total Costs and estimated earnings in excess of billings on uncompleted contracts&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;24&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;540&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;Included in the accompanying&#13;condensed consolidated balance sheets under the following captions:&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;March 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;June 30, 2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 56%; text-align: left; text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Costs and estimated earnings in excess of billings on uncompleted contracts&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;279&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;682&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Less: Billings in excess of costs and estimated earnings on uncompleted contracts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;255&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;142&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Total Costs and estimated earnings in excess of billings on uncompleted contracts&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;24&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;540&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;</FONR:CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;FONAR CORPORATION AND SUBSIDIARIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;MARCH 31, 2016 and 2015&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(Amounts and shares in thousands,&#13;except per share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; text-align: center; margin-bottom: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 6 &amp;#150; OTHER INTANGIBLE ASSETS&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Other intangible assets, net of accumulated&#13;amortization, in the accompanying condensed consolidated balance sheet consist of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 11pt"&gt;March 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 11pt"&gt;June 30, 2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 56%; text-align: left; padding-left: 8.85pt; font-size: 11pt"&gt;Capitalized software development costs&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;7,005&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;7,005&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 8.85pt; font-size: 11pt"&gt;Patents and copyrights&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;4,612&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;4,547&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="padding-left: 8.85pt; font-size: 11pt"&gt;Non-compete&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;4,100&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;4,100&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 8.85pt; font-size: 11pt"&gt;Customer relationships&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;3,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;3,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 8.85pt; font-size: 11pt"&gt;Gross Other intangible assets&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;19,517&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;19,452&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 8.85pt; font-size: 11pt"&gt;Less: Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;11,451&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;10,502&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 8.85pt; font-size: 11pt"&gt;Other Intangible Assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;8,066&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;8,950&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;Amortization of patents&#13;and copyrights for the three months ended March 31, 2016 and 2015 amounted to $47 and $46, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;Amortization of capitalized&#13;software development costs for the three months ended March 31, 2016 and 2015 amounted to $65 and $81, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;Amortization of non-compete&#13;for the three months ended March 31, 2016 and 2015 amounted to $146 and $146, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;Amortization of customer&#13;relationships for the three months ended March 31, 2016 and 2015 amounted to $47 and $47, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;Amortization of patents&#13;and copyrights for the nine months ended March 31, 2016 and 2015 amounted to $141 and $137, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;Amortization of capitalized&#13;software development costs for the nine months ended March 31, 2016 and 2015 amounted to $227 and $246, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;Amortization of non-compete&#13;for the nine months ended March 31, 2016 and 2015 amounted to $439 and $439, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;Amortization of customer&#13;relationships for the nine months ended March 31, 2016 and 2015 amounted to $142 and $142, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&amp;#160;&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;FONAR CORPORATION AND SUBSIDIARIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;MARCH 31, 2016 and 2015&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(Amounts and shares in thousands,&#13;except per share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;NOTE 7 &amp;#150; OTHER CURRENT LIABILITIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Other current liabilities in the accompanying&#13;condensed consolidated balance sheet consist of the following:&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;March 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;June 30, 2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 56%; text-align: left; text-indent: -8.95pt; padding-left: 8.95pt; font-size: 11pt"&gt;Accrued salaries, commissions and payroll taxes&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;903&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;992&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Accrued interest&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;117&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;117&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Litigation accruals&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;493&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;521&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Sales tax payable&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,565&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,539&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Legal and other professional fees&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;307&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;344&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Accounting fees&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;193&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;235&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Self-funded health insurance reserve&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;434&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;510&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Interest and penalty - sales tax&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,644&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,509&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt; font-size: 11pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;982&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;486&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 2.5pt; padding-left: 5.4pt; font-size: 11pt"&gt;Total Other Current Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;8,638&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;8,253&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;FONAR CORPORATION AND SUBSIDIARIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;MARCH 31, 2016 and 2015&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(Amounts and shares in thousands,&#13;except per share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 8 - SEGMENT AND RELATED INFORMATION&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company operates in two industry segments&#13;- manufacturing and the servicing of medical equipment and management of diagnostic imaging centers.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The accounting policies of the segments are&#13;the same as those described in the summary of significant accounting policies as disclosed in the Company&amp;#146;s 10-K as of June&#13;30, 2015. All inter-segment sales are market-based. The Company evaluates performance based on income or loss from operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Summarized financial information concerning&#13;the Company's reportable segments is shown in the following table:&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;Medical&lt;/p&gt; &lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;Equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;Management&lt;/p&gt; &lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;of&lt;/p&gt; &lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;Diagnostic&lt;/p&gt; &lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;Imaging&lt;/p&gt; &lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;Centers&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center; font-size: 11pt"&gt;&lt;font style="font-family: Arial, Helvetica, Sans-Serif"&gt;Totals&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt"&gt;For the three months ended March 31, 2016&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 46%; text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="width: 5%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-size: 11pt"&gt;2,454&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-size: 11pt"&gt;16,165&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-size: 11pt"&gt;18,619&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;546&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;546&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;(Loss) income from operations&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;(207&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;)&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;4,304&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;4,097&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;79&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;751&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;830&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;31&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;117&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;148&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="padding-left: 5.4pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt"&gt;For the three months ended March 31, 2015&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,486&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;14,610&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;17,096&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;502&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;502&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;(Loss) income from operations&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;(367&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;)&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;3,033&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,666&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;78&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;811&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;889&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;111&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;111&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="padding-left: 5.4pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt"&gt;For the nine months ended March 31, 2016&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;7,833&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;46,766&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;54,599&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;1,594&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;1,594&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Income from operations&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;18&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;11,919&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;11,937&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;242&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,265&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,507&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;390&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;209&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;599&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="padding-left: 5.4pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt"&gt;For the nine months ended March 31, 2015&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;9,177&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;42,996&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;52,173&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;1,504&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;1,504&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Income from operations&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;457&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;9,246&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;9,703&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;229&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,436&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,665&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;178&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;55&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;233&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;FONAR CORPORATION AND SUBSIDIARIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;MARCH 31, 2016 and 2015&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(Amounts and shares in thousands,&#13;except per share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 9&amp;#150; SUPPLEMENTAL CASH FLOW INFORMATION&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;During the nine months ended March 31, 2016&#13;and March 31, 2015, the Company paid $280 and $406 for interest, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;During the nine months ended March 31, 2016&#13;and March 31, 2015, the Company paid $235 and $99 for income taxes, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;FONAR CORPORATION AND SUBSIDIARIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;MARCH 31, 2016 and 2015&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(Amounts and shares in thousands,&#13;except per share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;NOTE 10 &amp;#150; COMMITMENTS AND CONTINGENCIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;u&gt;Litigation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company is subject to legal proceedings&#13;and claims arising from the ordinary course of its business, including personal injury, customer contract and employment claims.&#13;In the opinion of management, the aggregate liability, if any, with respect to such actions, will not have a material adverse effect&#13;on the consolidated financial position or results of operations of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;There were no material changes in litigation&#13;from that reported in our Form 10-K for the fiscal year ended June 30, 2015 with the exception of the case with Dr. Shapiro. The&#13;case was settled for $258,400 plus interest on February 18. 2016.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Other Matters&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company is also delinquent in filing sales&#13;tax returns for certain states, for which the Company has transacted business. As of March 31, 2016, the Company has recorded tax&#13;obligations of approximately $2,565 plus interest and penalties of approximately $2,644. The Company is in the process of determining&#13;the regulatory requirements in order to become compliant.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company maintains a self-funded health insurance&#13;program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims&#13;to $100 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company&#13;considers historical and projected medical utilization data when estimating its health insurance program liability and related&#13;expense. As of March 31, 2016 and June 30, 2015, the Company had approximately $434 and $510, respectively, in reserve for its&#13;self-funded health insurance programs. The reserves are included in &amp;#147;Other current liabilities&amp;#148; in the condensed consolidated&#13;balance sheets.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company regularly analyzes its reserves&#13;for incurred but not reported claims, and for reported but not paid claims related to its reinsurance and self-funded insurance&#13;programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing these reserves&#13;such as assessing historical paid claims, average lags between the claims&amp;#146; incurred date, reported dates and paid dates,&#13;and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and&#13;any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded&#13;in the periods covered by this report.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;In March 2016, the Company signed a 2nd amendment&#13;with Signature Bank to extend the terms of the revolving loan to September 2018. As of March 31, 2016, the Company has not been&#13;advanced any money under this revolving loan.&amp;#160;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;FONAR CORPORATION AND SUBSIDIARIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;MARCH 31, 2016 and 2015&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(Amounts and shares in thousands,&#13;except per share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;NOTE 11 - INCOME TAXES&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;ASC topic 740 prescribes a recognition threshold&#13;and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken&#13;in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon&#13;examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit&#13;recognized and measured pursuant to the interpretation are referred to as &amp;#147;unrecognized benefits&amp;#148;. A liability is recognized&#13;(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it&#13;represents an enterprise&amp;#146;s potential future obligation to the taxing authority for a tax position that was not recognized&#13;as a result of applying the provisions of ASC topic 740.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;In accordance with ASC topic 740, interest costs&#13;related to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &amp;#147;Interest expense,&#13;net&amp;#148;. Penalties if incurred would be recognized as a component of &amp;#147;Selling, general and administrative&amp;#148; expenses.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company files corporate income tax returns&#13;in the United States (federal) and in various state and local jurisdictions. In most instances, the Company is no longer subject&#13;to federal, state and local income tax examinations by tax authorities for years prior to 2009.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company recorded a deferred tax asset of&#13;$8,423 and a deferred tax liability of $510 as of March 31, 2016, primarily relating to net operating loss carryforwards of approximately&#13;$122,926 available to offset future taxable income through 2034. The net operating losses begin to expire in 2019 for federal tax&#13;purposes and in 2015 for state income tax purposes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The ultimate realization of deferred tax assets&#13;is dependent on the generation of future taxable income during the periods in which those temporary differences become deductible.&#13;The Company considers projected future taxable income and tax planning strategies in making this assessment. At present, the Company&#13;does have a sufficient history of income and anticipates profitability in the coming years and has concluded that it is more-likely-than-not&#13;that the Company will be able to realize a portion of its tax benefits in the near future and therefore a valuation allowance was&#13;established for the partial value of the deferred tax asset.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;A valuation allowance will be maintained until&#13;sufficient positive evidence exists to support the reversal of the remainder of the valuation. Should the Company continue to remain&#13;profitable in future periods with supportable trends, the valuation allowance will be reversed accordingly.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0pt"&gt;&amp;#160;&amp;#160;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;FONAR CORPORATION AND SUBSIDIARIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;MARCH 31, 2016 and 2015&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(Amounts and shares in thousands,&#13;except per share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;NOTE 12- SUBSEQUENT EVENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;On May 2, 2016, the Company repaid the balance&#13;of the Class A Stockholders capital contribution in the amount of $1,125. As a result, the Company&amp;#146;s subsidiary, HMCA, owns&#13;a 100% interest in Imperial Management Services.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;u&gt;Principles of Consolidation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The unaudited condensed consolidated financial statements include&#13;the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships (collectively the &amp;#147;Company&amp;#148;).&#13;All significant intercompany accounts and transactions have been eliminated in consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;(Amounts and shares in&#13;thousands, except per share amounts) (UNAUDITED)&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;u&gt;Earnings Per Share&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Basic earnings per share (&amp;#147;EPS&amp;#148;)&#13;is computed based on weighted average number of shares common stock and stock equivalents outstanding, net of common stock. In&#13;accordance with ASC topic 260-10, &amp;#147;Participating Securities and the Two-Class method&amp;#148;, the Company used the Two-Class&#13;method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for&#13;the three and nine months ended March 31, 2016 and March 31, 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;Diluted EPS reflects the potential dilution&#13;from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares&#13;outstanding during the period. For the three and nine months ended March 31, 2016 and March 31, 2015, diluted EPS for common shareholders&#13;includes 128 shares upon conversion of Class C Common.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Three months ended &lt;br /&gt;March 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Three months ended &lt;br /&gt;March 31, 2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;u&gt;&lt;/u&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Basic&lt;/u&gt;&lt;/p&gt;&#13;        &lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Numerator:&lt;/u&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; width: 33%; font-size: 11pt"&gt;Net income available to&amp;#160;common stockholders&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;3,005&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;2,810&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;50&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;2,019&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1,888&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;33&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;&lt;u&gt;Denominator:&lt;/u&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.46&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&#13;                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;0.33&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.09&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Diluted&lt;/u&gt;&lt;/p&gt;&#13;        &lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Denominator:&lt;/u&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Convertible Class C Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Total denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.45&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.09&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Nine months ended &lt;br /&gt;March 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Nine months ended &lt;br /&gt;March 31, 2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;u&gt;&lt;/u&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Basic&lt;/u&gt;&lt;/p&gt;&#13;        &lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Numerator:&lt;/u&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; width: 33%; font-size: 11pt"&gt;Net income available to&amp;#160;common stockholders&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;9,360&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;8,752&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;155&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;7,212&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,743&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;119&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;&lt;u&gt;Denominator:&lt;/u&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.55&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.45&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.19&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.11&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Diluted&lt;/u&gt;&lt;/p&gt;&#13;        &lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Denominator:&lt;/u&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Convertible Class C Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Total denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.42&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.09&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Recent Accounting Pronouncements &lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;In March 2016, the FASB issued ASU No. 2016-09,&#13;&amp;#147;Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting&amp;#148;. This update&#13;includes provisions intended to simplify various aspects of accounting for share-based compensation. ASU No. 2016-09 will take&#13;effect for public companies for the annual periods beginning after December 15, 2016. The Company is currently assessing the potential&#13;impact of ASU No. 2016-09 on the Company&amp;#146;s consolidated condensed financial statements.&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;In November 2015, the FASB issued ASU No. 2015-17,&#13;Balance Sheet Classification of Deferred Taxes, which will require entities to present deferred tax assets and deferred tax liabilities&#13;as non-current in a classified balance sheet. The ASU simplified the current guidance, which requires entities to separately present&#13;deferred tax assets and deferred tax liabilities as current and non-current in a classified balance sheet. This standard is effective&#13;for annual periods and interim periods within those fiscal years, beginning after December 15, 2016 but permits entities to early&#13;adopt at the beginning of any interim or annual period. During the quarter ended December 31, 2015, the Company elected to early&#13;adopt ASU 2015-17 and applied the change retrospectively to all periods present. As a result, the Company presented all deferred&#13;assets and liabilities as non-current in its consolidated balance sheet. The adoption of this ASU did not result in a reclassification&#13;of the Company&amp;#146;s net deferred tax assets and liabilities as of June 30, 2015. As of March 31, 2016, there was no impact on&#13;the Company&amp;#146;s results of operations as a result of the adoption of ASU No. 2015-17&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The FASB has issued ASU No. 2014-09, &lt;i&gt;Revenue&#13;from Contracts with Customers&lt;/i&gt;. This ASU supercedes the revenue recognition requirements in Accounting Standards Codification&#13;605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity&#13;recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration&#13;to which the company expects to be entitled in exchange for those goods or services. This ASU is effective for annual reporting&#13;periods beginning after December 15, 2017, as deferred including interim periods within the reporting period and should be applied&#13;retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the&#13;ASU recognized at the date of initial application. The Company is currently evaluating the effect that this ASU will have on its&#13;condensed consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has&#13;it determined the effect of the standard on it ongoing financial reporting.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;In July 2015, the FASB issued Accounting Standards&#13;Update No. 2015-11, &amp;#147;&lt;i&gt;Simplifying the Measurement of Inventory&lt;/i&gt;&amp;#148; (&amp;#147;ASU 2015-11&amp;#148;). ASU 2015-11 requires&#13;an entity to measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices&#13;in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement&#13;is unchanged for inventory measured using last-in, first-out (&amp;#147;LIFO&amp;#148;) or the retail inventory method. It is effective&#13;for annual reporting periods beginning after December 15, 2016. The amendments should be applied prospectively with earlier application&#13;permitted as of the beginning of an interim or annual reporting period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;FASB, the Emerging Issues Task Force and the&#13;SEC have issued certain other accounting standards, updates, and regulations as of March 31, 2016 that will become effective in&#13;subsequent periods; however, management does not believe that any of those updates would have significantly affected our financial&#13;accounting measures or disclosures had they been in effect during 2016 or 2015, and it does not believe that any of those pronouncements&#13;will have a significant impact on our condensed consolidated financial statements at the time they become effective.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;u style="text-decoration: none"&gt;&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;u&gt;Reclassifications&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;u style="text-decoration: none"&gt;&amp;#160;&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Certain prior year amounts have been reclassified&#13;to conform to the current year presentation. The reclassifications did not have any effect on reported consolidated net income&#13;for any periods presented.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;(Amounts and shares in thousands,&#13;except per share amounts) (UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;u&gt;Earnings Per Share&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Three months ended &lt;br /&gt;March 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Three months ended &lt;br /&gt;March 31, 2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;u&gt;&lt;/u&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Basic&lt;/u&gt;&lt;/p&gt;&#13;        &lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Numerator:&lt;/u&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; width: 33%; font-size: 11pt"&gt;Net income available to&amp;#160;common stockholders&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;3,005&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;2,810&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;50&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;2,019&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1,888&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;33&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;&lt;u&gt;Denominator:&lt;/u&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.46&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&#13;                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;0.33&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.09&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Diluted&lt;/u&gt;&lt;/p&gt;&#13;        &lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Denominator:&lt;/u&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Convertible Class C Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Total denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.45&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.09&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Nine months ended &lt;br /&gt;March 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Nine months ended &lt;br /&gt;March 31, 2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;u&gt;&lt;/u&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Basic&lt;/u&gt;&lt;/p&gt;&#13;        &lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Numerator:&lt;/u&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; width: 33%; font-size: 11pt"&gt;Net income available to&amp;#160;common stockholders&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;9,360&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;8,752&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;155&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;7,212&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,743&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;119&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;&lt;u&gt;Denominator:&lt;/u&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.55&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.45&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.19&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.11&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Diluted&lt;/u&gt;&lt;/p&gt;&#13;        &lt;p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"&gt;&lt;u&gt;Denominator:&lt;/u&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;6,050&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Convertible Class C Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Total denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.42&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;1.09&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;0.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;(Amounts in thousands)&#13;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Receivables, net is comprised of the following&#13;at March 31, 2016:&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Gross &lt;br /&gt;Receivable&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Allowance for &lt;br /&gt;doubtful accounts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Net&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;4,614&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;288&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;4,326&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Accounts receivable - related party&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Medical receivable&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;36,164&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;26,067&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;10,097&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Management and other fees receivable&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;28,873&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;12,972&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;15,901&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Management and other fees receivable - related medical practices ("PC&amp;#146;s")&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;4,462&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;403&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;4,059&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Receivables, net is comprised of the following&#13;at June 30, 2015:&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Gross &lt;br /&gt;Receivable&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Allowance for &lt;br /&gt;doubtful accounts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;Net&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;4,153&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;362&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;3,791&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Accounts receivable - related party&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Medical receivable&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;24,541&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;15,459&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;9,082&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Management and other fees receivable&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;27,330&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;13,272&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;14,058&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt"&gt;Management and other fees receivable -&amp;#160;&amp;#160;related medical practices ("PC&amp;#146;s")&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;3,910&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;403&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;3,507&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock>
    <us-gaap:ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;(Amounts in thousands) (UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company&amp;#146;s patient fee revenue, net&#13;of contractual allowances and discounts less the provision for bad debts for the three and nine months ended March 31, 2016 and&#13;2015 are summarized in the following tables.&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: center; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;For the Three Months Ended &lt;br /&gt;March 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 60%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;&lt;td style="width: 6%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-size: 11pt"&gt;1,245&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-size: 11pt"&gt;1,091&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Medicare/Medicaid&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;332&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;292&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Workers' Compensation/Personal Injury&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;5,453&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;4,513&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;1,665&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;1,388&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Patient Fee Revenue, net of contractual allowances and discounts&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;8,695&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;7,284&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Provision for Bad Debts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;(3,830&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;(3,201&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Net Patient Fee for Revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;4,865&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;4,083&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: center; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;For the Nine Months Ended &lt;br /&gt;March 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 60%; text-align: left; padding-left: 0pt; font-size: 11pt"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;&lt;td style="width: 6%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-size: 11pt"&gt;3,438&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-size: 11pt"&gt;3,245&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="padding-left: 0pt; font-size: 11pt"&gt;Medicare/Medicaid&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;874&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;896&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;Workers' Compensation/Personal Injury&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;15,649&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;11,354&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;4,635&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;5,205&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt"&gt;Patient Fee Revenue, net of contractual allowances and discounts&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;24,596&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;20,700&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; font-size: 11pt"&gt;Provision for Bad Debts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;(10,608&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;(9,244&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; font-size: 11pt"&gt;Net Patient Fee for Revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;13,988&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;11,456&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;(Amounts in thousands) (UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Inventories included in the accompanying condensed consolidated balance&#13;sheet consist of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: center; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;March 31, &lt;br /&gt;2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;June 30, &lt;br /&gt;2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 56%; text-align: left; text-indent: -0.25in; padding-left: 0.25in; font-size: 11pt"&gt;Purchased parts, components and supplies&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;2,033&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;2,043&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; font-size: 11pt"&gt;Work-in-process&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;201&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;149&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; font-size: 11pt"&gt;Total Inventories&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;2,234&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;2,192&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <FONR:CustomerAdvancesTableTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;(Amounts in thousands)&#13;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;Information relating&#13;to uncompleted contracts is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;March 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;June 30, 2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 56%; text-align: left; text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Costs incurred on uncompleted contracts&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;2,310&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;1,862&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Estimated earnings&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;1,622&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;1,371&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Subtotal&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;3,932&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;3,233&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Less: Billings to date&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;3,908&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;2,693&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Total Costs and estimated earnings in excess of billings on uncompleted contracts&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;24&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;540&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt"&gt;&amp;#160;&lt;/p&gt;</FONR:CustomerAdvancesTableTextBlock>
    <FONR:IncludedInAccompanyingCondensedConsolidatedBalanceSheets contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;(Amounts in thousands) (UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&amp;#160;Included in&#13;the accompanying condensed consolidated balance sheets under the following captions:&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;March 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;June 30, 2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 56%; text-align: left; text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Costs and estimated earnings in excess of billings on uncompleted contracts&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;279&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;682&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Less: Billings in excess of costs and estimated earnings on uncompleted contracts&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;255&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;142&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt"&gt;Total Costs and estimated earnings in excess of billings on uncompleted contracts&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;24&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;540&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;</FONR:IncludedInAccompanyingCondensedConsolidatedBalanceSheets>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;(Amounts in thousands)&#13;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; text-align: center; margin-bottom: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Other intangible assets, net of accumulated&#13;amortization, in the accompanying condensed consolidated balance sheet consist of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 11pt"&gt;March 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 11pt"&gt;June 30, 2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 56%; text-align: left; padding-left: 8.85pt; font-size: 11pt"&gt;Capitalized software development costs&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;7,005&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;7,005&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 8.85pt; font-size: 11pt"&gt;Patents and copyrights&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;4,612&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;4,547&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="padding-left: 8.85pt; font-size: 11pt"&gt;Non-compete&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;4,100&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;4,100&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 8.85pt; font-size: 11pt"&gt;Customer relationships&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;3,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;3,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 8.85pt; font-size: 11pt"&gt;Gross Other intangible assets&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;19,517&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;19,452&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 8.85pt; font-size: 11pt"&gt;Less: Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;11,451&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;10,502&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 8.85pt; font-size: 11pt"&gt;Other Intangible Assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;8,066&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;8,950&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;(Amounts in thousands) (UNAUDITED)&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Other current liabilities in the accompanying&#13;condensed consolidated balance sheet consist of the following:&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;March 31, 2016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt"&gt;June 30, 2015&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 56%; text-align: left; text-indent: -8.95pt; padding-left: 8.95pt; font-size: 11pt"&gt;Accrued salaries, commissions and payroll taxes&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;903&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right; font-size: 11pt"&gt;992&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Accrued interest&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;117&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;117&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Litigation accruals&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;493&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;521&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Sales tax payable&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,565&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,539&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Legal and other professional fees&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;307&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;344&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Accounting fees&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;193&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;235&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Self-funded health insurance reserve&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;434&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;510&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Interest and penalty - sales tax&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,644&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,509&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt; font-size: 11pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;982&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;486&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: right; padding-bottom: 2.5pt; padding-left: 5.4pt; font-size: 11pt"&gt;Total Other Current Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;8,638&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"&gt;8,253&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock contextRef="From2015-07-01to2016-03-31">&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;(Amounts  in&#13;thousands) (UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Summarized financial information concerning&#13;the Company's reportable segments is shown in the following table:&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;Medical&lt;/p&gt; &lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;Equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"&gt;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;Management&lt;/p&gt; &lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;of&lt;/p&gt; &lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;Diagnostic&lt;/p&gt; &lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;Imaging&lt;/p&gt; &lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;Centers&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center; font-size: 11pt"&gt;&lt;font style="font-family: Arial, Helvetica, Sans-Serif"&gt;Totals&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt"&gt;For the three months ended March 31, 2016&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="width: 46%; text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="width: 5%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-size: 11pt"&gt;2,454&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-size: 11pt"&gt;16,165&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-size: 11pt"&gt;18,619&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;546&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;546&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;(Loss) income from operations&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;(207&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;)&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;4,304&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;4,097&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;79&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;751&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;830&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;31&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;117&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;148&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="padding-left: 5.4pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt"&gt;For the three months ended March 31, 2015&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,486&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;14,610&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;17,096&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;502&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;502&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;(Loss) income from operations&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;(367&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;)&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;3,033&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,666&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;78&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;811&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;889&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;111&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;111&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="padding-left: 5.4pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt"&gt;For the nine months ended March 31, 2016&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;7,833&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;46,766&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;54,599&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;1,594&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;1,594&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Income from operations&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;18&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;11,919&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;11,937&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;242&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,265&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,507&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;390&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;209&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;599&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="padding-left: 5.4pt; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt"&gt;For the nine months ended March 31, 2015&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;9,177&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;42,996&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;52,173&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;1,504&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;&amp;#151;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;1,504&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Income from operations&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;457&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;9,246&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;9,703&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;229&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,436&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;2,665&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; font-size: 11pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;178&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;55&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-size: 11pt"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 11pt"&gt;233&lt;/td&gt;&lt;td style="text-align: left; font-size: 11pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">403000</us-gaap:IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract>
    <us-gaap:IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">79000</us-gaap:IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract>
    <us-gaap:IncreaseDecreaseInUnbilledReceivables contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">112000</us-gaap:IncreaseDecreaseInUnbilledReceivables>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">117000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">117000</us-gaap:InterestPayableCurrent>
    <FONR:OwnershipInterestOfImperialInHdm contextRef="AsOf2016-05-02" unitRef="Pure" decimals="INF">1.00</FONR:OwnershipInterestOfImperialInHdm>
    <FONR:RepaymentOfBalanceOfClassStockholdersCapitalContribution contextRef="AsOf2016-05-02" unitRef="USD" decimals="-3">1125000</FONR:RepaymentOfBalanceOfClassStockholdersCapitalContribution>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">4097000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">2666000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">11937000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">9703000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:InterestExpense contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">-127000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">-169000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-416000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-545000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">1000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-2000</us-gaap:NonoperatingIncomeExpense>
    <FONR:BuyoutOfNoncontrollingInterests contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">-4971000</FONR:BuyoutOfNoncontrollingInterests>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">4865000</us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts contextRef="From2015-01-01to2015-03-31" unitRef="USD" decimals="-3">4083000</us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">13988000</us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts contextRef="From2014-07-01to2015-03-31" unitRef="USD" decimals="-3">11456000</us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>fonr-20160331.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: XFR%2DMayQ%2Dfinal.xfr; Date: 2016%2D05%2D10T19:03:03Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9a45o7xRiXhun8uGbHdcOaKICaP9wZ93yekhsGR8bblaPygpgo+k6Cq/1PUWgWYH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:FONR="http://fonar.com/20160331" elementFormDefault="qualified" targetNamespace="http://fonar.com/20160331">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://fonar.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/StatementsOfIncome" id="StatementsOfIncome">
	  <link:definition>00000004 - Statement - Consolidated Statements of Income</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000005 - Statement - Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" id="Note1-DescriptionOfBusinessAndBasisOfPresentationUsd">
	  <link:definition>00000006 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (USD $)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd" id="Note2-SummaryOfSignificantAccountingPoliciesUsd">
	  <link:definition>00000007 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (USD $)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" id="Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd">
	  <link:definition>00000008 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note4-Inventories" id="Note4-Inventories">
	  <link:definition>00000009 - Disclosure - NOTE 4 - INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts" id="Note5-CostsAndEstimatedEarningsOnUncompletedContracts">
	  <link:definition>00000010 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets" id="Note6-OtherIntangibleAssets">
	  <link:definition>00000011 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities" id="Note7-OtherCurrentLiabilities">
	  <link:definition>00000012 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note8-SegmentAndRelatedInformation" id="Note8-SegmentAndRelatedInformation">
	  <link:definition>00000013 - Disclosure - NOTE 8 - SEGMENT AND RELATED INFORMATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note9-SupplementalCashFlowInformation" id="Note9-SupplementalCashFlowInformation">
	  <link:definition>00000014 - Disclosure - NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note10-CommitmentsAndContingencies" id="Note10-CommitmentsAndContingencies">
	  <link:definition>00000015 - Disclosure - NOTE 10 - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note11-IncomeTaxes" id="Note11-IncomeTaxes">
	  <link:definition>00000016 - Disclosure - NOTE 11 - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note12-SubsequentEvents" id="Note12-SubsequentEvents">
	  <link:definition>00000017 - Disclosure - NOTE 12 - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" id="Note2-SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000018 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" id="Note2-SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000019 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" id="Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables">
	  <link:definition>00000020 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $) (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note4-InventoriesTables" id="Note4-InventoriesTables">
	  <link:definition>00000021 - Disclosure - NOTE 4 - INVENTORIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" id="Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables">
	  <link:definition>00000022 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note6-OtherIntangibleAssetsTables" id="Note6-OtherIntangibleAssetsTables">
	  <link:definition>00000023 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables" id="Note7-OtherCurrentLiabilitiesTables">
	  <link:definition>00000024 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note8-SegmentAndRelatedInformationTables" id="Note8-SegmentAndRelatedInformationTables">
	  <link:definition>00000025 - Disclosure - NOTE 8 - SEGMENT AND RELATED INFORMATION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" id="Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails">
	  <link:definition>00000026 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" id="Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details">
	  <link:definition>00000027 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Receivables, Net - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" id="Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details">
	  <link:definition>00000028 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Patient Fees Revenue - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note4-InventoriesDetails" id="Note4-InventoriesDetails">
	  <link:definition>00000029 - Disclosure - NOTE 4 - INVENTORIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" id="Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details">
	  <link:definition>00000030 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Information relating to uncompleted contracts -  (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" id="Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details">
	  <link:definition>00000031 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Balance Sheet Items -  (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-Details" id="Note6-OtherIntangibleAssets-Details">
	  <link:definition>00000032 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities-Details" id="Note7-OtherCurrentLiabilities-Details">
	  <link:definition>00000033 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES -  (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note8-SegmentAndRelatedInformation-SegmentInformation-Details" id="Note8-SegmentAndRelatedInformation-SegmentInformation-Details">
	  <link:definition>00000034 - Disclosure - NOTE 8 - SEGMENT AND RELATED INFORMATION - Segment Information - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" id="Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative">
	  <link:definition>00000035 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" id="Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative">
	  <link:definition>00000036 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" id="Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative">
	  <link:definition>00000037 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative" id="Note6-OtherIntangibleAssets-DetailsNarrative">
	  <link:definition>00000038 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note9-SupplementalCashFlowInformation-DetailsNarrative" id="Note9-SupplementalCashFlowInformation-DetailsNarrative">
	  <link:definition>00000039 - Disclosure - NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION ($)- (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note10-CommitmentsAndContingencies-DetailsNarrative" id="Note10-CommitmentsAndContingencies-DetailsNarrative">
	  <link:definition>00000040 - Disclosure - NOTE 10 - COMMITMENTS AND CONTINGENCIES - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note11-IncomeTaxes-DetailsNarrative" id="Note11-IncomeTaxes-DetailsNarrative">
	  <link:definition>00000041 - Disclosure - NOTE 11 - INCOME TAXES - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note12-SubsequentEvents-DetailsNarrative" id="Note12-SubsequentEvents-DetailsNarrative">
	  <link:definition>00000042 - Disclosure - NOTE 12 - SUBSEQUENT EVENTS - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20160331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20160331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20160331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20160331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <element id="FONR_ServiceAndRepairFeesRelatedPartiesNet" name="ServiceAndRepairFeesRelatedPartiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" name="ManagementAndOtherFeesRelatedMedicalPracticesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" name="CostsRelatedToServiceAndRepairFeesRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" name="CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" name="NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" name="NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" name="MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalReceivable" name="MedicalReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFees_NonRelatedParties" name="ManagementAndOtherFees_NonRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetRelatedParty" name="AccountsReceivableNetRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsIncurredOnUncompletedContracts" name="CostsIncurredOnUncompletedContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EstimatedEarnings" name="EstimatedEarnings" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" name="SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" name="ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableServiceAndRepairFees" name="AccountsReceivableServiceAndRepairFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProvisionForBadDebts" name="ProvisionForBadDebts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" name="HmcaOwnershipSizeOfImperialManagementServicesPercent" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" name="OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" name="OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" name="CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerAdvancesTableTextBlock" name="CustomerAdvancesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets" name="IncludedInAccompanyingCondensedConsolidatedBalanceSheets" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestOfImperialInHdm" name="OwnershipInterestOfImperialInHdm" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RepaymentOfBalanceOfClassStockholdersCapitalContribution" name="RepaymentOfBalanceOfClassStockholdersCapitalContribution" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BuyoutOfNoncontrollingInterests" name="BuyoutOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PreferredStockClassAMember" name="PreferredStockClassAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassANonVotingPreferredStockMember" name="ClassANonVotingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatentsAndCopyrightsMember" name="PatentsAndCopyrightsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableGrossMember" name="AccountsReceivableGrossMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommercialInsuranceManagedCareMember" name="CommercialInsuranceManagedCareMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicareMedicaidMember" name="MedicareMedicaidMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WorkersCompensationPersonalInjuryMember" name="WorkersCompensationPersonalInjuryMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherRevenueSourceMember" name="OtherRevenueSourceMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalEquipmentMember" name="MedicalEquipmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementOfDiagnosticImagingCentersMember" name="ManagementOfDiagnosticImagingCentersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NotesToFinancialStatementsAbstract" name="NotesToFinancialStatementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract" name="SummaryOfSignificantAccountingPoliciesPoliciesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivablesReceivablesNetDetailsAbstract" name="AccountsReceivablesReceivablesNetDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Note2SummaryOfSignificantAccountingPoliciesPatientFeeRevenueRecognitionDetailsAbstract" name="Note2SummaryOfSignificantAccountingPoliciesPatientFeeRevenueRecognitionDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Note9ControllingAndNoncontrollingInterestsAbstract" name="Note9ControllingAndNoncontrollingInterestsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" name="AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract" name="Note11SupplementalCashFlowInformationDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_InventoryAxis" name="InventoryAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>fonr-20160331_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: XFR%2DMayQ%2Dfinal.xfr; Date: 2016%2D05%2D10T19:03:03Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/DocumentAndEntityInformation" xlink:href="fonr-20160331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/BalanceSheets" xlink:href="fonr-20160331.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/BalanceSheetsParenthetical" xlink:href="fonr-20160331.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/StatementsOfIncome" xlink:href="fonr-20160331.xsd#StatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/StatementsOfCashFlows" xlink:href="fonr-20160331.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:href="fonr-20160331.xsd#Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:href="fonr-20160331.xsd#Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:href="fonr-20160331.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-Inventories" xlink:href="fonr-20160331.xsd#Note4-Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:href="fonr-20160331.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets" xlink:href="fonr-20160331.xsd#Note6-OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities" xlink:href="fonr-20160331.xsd#Note7-OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-SegmentAndRelatedInformation" xlink:href="fonr-20160331.xsd#Note8-SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-SupplementalCashFlowInformation" xlink:href="fonr-20160331.xsd#Note9-SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-CommitmentsAndContingencies" xlink:href="fonr-20160331.xsd#Note10-CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-IncomeTaxes" xlink:href="fonr-20160331.xsd#Note11-IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-SubsequentEvents" xlink:href="fonr-20160331.xsd#Note12-SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20160331.xsd#Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20160331.xsd#Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:href="fonr-20160331.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-InventoriesTables" xlink:href="fonr-20160331.xsd#Note4-InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:href="fonr-20160331.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssetsTables" xlink:href="fonr-20160331.xsd#Note6-OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables" xlink:href="fonr-20160331.xsd#Note7-OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-SegmentAndRelatedInformationTables" xlink:href="fonr-20160331.xsd#Note8-SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:href="fonr-20160331.xsd#Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:href="fonr-20160331.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:href="fonr-20160331.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-InventoriesDetails" xlink:href="fonr-20160331.xsd#Note4-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:href="fonr-20160331.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:href="fonr-20160331.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-Details" xlink:href="fonr-20160331.xsd#Note6-OtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities-Details" xlink:href="fonr-20160331.xsd#Note7-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:href="fonr-20160331.xsd#Note8-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note6-OtherIntangibleAssets-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-SupplementalCashFlowInformation-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note9-SupplementalCashFlowInformation-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-CommitmentsAndContingencies-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note10-CommitmentsAndContingencies-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-IncomeTaxes-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note11-IncomeTaxes-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-SubsequentEvents-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note12-SubsequentEvents-DetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountsReceivableNetRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="loc_FONRManagementAndOtherFees_NonRelatedParties" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagementAndOtherFees_NonRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNet" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNet" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNet" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNet" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherDeferredCreditsCurrent" xlink:label="loc_us-gaapOtherDeferredCreditsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherDeferredCreditsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerAdvancesCurrent" xlink:label="loc_us-gaapCustomerAdvancesCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapCustomerAdvancesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BillingsInExcessOfCostCurrent" xlink:label="loc_us-gaapBillingsInExcessOfCostCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapBillingsInExcessOfCostCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital" xlink:label="loc_us-gaapStockholdersEquityAttributableToParentNotAllowableForNetCapital" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:to="loc_us-gaapStockholdersEquityAttributableToParentNotAllowableForNetCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/StatementsOfIncome" xlink:title="00000004 - Statement - Consolidated Statements of Income">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaapCostOfGoodsSold" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapCostOfGoodsSold" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaintenanceCosts" xlink:label="loc_us-gaapMaintenanceCosts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapMaintenanceCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ServiceManagementCosts" xlink:label="loc_us-gaapServiceManagementCosts" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapServiceManagementCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Statements of Cash Flows" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:title="00000006 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (USD $)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:title="00000007 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (USD $)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:title="00000008 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-Inventories" xlink:title="00000009 - Disclosure - NOTE 4 - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:title="00000010 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets" xlink:title="00000011 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilities" xlink:title="00000012 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-SegmentAndRelatedInformation" xlink:title="00000013 - Disclosure - NOTE 8 - SEGMENT AND RELATED INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-SupplementalCashFlowInformation" xlink:title="00000014 - Disclosure - NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - NOTE 10 - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-IncomeTaxes" xlink:title="00000016 - Disclosure - NOTE 11 - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-SubsequentEvents" xlink:title="00000017 - Disclosure - NOTE 12 - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000018 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000019 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:title="00000020 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $) (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-InventoriesTables" xlink:title="00000021 - Disclosure - NOTE 4 - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:title="00000022 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssetsTables" xlink:title="00000023 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables" xlink:title="00000024 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-SegmentAndRelatedInformationTables" xlink:title="00000025 - Disclosure - NOTE 8 - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:title="00000026 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:title="00000027 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Receivables, Net - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:title="00000028 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Patient Fees Revenue - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-InventoriesDetails" xlink:title="00000029 - Disclosure - NOTE 4 - INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:title="00000030 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Information relating to uncompleted contracts -  (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:label="loc_FONRSubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CostsIncurredOnUncompletedContracts" xlink:label="loc_FONRCostsIncurredOnUncompletedContracts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRSubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:to="loc_FONRCostsIncurredOnUncompletedContracts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_EstimatedEarnings" xlink:label="loc_FONREstimatedEarnings" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRSubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:to="loc_FONREstimatedEarnings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:to="loc_FONRSubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerAdvancesAndDeposits" xlink:label="loc_us-gaapCustomerAdvancesAndDeposits" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:to="loc_us-gaapCustomerAdvancesAndDeposits" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:title="00000031 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Balance Sheet Items -  (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BillingsInExcessOfCostCurrent" xlink:label="loc_us-gaapBillingsInExcessOfCostCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:to="loc_us-gaapBillingsInExcessOfCostCurrent" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets-Details" xlink:title="00000032 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilities-Details" xlink:title="00000033 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES -  (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:title="00000034 - Disclosure - NOTE 8 - SEGMENT AND RELATED INFORMATION - Segment Information - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:title="00000035 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION - (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:title="00000036 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:title="00000037 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative" xlink:title="00000038 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-SupplementalCashFlowInformation-DetailsNarrative" xlink:title="00000039 - Disclosure - NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION ($)- (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-CommitmentsAndContingencies-DetailsNarrative" xlink:title="00000040 - Disclosure - NOTE 10 - COMMITMENTS AND CONTINGENCIES - (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-IncomeTaxes-DetailsNarrative" xlink:title="00000041 - Disclosure - NOTE 11 - INCOME TAXES - (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-SubsequentEvents-DetailsNarrative" xlink:title="00000042 - Disclosure - NOTE 12 - SUBSEQUENT EVENTS - (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>fonr-20160331_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: XFR%2DMayQ%2Dfinal.xfr; Date: 2016%2D05%2D10T19:03:03Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/DocumentAndEntityInformation" xlink:href="fonr-20160331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/BalanceSheets" xlink:href="fonr-20160331.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/BalanceSheetsParenthetical" xlink:href="fonr-20160331.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/StatementsOfIncome" xlink:href="fonr-20160331.xsd#StatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/StatementsOfCashFlows" xlink:href="fonr-20160331.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:href="fonr-20160331.xsd#Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:href="fonr-20160331.xsd#Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:href="fonr-20160331.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-Inventories" xlink:href="fonr-20160331.xsd#Note4-Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:href="fonr-20160331.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets" xlink:href="fonr-20160331.xsd#Note6-OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities" xlink:href="fonr-20160331.xsd#Note7-OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-SegmentAndRelatedInformation" xlink:href="fonr-20160331.xsd#Note8-SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-SupplementalCashFlowInformation" xlink:href="fonr-20160331.xsd#Note9-SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-CommitmentsAndContingencies" xlink:href="fonr-20160331.xsd#Note10-CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-IncomeTaxes" xlink:href="fonr-20160331.xsd#Note11-IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-SubsequentEvents" xlink:href="fonr-20160331.xsd#Note12-SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20160331.xsd#Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20160331.xsd#Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:href="fonr-20160331.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-InventoriesTables" xlink:href="fonr-20160331.xsd#Note4-InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:href="fonr-20160331.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssetsTables" xlink:href="fonr-20160331.xsd#Note6-OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables" xlink:href="fonr-20160331.xsd#Note7-OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-SegmentAndRelatedInformationTables" xlink:href="fonr-20160331.xsd#Note8-SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:href="fonr-20160331.xsd#Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:href="fonr-20160331.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:href="fonr-20160331.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-InventoriesDetails" xlink:href="fonr-20160331.xsd#Note4-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:href="fonr-20160331.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:href="fonr-20160331.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-Details" xlink:href="fonr-20160331.xsd#Note6-OtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities-Details" xlink:href="fonr-20160331.xsd#Note7-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:href="fonr-20160331.xsd#Note8-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note6-OtherIntangibleAssets-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-SupplementalCashFlowInformation-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note9-SupplementalCashFlowInformation-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-CommitmentsAndContingencies-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note10-CommitmentsAndContingencies-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-IncomeTaxes-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note11-IncomeTaxes-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-SubsequentEvents-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note12-SubsequentEvents-DetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_PreferredStockClassAMember" xlink:label="loc_FONRPreferredStockClassAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRPreferredStockClassAMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_60" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_110" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/StatementsOfIncome" xlink:title="00000004 - Statement - Consolidated Statements of Income">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_PreferredStockClassAMember" xlink:label="loc_FONRPreferredStockClassAMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRPreferredStockClassAMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaapSalesRevenueGoodsNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_us-gaapSalesRevenueGoodsNet_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaintenanceRevenue" xlink:label="loc_us-gaapMaintenanceRevenue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_us-gaapMaintenanceRevenue_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenue_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ManagementFeesRevenue" xlink:label="loc_us-gaapManagementFeesRevenue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_us-gaapManagementFeesRevenue_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_170" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_us-gaapSalesRevenueNet_170" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract_170" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaapCostOfGoodsSold_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapCostOfGoodsSold_170" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaintenanceCosts" xlink:label="loc_us-gaapMaintenanceCosts_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapMaintenanceCosts_170" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_170" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue_170" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ServiceManagementCosts" xlink:label="loc_us-gaapServiceManagementCosts_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapServiceManagementCosts_170" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_170" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_170" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_170" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts_170" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapCostsAndExpenses_170" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAbstract" xlink:label="loc_us-gaapOtherIncomeAbstract_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherIncomeAbstract_170" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_170" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapInterestExpense_170" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapInvestmentIncomeNet_170" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapNonoperatingIncomeExpense_170" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_170" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_170" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapProfitLoss_170" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_170" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapNetIncomeLoss_170" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapEarningsPerShareBasic_170" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapEarningsPerShareDiluted_170" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_170" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_170" xlink:type="arc" order="37" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:title="00000006 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (USD $)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:title="00000007 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (USD $)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:title="00000008 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-Inventories" xlink:title="00000009 - Disclosure - NOTE 4 - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:title="00000010 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets" xlink:title="00000011 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilities" xlink:title="00000012 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-SegmentAndRelatedInformation" xlink:title="00000013 - Disclosure - NOTE 8 - SEGMENT AND RELATED INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-SupplementalCashFlowInformation" xlink:title="00000014 - Disclosure - NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - NOTE 10 - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-IncomeTaxes" xlink:title="00000016 - Disclosure - NOTE 11 - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-SubsequentEvents" xlink:title="00000017 - Disclosure - NOTE 12 - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000018 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000019 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:title="00000020 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $) (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-InventoriesTables" xlink:title="00000021 - Disclosure - NOTE 4 - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:title="00000022 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssetsTables" xlink:title="00000023 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables" xlink:title="00000024 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-SegmentAndRelatedInformationTables" xlink:title="00000025 - Disclosure - NOTE 8 - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:title="00000026 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_130" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:title="00000027 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Receivables, Net - (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsCurrentMember" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsCurrentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsCurrentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRAccountsReceivableNetRelatedParty_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRMedicalReceivable_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="loc_FONRManagementAndOtherFees_NonRelatedParties_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagementAndOtherFees_NonRelatedParties_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:title="00000028 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Patient Fees Revenue - (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenue_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenue_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_210" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-InventoriesDetails" xlink:title="00000029 - Disclosure - NOTE 4 - INVENTORIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:title="00000030 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Information relating to uncompleted contracts -  (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:title="00000031 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Balance Sheet Items -  (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets-Details" xlink:title="00000032 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilities-Details" xlink:title="00000033 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES -  (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:title="00000034 - Disclosure - NOTE 8 - SEGMENT AND RELATED INFORMATION - Segment Information - (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_MedicalEquipmentMember" xlink:label="loc_FONRMedicalEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRMedicalEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSalesRevenueNet_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid_130" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:title="00000035 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION - (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:title="00000036 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:title="00000037 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative" xlink:title="00000038 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_170" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-SupplementalCashFlowInformation-DetailsNarrative" xlink:title="00000039 - Disclosure - NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION ($)- (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-CommitmentsAndContingencies-DetailsNarrative" xlink:title="00000040 - Disclosure - NOTE 10 - COMMITMENTS AND CONTINGENCIES - (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-IncomeTaxes-DetailsNarrative" xlink:title="00000041 - Disclosure - NOTE 11 - INCOME TAXES - (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-SubsequentEvents-DetailsNarrative" xlink:title="00000042 - Disclosure - NOTE 12 - SUBSEQUENT EVENTS - (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>fonr-20160331_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: XFR%2DMayQ%2Dfinal.xfr; Date: 2016%2D05%2D10T19:03:03Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Class B Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="us-gaap_CommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassCMember_lbl" xml:lang="en-US">Class C Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_PreferredStockClassAMember" xlink:label="FONR_PreferredStockClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PreferredStockClassAMember" xlink:to="FONR_PreferredStockClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PreferredStockClassAMember_lbl" xml:lang="en-US">Preferred Stock Class A</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="FONR_ClassANonVotingPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockMember_lbl" xml:lang="en-US">Class A NonVoting Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Capitalized software development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="FONR_PatentsAndCopyrightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatentsAndCopyrightsMember_lbl" xml:lang="en-US">Patents and copyrights</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer relationships</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="us-gaap_OtherIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsMember" xlink:to="us-gaap_OtherIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsMember_lbl" xml:lang="en-US">Gross Other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="us-gaap_NoncompeteAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US">Non-compete</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoriesMember" xlink:label="us-gaap_InventoriesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoriesMember" xlink:to="us-gaap_InventoriesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoriesMember_lbl" xml:lang="en-US">InventoriesMember</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_InventoryAxis" xlink:label="FONR_InventoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InventoryAxis" xlink:to="FONR_InventoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_InventoryAxis_lbl" xml:lang="en-US">Inventory [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsCurrentMember" xlink:label="us-gaap_AllowanceForDoubtfulAccountsCurrentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsCurrentMember" xlink:to="us-gaap_AllowanceForDoubtfulAccountsCurrentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsCurrentMember_lbl" xml:lang="en-US">Allowance for Doubtful Accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xml:lang="en-US">AccountsNotesLoansAndFinancingReceivableByReceivableType [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_AccountsReceivableGrossMember" xlink:label="FONR_AccountsReceivableGrossMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableGrossMember" xlink:to="FONR_AccountsReceivableGrossMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableGrossMember_lbl" xml:lang="en-US">Accounts Receivable, Gross</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Gross Receivabe</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="FONR_CommercialInsuranceManagedCareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommercialInsuranceManagedCareMember_lbl" xml:lang="en-US">Commercial Insurance / Managed Care</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_MedicareMedicaidMember" xlink:label="FONR_MedicareMedicaidMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicareMedicaidMember_lbl" xml:lang="en-US">Medicare/Medicaid</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="FONR_WorkersCompensationPersonalInjuryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_lbl" xml:lang="en-US">Workers Compensation/Personal Injury</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_OtherRevenueSourceMember" xlink:label="FONR_OtherRevenueSourceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherRevenueSourceMember_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_MedicalEquipmentMember" xlink:label="FONR_MedicalEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalEquipmentMember" xlink:to="FONR_MedicalEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalEquipmentMember_lbl" xml:lang="en-US">Medical Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xml:lang="en-US">Statement, Operating Activities Segment [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xml:lang="en-US">Management Of Diagnostic Imaging Centers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Is Entity a Well-known Seasoned Issuer?</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Is Entity a Voluntary Filer?</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Is Entity's Reporting Status Current?</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="FONR_AccountsReceivableServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_lbl" xml:lang="en-US">Accounts receivable - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="FONR_AccountsReceivableNetRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetRelatedParty" xlink:to="FONR_AccountsReceivableNetRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetRelatedParty_lbl" xml:lang="en-US">Accounts receivable - Related party</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_MedicalReceivable" xlink:label="FONR_MedicalReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalReceivable_lbl" xml:lang="en-US">Medical receivables -net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="FONR_ManagementAndOtherFees_NonRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees_NonRelatedParties" xlink:to="FONR_ManagementAndOtherFees_NonRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFees_NonRelatedParties_lbl" xml:lang="en-US">Management and other fees receivable -net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xml:lang="en-US">Management and other fees receivable - related medical practices -net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:label="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:to="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms_lbl" xml:lang="en-US">Costs and estimated earnings in excess of billings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Deferred income tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Other intangible assets - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsNet" xlink:label="us-gaap_AssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNet_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xml:lang="en-US">Current portion of long-term debt and capital leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherDeferredCreditsCurrent" xlink:label="us-gaap_OtherDeferredCreditsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDeferredCreditsCurrent" xlink:to="us-gaap_OtherDeferredCreditsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDeferredCreditsCurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerAdvancesCurrent" xlink:label="us-gaap_CustomerAdvancesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerAdvancesCurrent" xlink:to="us-gaap_CustomerAdvancesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerAdvancesCurrent_lbl" xml:lang="en-US">Customer advances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BillingsInExcessOfCostCurrent" xlink:label="us-gaap_BillingsInExcessOfCostCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BillingsInExcessOfCostCurrent" xlink:to="us-gaap_BillingsInExcessOfCostCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BillingsInExcessOfCostCurrent_lbl" xml:lang="en-US">Billings in excess of costs and estimated earnings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-Term Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_lbl" xml:lang="en-US">Deferred income tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableRelatedPartiesNoncurrent_lbl" xml:lang="en-US">Due to related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xml:lang="en-US">Long-term debt and capital leases, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Long-Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">STOCKHOLDERS' EQUITY:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Paid-in capital in excess of par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure" xlink:label="us-gaap_NotesReceivableFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReceivableFairValueDisclosure" xlink:to="us-gaap_NotesReceivableFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesReceivableFairValueDisclosure_lbl" xml:lang="en-US">Notes receivable from employee stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost - 12 shares of common stock at March 31, 2016 and June 30, 2015</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital" xlink:label="us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital" xlink:to="us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital_lbl" xml:lang="en-US">Total Fonar Corporation Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Non controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_lbl" xml:lang="en-US">Total Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred Stock, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">REVENUES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="us-gaap_SalesRevenueGoodsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueGoodsNet" xlink:to="us-gaap_SalesRevenueGoodsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueGoodsNet_lbl" xml:lang="en-US">Product sales - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaintenanceRevenue" xlink:label="us-gaap_MaintenanceRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaintenanceRevenue" xlink:to="us-gaap_MaintenanceRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaintenanceRevenue_lbl" xml:lang="en-US">Service and repair fees - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xml:lang="en-US">Service and repair fees - related parties - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:to="us-gaap_HealthCareOrganizationPatientServiceRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenue_lbl" xml:lang="en-US">Patient fee revenue, net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:to="us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_lbl" xml:lang="en-US">Provision for bad debts for patient fee</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ManagementFeesRevenue" xlink:label="us-gaap_ManagementFeesRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManagementFeesRevenue" xlink:to="us-gaap_ManagementFeesRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ManagementFeesRevenue_lbl" xml:lang="en-US">Management and other fees - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xml:lang="en-US">Management and other fees - related medical practices - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_SalesRevenueNet_lbl" xml:lang="en-US">Total Revenues - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US">COSTS AND EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="us-gaap_CostOfGoodsSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsSold" xlink:to="us-gaap_CostOfGoodsSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsSold_lbl" xml:lang="en-US">Costs related to product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaintenanceCosts" xlink:label="us-gaap_MaintenanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaintenanceCosts" xlink:to="us-gaap_MaintenanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaintenanceCosts_lbl" xml:lang="en-US">Costs related to service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xml:lang="en-US">Costs related to service and repair fees - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="us-gaap_OtherCostOfOperatingRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostOfOperatingRevenue" xlink:to="us-gaap_OtherCostOfOperatingRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostOfOperatingRevenue_lbl" xml:lang="en-US">Costs related to patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ServiceManagementCosts" xlink:label="us-gaap_ServiceManagementCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServiceManagementCosts" xlink:to="us-gaap_ServiceManagementCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServiceManagementCosts_lbl" xml:lang="en-US">Costs related to management and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xml:lang="en-US">Costs related to management and other fees - related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Provision for bad debts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAbstract" xlink:label="us-gaap_OtherIncomeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAbstract" xlink:to="us-gaap_OtherIncomeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAbstract_lbl" xml:lang="en-US">INCOME</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xml:lang="en-US">Income From Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Other Income (Expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income Before Provision for Income Taxes and Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net Income - Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income - Controlling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic Net Income Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted Net Income Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted Average Basic Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted Average Diluted Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ProvisionForBadDebts" xlink:label="FONR_ProvisionForBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_ProvisionForBadDebts_lbl" xml:lang="en-US">Provision for bad debts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Stock issued for costs and expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_lbl" xml:lang="en-US">Compensatory element of stock issuances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">(Increase) decrease in operating assets, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts, medical receivable(s) and management fee</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="us-gaap_IncreaseDecreaseInReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl" xml:lang="en-US">Notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" xlink:label="us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" xlink:to="us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract_lbl" xml:lang="en-US">Costs and estimated earnings in excess of billings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xml:lang="en-US">Increase (decrease) in operating liabilities, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:to="us-gaap_IncreaseDecreaseInCustomerAdvances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvances_lbl" xml:lang="en-US">Customer advances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:label="us-gaap_IncreaseDecreaseInUnbilledReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:to="us-gaap_IncreaseDecreaseInUnbilledReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInUnbilledReceivables_lbl" xml:lang="en-US">Billings in excess of costs and estimated earnings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_lbl" xml:lang="en-US">Due to related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Cost of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of borrowings and capital lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_BuyoutOfNoncontrollingInterests" xlink:label="FONR_BuyoutOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BuyoutOfNoncontrollingInterests" xlink:to="FONR_BuyoutOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BuyoutOfNoncontrollingInterests_lbl" xml:lang="en-US">Buyout of noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfOtherDebt" xlink:label="us-gaap_RepaymentsOfOtherDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfOtherDebt" xlink:to="us-gaap_RepaymentsOfOtherDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfOtherDebt_lbl" xml:lang="en-US">Repayment of notes receivable from employee stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash used in financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net Increase in Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and Cash Equivalents - Beginning of Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and Cash Equivalents - End of Period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 3 - ACCOUNTS RECEIVABLE. MEDICAL RECEIVABLES AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 4 - INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_NotesToFinancialStatementsAbstract" xlink:label="FONR_NotesToFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotesToFinancialStatementsAbstract" xlink:to="FONR_NotesToFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NotesToFinancialStatementsAbstract_lbl" xml:lang="en-US">Notes to Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" xlink:to="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock_lbl" xml:lang="en-US">NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 6 - OTHER INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">NOTE 7 - OTHER CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 8 - SEGMENT AND RELATED INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xml:lang="en-US">NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 10 - COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 11 - INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">NOTE 12 - SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:label="FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract_lbl" xml:lang="en-US">Note 2 - Summary Of Significant Accounting Policies Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_lbl" xml:lang="en-US">Receivables - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock" xlink:label="us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock_lbl" xml:lang="en-US">Patient fee revenue - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CustomerAdvancesTableTextBlock" xlink:label="FONR_CustomerAdvancesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerAdvancesTableTextBlock" xlink:to="FONR_CustomerAdvancesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerAdvancesTableTextBlock_lbl" xml:lang="en-US">Information relating to uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets" xlink:label="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets" xlink:to="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets_lbl" xml:lang="en-US">Included in the accompanying condensed consolidated balance sheets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Other intangible assets - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl" xml:lang="en-US">Segment information</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Basic Numerator: Net income available to common stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Basic Denominator: Weighted average shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Basic Income Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Convertible Class C Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Total Denominator for diluted earnings per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted Income Per Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2_lbl" xml:lang="en-US">Receivable Type [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_2_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_MedicalReceivable_2_lbl" xml:lang="en-US">Medical Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees_NonRelatedParties" xlink:to="FONR_ManagementAndOtherFees_NonRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_ManagementAndOtherFees_NonRelatedParties_2_lbl" xml:lang="en-US">Management and other fees receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_2_lbl" xml:lang="en-US">Management and other fees receivable from related medical practices ("PC's")</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" xlink:to="us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_lbl" xml:lang="en-US">Net patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherInventorySupplies" xlink:label="us-gaap_OtherInventorySupplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventorySupplies" xlink:to="us-gaap_OtherInventorySupplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventorySupplies_lbl" xml:lang="en-US">Purchased parts, components and supplies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-process</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xml:lang="en-US">Total inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CostsIncurredOnUncompletedContracts" xlink:label="FONR_CostsIncurredOnUncompletedContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsIncurredOnUncompletedContracts" xlink:to="FONR_CostsIncurredOnUncompletedContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsIncurredOnUncompletedContracts_lbl" xml:lang="en-US">Costs incurred on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_EstimatedEarnings" xlink:label="FONR_EstimatedEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedEarnings" xlink:to="FONR_EstimatedEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EstimatedEarnings_lbl" xml:lang="en-US">Estimated earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:label="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:to="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerAdvancesAndDeposits" xlink:label="us-gaap_CustomerAdvancesAndDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerAdvancesAndDeposits" xlink:to="us-gaap_CustomerAdvancesAndDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerAdvancesAndDeposits_lbl" xml:lang="en-US">Less: Billings to date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:label="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:to="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear_lbl" xml:lang="en-US">Total Costs and estimated earnings in excess of billings on uncompleted contracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BillingsInExcessOfCostCurrent" xlink:to="us-gaap_BillingsInExcessOfCostCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BillingsInExcessOfCostCurrent_2_lbl" xml:lang="en-US">Less: Billings in excess of costs and estimated earnings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross Other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Other Intangible Assets - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Accrued salaries, commissions and payroll taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Litigation accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xml:lang="en-US">Sales tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Legal and other professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SelfInsuranceReserve" xlink:label="us-gaap_SelfInsuranceReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SelfInsuranceReserve" xlink:to="us-gaap_SelfInsuranceReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SelfInsuranceReserve_lbl" xml:lang="en-US">Self-funded health insurance reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xml:lang="en-US">Interest and penalty - sales tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_2_lbl" xml:lang="en-US">Total Other current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="us-gaap_StatementOperatingActivitiesSegmentAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis_2_lbl" xml:lang="en-US">Operating Activities [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNet_2_lbl" xml:lang="en-US">Net revenues from external customers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Inter-segment net revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_Note9ControllingAndNoncontrollingInterestsAbstract" xlink:label="FONR_Note9ControllingAndNoncontrollingInterestsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Note9ControllingAndNoncontrollingInterestsAbstract" xlink:to="FONR_Note9ControllingAndNoncontrollingInterestsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_Note9ControllingAndNoncontrollingInterestsAbstract_lbl" xml:lang="en-US">Note 1 - Description Of Business And Basis Of Presentation - Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:to="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xml:lang="en-US">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM (percent).</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xml:lang="en-US">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM (percent).</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:label="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_lbl" xml:lang="en-US">The ownership interest of the original investors of HDM after reorganization of newly expanded HDM (percent).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_2_lbl" xml:lang="en-US">Shares included upon conversion of Class C Common to calculate a diluted EPS</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" xlink:label="FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" xlink:to="FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract_lbl" xml:lang="en-US">Note 3 - Accounts Receivable Medical Receivable And Management And Other Fees Receivable - Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xml:lang="en-US">Net revenues derived from no-fault and personal injury protection claims</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" xlink:label="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" xlink:to="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs_lbl" xml:lang="en-US">Net revenues from management and other fees charged to related PCs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract" xlink:label="FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract" xlink:to="FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract_lbl" xml:lang="en-US">Note 9 - Supplemental Cash Flow Information - Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income Taxes Paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Recorded tax obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xml:lang="en-US">Tax interest and penalties</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:label="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:to="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_lbl" xml:lang="en-US">Maximum limit for individual claims under stop-loss umbrella policy for health insurance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net deferred operating loss carryforwards</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Note9ControllingAndNoncontrollingInterestsAbstract" xlink:to="FONR_Note9ControllingAndNoncontrollingInterestsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_Note9ControllingAndNoncontrollingInterestsAbstract_2_lbl" xml:lang="en-US">Note 12 - Subsequent Events - Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_OwnershipInterestOfImperialInHdm" xlink:label="FONR_OwnershipInterestOfImperialInHdm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestOfImperialInHdm" xlink:to="FONR_OwnershipInterestOfImperialInHdm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestOfImperialInHdm_lbl" xml:lang="en-US">Company's (HMCA) ownership interest of Imperial</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_RepaymentOfBalanceOfClassStockholdersCapitalContribution" xlink:label="FONR_RepaymentOfBalanceOfClassStockholdersCapitalContribution" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RepaymentOfBalanceOfClassStockholdersCapitalContribution" xlink:to="FONR_RepaymentOfBalanceOfClassStockholdersCapitalContribution_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RepaymentOfBalanceOfClassStockholdersCapitalContribution_lbl" xml:lang="en-US">Repayment of balance of Class A Stockholders capital contribution</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableGrossMember" xlink:to="FONR_AccountsReceivableGrossMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsReceivableGrossMember_doc" xml:lang="en-US">Gross Accounts Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetRelatedParty" xlink:to="FONR_AccountsReceivableNetRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsReceivableNetRelatedParty_doc" xml:lang="en-US">Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_doc" xml:lang="en-US">Accounts receivable from service and repair fees of Non Related MRI scanner customers; net of allowances for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BuyoutOfNoncontrollingInterests" xlink:to="FONR_BuyoutOfNoncontrollingInterests_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_BuyoutOfNoncontrollingInterests_doc" xml:lang="en-US">Purchase of noncontrolling interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ClassANonVotingPreferredStockMember_doc" xml:lang="en-US">Class A NonVoting Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CommercialInsuranceManagedCareMember_doc" xml:lang="en-US">Commercial Insurance Managed Care Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" xlink:to="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock_doc" xml:lang="en-US">Costs And EstimatedEarningsOn Uncompleted Contracts And Customer Advances</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsIncurredOnUncompletedContracts" xlink:to="FONR_CostsIncurredOnUncompletedContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsIncurredOnUncompletedContracts_doc" xml:lang="en-US">Costs incurred on uncompleted contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_doc" xml:lang="en-US">Costs related to the management and other fees - related medical practices</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_doc" xml:lang="en-US">Costs incurred and are directly related to generatingmaintenance revenues. Also includes costs of maintenance on client contracts - for related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerAdvancesTableTextBlock" xlink:to="FONR_CustomerAdvancesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CustomerAdvancesTableTextBlock_doc" xml:lang="en-US">Table of total customer advances</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedEarnings" xlink:to="FONR_EstimatedEarnings_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_EstimatedEarnings_doc" xml:lang="en-US">Estimated earnings.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:to="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_doc" xml:lang="en-US">Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name, &amp;#8221;Health Management Company of America&amp;#8221;.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets" xlink:to="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets_doc" xml:lang="en-US">Table of balance sheet items</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InventoryAxis" xlink:to="FONR_InventoryAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_InventoryAxis_doc" xml:lang="en-US">Custom element - Inventory axis</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_doc" xml:lang="en-US">Revenue, comprised of base and incentive revenue derived from the management of joint ventures, managing third-party properties, or another entity's operations - for related medical practices - net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees_NonRelatedParties" xlink:to="FONR_ManagementAndOtherFees_NonRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAndOtherFees_NonRelatedParties_doc" xml:lang="en-US">Management of, and other fees receivable from MRI Centers owned by non-related parties, - net of allowances for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xml:lang="en-US">Management of Diagnostic Imaging Centers - Member - Custom element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_doc" xml:lang="en-US">Management of, and other fees receivable from MRI Centers owned by related medical practices - net of allowances for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:to="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_doc" xml:lang="en-US">The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalEquipmentMember" xlink:to="FONR_MedicalEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicalEquipmentMember_doc" xml:lang="en-US">Medical equipment - Member - Custom element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicalReceivable_doc" xml:lang="en-US">Medical receivable from management of specific centers - net of allowances for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicareMedicaidMember_doc" xml:lang="en-US">Medicare Medicaid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xml:lang="en-US">Approximate per cent ofthePCs net revenues derived from no-fault and personal injury protection claims</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" xlink:to="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs_doc" xml:lang="en-US">Net revenues from Management and other fees charged to related PCs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OtherRevenueSourceMember_doc" xml:lang="en-US">Other Revenue Source</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_doc" xml:lang="en-US">Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name, &amp;#8221;Health Management Company of America&amp;#8221;.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_doc" xml:lang="en-US">Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name, &amp;#8221;Health Management Company of America&amp;#8221;.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestOfImperialInHdm" xlink:to="FONR_OwnershipInterestOfImperialInHdm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OwnershipInterestOfImperialInHdm_doc" xml:lang="en-US">On May 2, 2016, the Company repaid the balance of the Class A Stockholders capital contribution in the amount of $1,125,000. As a result, the Company's subsidiary, HMCA, owns 100% interest in Imperial Management Services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PatentsAndCopyrightsMember_doc" xml:lang="en-US">Patents and copyrights - Member - Custom elements</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PreferredStockClassAMember" xlink:to="FONR_PreferredStockClassAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PreferredStockClassAMember_doc" xml:lang="en-US">Preferred stock class A - Member - Custom element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ProvisionForBadDebts_doc" xml:lang="en-US">Provision for bad debts used for calculationof cash flow statements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RepaymentOfBalanceOfClassStockholdersCapitalContribution" xlink:to="FONR_RepaymentOfBalanceOfClassStockholdersCapitalContribution_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_RepaymentOfBalanceOfClassStockholdersCapitalContribution_doc" xml:lang="en-US">On May 2, 2016, the Company repaid the balance of the Class A Stockholders capital contribution in the amount of $1,125,000. As a result, the Company's subsidiary, HMCA, owns 100% interest in Imperial Management Services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_doc" xml:lang="en-US">Revenue derived from maintenance services provided under contracts or arrangements with clients for related parties - net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:to="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts_doc" xml:lang="en-US">The calculation of the subtotal of costs, estimated earnings, and billings on uncompleted contracts plus costs incurred on uncompleted contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_doc" xml:lang="en-US">Workers Compensation Personal Injury</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNet_2_lbl" xml:lang="en-US">Net Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_2_lbl" xml:lang="en-US">Common Stock, Value, Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital" xlink:to="us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent, Not Allowable for Net Capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_2_lbl" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_2_lbl" xml:lang="en-US">Costs and Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProvisionForBadDebts_3_lbl" xml:lang="en-US">ProvisionForBadDebts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" xlink:to="us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract_2_lbl" xml:lang="en-US">Increase (Decrease) in Cost in Excess of Billing on Uncompleted Contract</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:to="us-gaap_IncreaseDecreaseInCustomerAdvances_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvances_2_lbl" xml:lang="en-US">Increase (Decrease) in Customer Advances</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:to="us-gaap_IncreaseDecreaseInUnbilledReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInUnbilledReceivables_2_lbl" xml:lang="en-US">Increase (Decrease) in Unbilled Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Related Parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" xlink:to="us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_2_lbl" xml:lang="en-US">Health Care Organization, Patient Service Revenue Less Provision for Bad Debts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:to="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts_3_lbl" xml:lang="en-US">SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:to="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear_2_lbl" xml:lang="en-US">Costs in Excess of Billings, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" xlink:to="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs_3_lbl" xml:lang="en-US">NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>fonr-20160331_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: XFR%2DMayQ%2Dfinal.xfr; Date: 2016%2D05%2D10T19:03:03Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/DocumentAndEntityInformation" xlink:href="fonr-20160331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/BalanceSheets" xlink:href="fonr-20160331.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/BalanceSheetsParenthetical" xlink:href="fonr-20160331.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/StatementsOfIncome" xlink:href="fonr-20160331.xsd#StatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/StatementsOfCashFlows" xlink:href="fonr-20160331.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:href="fonr-20160331.xsd#Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:href="fonr-20160331.xsd#Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:href="fonr-20160331.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-Inventories" xlink:href="fonr-20160331.xsd#Note4-Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:href="fonr-20160331.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets" xlink:href="fonr-20160331.xsd#Note6-OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities" xlink:href="fonr-20160331.xsd#Note7-OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-SegmentAndRelatedInformation" xlink:href="fonr-20160331.xsd#Note8-SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-SupplementalCashFlowInformation" xlink:href="fonr-20160331.xsd#Note9-SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-CommitmentsAndContingencies" xlink:href="fonr-20160331.xsd#Note10-CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-IncomeTaxes" xlink:href="fonr-20160331.xsd#Note11-IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-SubsequentEvents" xlink:href="fonr-20160331.xsd#Note12-SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20160331.xsd#Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20160331.xsd#Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:href="fonr-20160331.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-InventoriesTables" xlink:href="fonr-20160331.xsd#Note4-InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:href="fonr-20160331.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssetsTables" xlink:href="fonr-20160331.xsd#Note6-OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables" xlink:href="fonr-20160331.xsd#Note7-OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-SegmentAndRelatedInformationTables" xlink:href="fonr-20160331.xsd#Note8-SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:href="fonr-20160331.xsd#Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:href="fonr-20160331.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:href="fonr-20160331.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-InventoriesDetails" xlink:href="fonr-20160331.xsd#Note4-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:href="fonr-20160331.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:href="fonr-20160331.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-Details" xlink:href="fonr-20160331.xsd#Note6-OtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities-Details" xlink:href="fonr-20160331.xsd#Note7-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:href="fonr-20160331.xsd#Note8-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note6-OtherIntangibleAssets-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-SupplementalCashFlowInformation-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note9-SupplementalCashFlowInformation-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-CommitmentsAndContingencies-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note10-CommitmentsAndContingencies-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-IncomeTaxes-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note11-IncomeTaxes-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-SubsequentEvents-DetailsNarrative" xlink:href="fonr-20160331.xsd#Note12-SubsequentEvents-DetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_DocumentAndEntityInformationAbstract" xlink:label="loc_FONRDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDocumentAndEntityInformationAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_PreferredStockClassAMember" xlink:label="loc_FONRPreferredStockClassAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRPreferredStockClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableNetRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="loc_FONRManagementAndOtherFees_NonRelatedParties" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagementAndOtherFees_NonRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherDeferredCreditsCurrent" xlink:label="loc_us-gaapOtherDeferredCreditsCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherDeferredCreditsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerAdvancesCurrent" xlink:label="loc_us-gaapCustomerAdvancesCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapCustomerAdvancesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BillingsInExcessOfCostCurrent" xlink:label="loc_us-gaapBillingsInExcessOfCostCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapBillingsInExcessOfCostCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:label="loc_us-gaapDevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapDevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure" xlink:label="loc_us-gaapNotesReceivableFairValueDisclosure" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapNotesReceivableFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital" xlink:label="loc_us-gaapStockholdersEquityAttributableToParentNotAllowableForNetCapital" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAttributableToParentNotAllowableForNetCapital" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/StatementsOfIncome" xlink:title="00000004 - Statement - Consolidated Statements of Income">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_PreferredStockClassAMember" xlink:label="loc_FONRPreferredStockClassAMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRPreferredStockClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaapSalesRevenueGoodsNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapSalesRevenueGoodsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaintenanceRevenue" xlink:label="loc_us-gaapMaintenanceRevenue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapMaintenanceRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ManagementFeesRevenue" xlink:label="loc_us-gaapManagementFeesRevenue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapManagementFeesRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaapCostOfGoodsSold" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapCostOfGoodsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaintenanceCosts" xlink:label="loc_us-gaapMaintenanceCosts" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapMaintenanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ServiceManagementCosts" xlink:label="loc_us-gaapServiceManagementCosts" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapServiceManagementCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAbstract" xlink:label="loc_us-gaapOtherIncomeAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherIncomeAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" xlink:label="loc_us-gaapIncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:label="loc_us-gaapIncreaseDecreaseInCustomerAdvances" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInCustomerAdvances" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInUnbilledReceivables" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInUnbilledReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_BuyoutOfNoncontrollingInterests" xlink:label="loc_FONRBuyoutOfNoncontrollingInterests" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_FONRBuyoutOfNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfOtherDebt" xlink:label="loc_us-gaapRepaymentsOfOtherDebt" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfOtherDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:title="00000006 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (USD $)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:title="00000007 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (USD $)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:title="00000008 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-Inventories" xlink:title="00000009 - Disclosure - NOTE 4 - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:title="00000010 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS">
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_NotesToFinancialStatementsAbstract" xlink:label="loc_FONRNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" xlink:label="loc_FONRCostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_FONRCostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets" xlink:title="00000011 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilities" xlink:title="00000012 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-SegmentAndRelatedInformation" xlink:title="00000013 - Disclosure - NOTE 8 - SEGMENT AND RELATED INFORMATION">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-SupplementalCashFlowInformation" xlink:title="00000014 - Disclosure - NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - NOTE 10 - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-IncomeTaxes" xlink:title="00000016 - Disclosure - NOTE 11 - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-SubsequentEvents" xlink:title="00000017 - Disclosure - NOTE 12 - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000018 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:label="loc_FONRSummaryOfSignificantAccountingPoliciesPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000019 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_NotesToFinancialStatementsAbstract" xlink:label="loc_FONRNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:title="00000020 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $) (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock" xlink:label="loc_us-gaapScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-InventoriesTables" xlink:title="00000021 - Disclosure - NOTE 4 - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:title="00000022 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_NotesToFinancialStatementsAbstract" xlink:label="loc_FONRNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CustomerAdvancesTableTextBlock" xlink:label="loc_FONRCustomerAdvancesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_FONRCustomerAdvancesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets" xlink:label="loc_FONRIncludedInAccompanyingCondensedConsolidatedBalanceSheets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_FONRIncludedInAccompanyingCondensedConsolidatedBalanceSheets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssetsTables" xlink:title="00000023 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables" xlink:title="00000024 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-SegmentAndRelatedInformationTables" xlink:title="00000025 - Disclosure - NOTE 8 - SEGMENT AND RELATED INFORMATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:title="00000026 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_NotesToFinancialStatementsAbstract" xlink:label="loc_FONRNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:title="00000027 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Receivables, Net - (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_AccountsReceivablesReceivablesNetDetailsAbstract" xlink:label="loc_FONRAccountsReceivablesReceivablesNetDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRAccountsReceivablesReceivablesNetDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsCurrentMember" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsCurrentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsCurrentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRAccountsReceivableNetRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="loc_FONRManagementAndOtherFees_NonRelatedParties" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagementAndOtherFees_NonRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:title="00000028 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Patient Fees Revenue - (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_Note2SummaryOfSignificantAccountingPoliciesPatientFeeRevenueRecognitionDetailsAbstract" xlink:label="loc_FONRNote2SummaryOfSignificantAccountingPoliciesPatientFeeRevenueRecognitionDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNote2SummaryOfSignificantAccountingPoliciesPatientFeeRevenueRecognitionDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-InventoriesDetails" xlink:title="00000029 - Disclosure - NOTE 4 - INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:title="00000030 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Information relating to uncompleted contracts -  (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_NotesToFinancialStatementsAbstract" xlink:label="loc_FONRNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_CostsIncurredOnUncompletedContracts" xlink:label="loc_FONRCostsIncurredOnUncompletedContracts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_FONRCostsIncurredOnUncompletedContracts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_EstimatedEarnings" xlink:label="loc_FONREstimatedEarnings" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_FONREstimatedEarnings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:label="loc_FONRSubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_FONRSubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerAdvancesAndDeposits" xlink:label="loc_us-gaapCustomerAdvancesAndDeposits" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapCustomerAdvancesAndDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:title="00000031 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Balance Sheet Items -  (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_NotesToFinancialStatementsAbstract" xlink:label="loc_FONRNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BillingsInExcessOfCostCurrent" xlink:label="loc_us-gaapBillingsInExcessOfCostCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapBillingsInExcessOfCostCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets-Details" xlink:title="00000032 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilities-Details" xlink:title="00000033 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES -  (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:title="00000034 - Disclosure - NOTE 8 - SEGMENT AND RELATED INFORMATION - Segment Information - (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_MedicalEquipmentMember" xlink:label="loc_FONRMedicalEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRMedicalEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:title="00000035 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_Note9ControllingAndNoncontrollingInterestsAbstract" xlink:label="loc_FONRNote9ControllingAndNoncontrollingInterestsAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNote9ControllingAndNoncontrollingInterestsAbstract" xlink:to="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNote9ControllingAndNoncontrollingInterestsAbstract" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNote9ControllingAndNoncontrollingInterestsAbstract" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:title="00000036 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:title="00000037 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" xlink:label="loc_FONRAccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="loc_FONRNetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRAccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" xlink:to="loc_FONRNetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" xlink:label="loc_FONRNetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRAccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" xlink:to="loc_FONRNetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative" xlink:title="00000038 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-SupplementalCashFlowInformation-DetailsNarrative" xlink:title="00000039 - Disclosure - NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION ($)- (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract" xlink:label="loc_FONRNote11SupplementalCashFlowInformationDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNote11SupplementalCashFlowInformationDetailsNarrativeAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNote11SupplementalCashFlowInformationDetailsNarrativeAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-CommitmentsAndContingencies-DetailsNarrative" xlink:title="00000040 - Disclosure - NOTE 10 - COMMITMENTS AND CONTINGENCIES - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrentAndNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:label="loc_FONRMaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRMaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-IncomeTaxes-DetailsNarrative" xlink:title="00000041 - Disclosure - NOTE 11 - INCOME TAXES - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-SubsequentEvents-DetailsNarrative" xlink:title="00000042 - Disclosure - NOTE 12 - SUBSEQUENT EVENTS - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_Note9ControllingAndNoncontrollingInterestsAbstract" xlink:label="loc_FONRNote9ControllingAndNoncontrollingInterestsAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_OwnershipInterestOfImperialInHdm" xlink:label="loc_FONROwnershipInterestOfImperialInHdm" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNote9ControllingAndNoncontrollingInterestsAbstract" xlink:to="loc_FONROwnershipInterestOfImperialInHdm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160331.xsd#FONR_RepaymentOfBalanceOfClassStockholdersCapitalContribution" xlink:label="loc_FONRRepaymentOfBalanceOfClassStockholdersCapitalContribution" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNote9ControllingAndNoncontrollingInterestsAbstract" xlink:to="loc_FONRRepaymentOfBalanceOfClassStockholdersCapitalContribution" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6729982816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Apr. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Fonar Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000355019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Is Entity a Well-known Seasoned Issuer?</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Is Entity a Voluntary Filer?</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Is Entity's Reporting Status Current?</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,050,840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Class C Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_PreferredStockClassAMember', window );">Preferred Stock Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_PreferredStockClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_PreferredStockClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6730553920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 13,147<span></span>
</td>
<td class="nump">$ 9,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable - net</a></td>
<td class="nump">4,326<span></span>
</td>
<td class="nump">3,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical receivables -net</a></td>
<td class="nump">10,097<span></span>
</td>
<td class="nump">9,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFees_NonRelatedParties', window );">Management and other fees receivable -net</a></td>
<td class="nump">15,901<span></span>
</td>
<td class="nump">14,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable - related medical practices -net</a></td>
<td class="nump">4,059<span></span>
</td>
<td class="nump">3,507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms', window );">Costs and estimated earnings in excess of billings on uncompleted contracts</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">Inventories</a></td>
<td class="nump">2,234<span></span>
</td>
<td class="nump">2,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">834<span></span>
</td>
<td class="nump">860<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">50,907<span></span>
</td>
<td class="nump">43,621<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred income tax asset</a></td>
<td class="nump">8,423<span></span>
</td>
<td class="nump">8,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment - net</a></td>
<td class="nump">11,877<span></span>
</td>
<td class="nump">12,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,767<span></span>
</td>
<td class="nump">1,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">8,066<span></span>
</td>
<td class="nump">8,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">972<span></span>
</td>
<td class="nump">830<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Total Assets</a></td>
<td class="nump">82,012<span></span>
</td>
<td class="nump">76,492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt and capital leases</a></td>
<td class="nump">2,455<span></span>
</td>
<td class="nump">2,490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,345<span></span>
</td>
<td class="nump">1,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">8,638<span></span>
</td>
<td class="nump">8,253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">4,350<span></span>
</td>
<td class="nump">4,187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDeferredCreditsCurrent', window );">Unearned revenue on service contracts - related parties</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerAdvancesCurrent', window );">Customer advances</a></td>
<td class="nump">1,511<span></span>
</td>
<td class="nump">1,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BillingsInExcessOfCostCurrent', window );">Billings in excess of costs and estimated earnings on uncompleted contracts</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">18,582<span></span>
</td>
<td class="nump">18,793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent', window );">Deferred income tax liability</a></td>
<td class="nump">510<span></span>
</td>
<td class="nump">510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesNoncurrent', window );">Due to related medical practices</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt and capital leases, less current portion</a></td>
<td class="nump">3,863<span></span>
</td>
<td class="nump">5,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">718<span></span>
</td>
<td class="nump">469<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long-Term Liabilities</a></td>
<td class="nump">5,328<span></span>
</td>
<td class="nump">6,915<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">23,910<span></span>
</td>
<td class="nump">25,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Paid-in capital in excess of par value</a></td>
<td class="nump">175,448<span></span>
</td>
<td class="nump">175,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage', window );">Accumulated deficit</a></td>
<td class="num">(126,989)<span></span>
</td>
<td class="num">(136,349)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Notes receivable from employee stockholders</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost - 12 shares of common stock at March 31, 2016 and June 30, 2015</a></td>
<td class="num">(675)<span></span>
</td>
<td class="num">(675)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital', window );">Total Fonar Corporation Stockholders' Equity</a></td>
<td class="nump">47,759<span></span>
</td>
<td class="nump">38,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non controlling interests</a></td>
<td class="nump">10,343<span></span>
</td>
<td class="nump">12,391<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1', window );">Total Stockholders' Equity</a></td>
<td class="nump">58,102<span></span>
</td>
<td class="nump">50,784<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">$ 82,012<span></span>
</td>
<td class="nump">$ 76,492<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from service and repair fees of Non Related MRI scanner customers; net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFees_NonRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management of, and other fees receivable from MRI Centers owned by non-related parties, - net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFees_NonRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management of, and other fees receivable from MRI Centers owned by related medical practices - net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical receivable from management of specific centers - net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accounts payable to related parties, due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 225<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488393&amp;loc=d3e606914-122999<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e604008-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64830158&amp;loc=SL35686385-199418<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 225<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488393&amp;loc=d3e606914-122999<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BillingsInExcessOfCostCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability attributable to (i) billings in excess of costs under the percentage of completion contract accounting method representing the difference between contractually invoiced amounts (billings) and revenue recognized based, for example, on costs incurred to estimated total costs at period end or (ii) contractually invoiced amounts (billings) in excess of costs incurred and accumulated under the completed contract accounting method that are expected to be realized within one year or one operating cycle, whichever is longer, from the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57788-111642<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57807-111642<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57795-111642<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BillingsInExcessOfCostCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable reflecting the cost incurred on uncompleted contracts in excess of related billings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68054760&amp;loc=d3e55302-109406<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57795-111642<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57807-111642<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerAdvancesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current portion of prepayments received from customers for goods or services to be provided in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerAdvancesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(c).Q3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative net losses reported during the development stage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1),(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and capital lease obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and capital leases due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDeferredCreditsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unearned revenue or income classified as other, expected to be taken into income within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDeferredCreditsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity attributable to the parent entity not allowable for net capital computed in accordance and used for compliance with regulatory requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Rule 15c3-1<br> -Number 240<br> -Section 15c3-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity including the portion attributable to noncontrolling interests, after the cumulative effect adjustment of a new accounting principle applied in the period of adoption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6730332208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A NonVoting Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par Value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Authorized</a></td>
<td class="nump">453,000<span></span>
</td>
<td class="nump">453,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Issued</a></td>
<td class="nump">313,000<span></span>
</td>
<td class="nump">313,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Outstanding</a></td>
<td class="nump">313,000<span></span>
</td>
<td class="nump">313,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par Value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Authorized</a></td>
<td class="nump">567,000<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par Value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Authorized</a></td>
<td class="nump">8,500,000<span></span>
</td>
<td class="nump">8,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Issued</a></td>
<td class="nump">6,062,000<span></span>
</td>
<td class="nump">6,062,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Outstanding</a></td>
<td class="nump">6,051,000<span></span>
</td>
<td class="nump">6,051,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par Value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Authorized</a></td>
<td class="nump">227,000<span></span>
</td>
<td class="nump">227,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Issued</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Outstanding</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Class C Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par Value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Authorized</a></td>
<td class="nump">567,000<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Issued</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Outstanding</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6728113392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product sales - net</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">$ 780<span></span>
</td>
<td class="nump">$ 1,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaintenanceRevenue', window );">Service and repair fees - net</a></td>
<td class="nump">2,406<span></span>
</td>
<td class="nump">2,299<span></span>
</td>
<td class="nump">6,970<span></span>
</td>
<td class="nump">7,288<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesRelatedPartiesNet', window );">Service and repair fees - related parties - net</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenue', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">8,695<span></span>
</td>
<td class="nump">7,284<span></span>
</td>
<td class="nump">24,596<span></span>
</td>
<td class="nump">20,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts', window );">Provision for bad debts for patient fee</a></td>
<td class="num">(3,830)<span></span>
</td>
<td class="num">(3,201)<span></span>
</td>
<td class="num">(10,608)<span></span>
</td>
<td class="num">(9,244)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ManagementFeesRevenue', window );">Management and other fees - net</a></td>
<td class="nump">9,394<span></span>
</td>
<td class="nump">8,653<span></span>
</td>
<td class="nump">27,180<span></span>
</td>
<td class="nump">26,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet', window );">Management and other fees - related medical practices - net</a></td>
<td class="nump">1,907<span></span>
</td>
<td class="nump">1,874<span></span>
</td>
<td class="nump">5,598<span></span>
</td>
<td class="nump">5,536<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Total Revenues - Net</a></td>
<td class="nump">18,619<span></span>
</td>
<td class="nump">17,096<span></span>
</td>
<td class="nump">54,599<span></span>
</td>
<td class="nump">52,173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>COSTS AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSold', window );">Costs related to product sales</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">352<span></span>
</td>
<td class="nump">939<span></span>
</td>
<td class="nump">1,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaintenanceCosts', window );">Costs related to service and repair fees</a></td>
<td class="nump">552<span></span>
</td>
<td class="nump">630<span></span>
</td>
<td class="nump">1,542<span></span>
</td>
<td class="nump">1,611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties', window );">Costs related to service and repair fees - related parties</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Costs related to patient fee revenue</a></td>
<td class="nump">2,549<span></span>
</td>
<td class="nump">2,044<span></span>
</td>
<td class="nump">7,015<span></span>
</td>
<td class="nump">5,845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ServiceManagementCosts', window );">Costs related to management and other fees</a></td>
<td class="nump">5,649<span></span>
</td>
<td class="nump">5,285<span></span>
</td>
<td class="nump">16,664<span></span>
</td>
<td class="nump">15,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices', window );">Costs related to management and other fees - related medical practices</a></td>
<td class="nump">1,045<span></span>
</td>
<td class="nump">1,284<span></span>
</td>
<td class="nump">3,116<span></span>
</td>
<td class="nump">3,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">395<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="nump">1,243<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">4,533<span></span>
</td>
<td class="nump">3,706<span></span>
</td>
<td class="nump">12,425<span></span>
</td>
<td class="nump">11,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for bad debts</a></td>
<td class="num">(470)<span></span>
</td>
<td class="nump">762<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="nump">1,540<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="nump">14,522<span></span>
</td>
<td class="nump">14,430<span></span>
</td>
<td class="nump">42,662<span></span>
</td>
<td class="nump">42,470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAbstract', window );"><strong>INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet', window );">Income From Operations</a></td>
<td class="nump">4,097<span></span>
</td>
<td class="nump">2,666<span></span>
</td>
<td class="nump">11,937<span></span>
</td>
<td class="nump">9,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="num">(127)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="num">(416)<span></span>
</td>
<td class="num">(545)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment Income</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income Before Provision for Income Taxes and Noncontrolling Interests</a></td>
<td class="nump">4,026<span></span>
</td>
<td class="nump">2,549<span></span>
</td>
<td class="nump">11,686<span></span>
</td>
<td class="nump">9,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">3,881<span></span>
</td>
<td class="nump">2,519<span></span>
</td>
<td class="nump">11,451<span></span>
</td>
<td class="nump">9,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income - Noncontrolling Interests</a></td>
<td class="num">(876)<span></span>
</td>
<td class="num">(500)<span></span>
</td>
<td class="num">(2,091)<span></span>
</td>
<td class="num">(2,018)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Controlling Interests</a></td>
<td class="nump">$ 3,005<span></span>
</td>
<td class="nump">$ 2,019<span></span>
</td>
<td class="nump">$ 9,360<span></span>
</td>
<td class="nump">$ 7,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 1.55<span></span>
</td>
<td class="nump">$ 1.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAbstract', window );"><strong>INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Controlling Interests</a></td>
<td class="nump">$ 2,810<span></span>
</td>
<td class="nump">$ 1,888<span></span>
</td>
<td class="nump">$ 8,752<span></span>
</td>
<td class="nump">$ 6,743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share</a></td>
<td class="nump">$ 0.46<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="nump">$ 1.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share</a></td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 1.42<span></span>
</td>
<td class="nump">$ 1.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding</a></td>
<td class="nump">6,178,000<span></span>
</td>
<td class="nump">6,178,000<span></span>
</td>
<td class="nump">6,178,000<span></span>
</td>
<td class="nump">6,178,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_PreferredStockClassAMember', window );">Preferred Stock Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAbstract', window );"><strong>INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Controlling Interests</a></td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">$ 453<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Class C Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAbstract', window );"><strong>INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Controlling Interests</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs related to the management and other fees - related medical practices</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred and are directly related to generatingmaintenance revenues. Also includes costs of maintenance on client contracts - for related parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFeesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue, comprised of base and incentive revenue derived from the management of joint ventures, managing third-party properties, or another entity's operations - for related medical practices - net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesRelatedPartiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue derived from maintenance services provided under contracts or arrangements with clients for related parties - net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesRelatedPartiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to goods produced and sold during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationPatientServiceRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=d3e8184-115640<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=d3e8195-115640<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052803&amp;loc=SL9156464-115641<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationPatientServiceRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the provision for bad debts related to patient service revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaintenanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred and are directly related to generating maintenance revenues. Also includes cost of maintenance on client contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaintenanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaintenanceRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue derived from maintenance services provided under contracts or arrangements with clients. For example, it may include the maintenance of software, plant and equipment, and facilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaintenanceRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementFeesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue, comprised of base and incentive revenue derived from the management of joint ventures, managing third-party properties, or another entity's operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementFeesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueGoodsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServiceManagementCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to delivering management services during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServiceManagementCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_PreferredStockClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_PreferredStockClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6716902528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 11,451<span></span>
</td>
<td class="nump">$ 9,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,507<span></span>
</td>
<td class="nump">2,665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ProvisionForBadDebts', window );">Provision for bad debts</a></td>
<td class="num">(300)<span></span>
</td>
<td class="nump">1,540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Stock issued for costs and expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Compensatory element of stock issuances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>(Increase) decrease in operating assets, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts, medical receivable(s) and management fee</a></td>
<td class="num">(3,674)<span></span>
</td>
<td class="num">(4,310)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Notes receivable</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract', window );">Costs and estimated earnings in excess of billings on uncompleted contracts</a></td>
<td class="nump">403<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(43)<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(143)<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract', window );"><strong>Increase (decrease) in operating liabilities, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(437)<span></span>
</td>
<td class="num">(178)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">576<span></span>
</td>
<td class="num">(501)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInCustomerAdvances', window );">Customer advances</a></td>
<td class="num">(427)<span></span>
</td>
<td class="num">(259)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInUnbilledReceivables', window );">Billings in excess of costs and estimated earnings on uncompleted contracts</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other liabilities</a></td>
<td class="nump">249<span></span>
</td>
<td class="num">(230)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties', window );">Due to related medical practices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">10,300<span></span>
</td>
<td class="nump">8,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(534)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Cost of patents</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(599)<span></span>
</td>
<td class="num">(233)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of borrowings and capital lease obligations</a></td>
<td class="num">(1,871)<span></span>
</td>
<td class="num">(2,166)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(4,138)<span></span>
</td>
<td class="num">(3,306)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_BuyoutOfNoncontrollingInterests', window );">Buyout of noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,971)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherDebt', window );">Repayment of notes receivable from employee stockholders</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(6,003)<span></span>
</td>
<td class="num">(10,437)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net Increase in Cash and Cash Equivalents</a></td>
<td class="nump">3,698<span></span>
</td>
<td class="num">(2,124)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents - Beginning of Period</a></td>
<td class="nump">9,449<span></span>
</td>
<td class="nump">9,952<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents - End of Period</a></td>
<td class="nump">$ 13,147<span></span>
</td>
<td class="nump">$ 7,828<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BuyoutOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BuyoutOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProvisionForBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision for bad debts used for calculationof cash flow statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProvisionForBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the asset reflecting the cost incurred on uncompleted contracts in excess of related billings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInCustomerAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of prepayments by customers for goods or services to be provided at a later date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInCustomerAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInUnbilledReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of the amount of revenue for work performed for which billing has not occurred, net of uncollectible accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInUnbilledReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6720892560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (USD $)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-size: 12pt">FONAR CORPORATION
AND SUBSIDIARIES</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 1 &#150; DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><u>Description of Business</u></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Effective July 1, 2015, the Company restructured the corporate organization
of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate
the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized
in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation
of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest
in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM,
operating under the name &#147;Health Management Company of America&#148;.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><u>Basis of Presentation</u></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The accompanying unaudited condensed consolidated
financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information
and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information
and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.
In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation
have been included. Operating results for the three and nine months ended March 31, 2016, are not necessarily indicative of the
results that may be expected for the fiscal year ending June 30, 2016. For further information, refer to the consolidated financial
statements and footnotes thereto included in the Company's Annual Report on Form 10-K filed on September 29, 2015 for the fiscal
year ended June 30, 2015.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6606366768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (USD $)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-size: 12pt">FONAR CORPORATION
AND SUBSIDIARIES</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><u>Principles of Consolidation</u></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The unaudited condensed consolidated financial statements include
the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships (collectively the &#147;Company&#148;).
All significant intercompany accounts and transactions have been eliminated in consolidation.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><u>Earnings Per Share</u></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Basic earnings per share (&#147;EPS&#148;)
is computed based on weighted average number of shares common stock and stock equivalents outstanding, net of common stock. In
accordance with ASC topic 260-10, &#147;Participating Securities and the Two-Class method&#148;, the Company used the Two-Class
method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for
the three and nine months ended March 31, 2016 and March 31, 2015.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">Diluted EPS reflects the potential dilution
from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares
outstanding during the period. For the three and nine months ended March 31, 2016 and March 31, 2015, diluted EPS for common shareholders
includes 128 shares upon conversion of Class C Common.&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Three months ended <br />March 31, 2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Three months ended <br />March 31, 2015</td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt"><u></u></td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="font-size: 11pt"><p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Basic</u></p>
        <p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Numerator:</u></p></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; width: 33%; font-size: 11pt">Net income available to&#160;common stockholders</td><td style="width: 3%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">3,005</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,810</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">50</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,019</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1,888</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">33</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"><u>Denominator:</u></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.50</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.46</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.13</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">0.33</p></td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.09</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="font-size: 11pt"></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="font-size: 11pt"><p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Diluted</u></p>
        <p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Denominator:</u></p></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">6,050</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">383</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">6,050</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">383</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Convertible Class C Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Total denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.45</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.13</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.09</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Nine months ended <br />March 31, 2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Nine months ended <br />March 31, 2015</td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt"><u></u></td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="font-size: 11pt"><p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Basic</u></p>
        <p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Numerator:</u></p></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; width: 33%; font-size: 11pt">Net income available to&#160;common stockholders</td><td style="width: 3%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">9,360</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,752</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">155</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">7,212</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,743</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">119</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"><u>Denominator:</u></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.55</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.45</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.40</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.19</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.11</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="font-size: 11pt"></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="font-size: 11pt"><p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Diluted</u></p>
        <p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Denominator:</u></p></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">6,050</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">383</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">6,050</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">383</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Convertible Class C Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Total denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.42</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.40</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.09</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Recent Accounting Pronouncements </u></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In March 2016, the FASB issued ASU No. 2016-09,
&#147;Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting&#148;. This update
includes provisions intended to simplify various aspects of accounting for share-based compensation. ASU No. 2016-09 will take
effect for public companies for the annual periods beginning after December 15, 2016. The Company is currently assessing the potential
impact of ASU No. 2016-09 on the Company&#146;s consolidated condensed financial statements.</p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In November 2015, the FASB issued ASU No. 2015-17,
Balance Sheet Classification of Deferred Taxes, which will require entities to present deferred tax assets and deferred tax liabilities
as non-current in a classified balance sheet. The ASU simplified the current guidance, which requires entities to separately present
deferred tax assets and deferred tax liabilities as current and non-current in a classified balance sheet. This standard is effective
for annual periods and interim periods within those fiscal years, beginning after December 15, 2016 but permits entities to early
adopt at the beginning of any interim or annual period. During the quarter ended December 31, 2015, the Company elected to early
adopt ASU 2015-17 and applied the change retrospectively to all periods present. As a result, the Company presented all deferred
assets and liabilities as non-current in its consolidated balance sheet. The adoption of this ASU did not result in a reclassification
of the Company&#146;s net deferred tax assets and liabilities as of June 30, 2015. As of March 31, 2016, there was no impact on
the Company&#146;s results of operations as a result of the adoption of ASU No. 2015-17</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The FASB has issued ASU No. 2014-09, <i>Revenue
from Contracts with Customers</i>. This ASU supercedes the revenue recognition requirements in Accounting Standards Codification
605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity
recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the company expects to be entitled in exchange for those goods or services. This ASU is effective for annual reporting
periods beginning after December 15, 2017, as deferred including interim periods within the reporting period and should be applied
retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the
ASU recognized at the date of initial application. The Company is currently evaluating the effect that this ASU will have on its
condensed consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has
it determined the effect of the standard on it ongoing financial reporting.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In July 2015, the FASB issued Accounting Standards
Update No. 2015-11, &#147;<i>Simplifying the Measurement of Inventory</i>&#148; (&#147;ASU 2015-11&#148;). ASU 2015-11 requires
an entity to measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices
in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement
is unchanged for inventory measured using last-in, first-out (&#147;LIFO&#148;) or the retail inventory method. It is effective
for annual reporting periods beginning after December 15, 2016. The amendments should be applied prospectively with earlier application
permitted as of the beginning of an interim or annual reporting period.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FASB, the Emerging Issues Task Force and the
SEC have issued certain other accounting standards, updates, and regulations as of March 31, 2016 that will become effective in
subsequent periods; however, management does not believe that any of those updates would have significantly affected our financial
accounting measures or disclosures had they been in effect during 2016 or 2015, and it does not believe that any of those pronouncements
will have a significant impact on our condensed consolidated financial statements at the time they become effective.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><u>Reclassifications</u></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><u style="text-decoration: none">&#160;</u></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Certain prior year amounts have been reclassified to conform
to the current year presentation. The reclassifications did not have any effect on reported consolidated net income for any periods
presented.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18861-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18743-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18854-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6720897568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">NOTE 3 - ACCOUNTS RECEIVABLE. MEDICAL RECEIVABLES AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 3 &#150; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT
AND OTHER FEES RECEIVABLE</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Receivables, net is comprised of the following
at March 31, 2016:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Gross <br />Receivable</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Allowance for <br />doubtful accounts</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Net</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Accounts receivable</td><td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,614</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">288</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,326</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Accounts receivable - related party</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">30</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">30</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Medical receivable</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">36,164</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">26,067</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">10,097</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Management and other fees receivable</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">28,873</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">12,972</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">15,901</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Management and other fees receivable - related medical practices ("PC&#146;s")</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,462</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">403</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,059</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Receivables, net is comprised of the following
at June 30, 2015:</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Gross <br />Receivable</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Allowance for <br />doubtful accounts</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Net</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Accounts receivable</td><td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,153</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">362</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">3,791</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Accounts receivable - related party</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Medical receivable</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">24,541</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">15,459</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">9,082</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Management and other fees receivable</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">27,330</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">13,272</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">14,058</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Management and other fees receivable -&#160;&#160;related medical practices ("PC&#146;s")</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">3,910</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">403</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">3,507</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company's customers are concentrated in
the healthcare industry.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><u>Accounts Receivable</u></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Credit risk with respect to the Company&#146;s
accounts receivable related to product sales and service and repair fees is limited due to the customer advances received prior
to the commencement of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair
fees are billed on a monthly or quarterly basis and the Company does not continue providing these services if accounts receivable
become past due. The Company controls credit risk with respect to accounts receivable from service and repair fees through its
credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs ongoing
credit authorizations before a product sales contract is entered into or service and repair fees are provided.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;<u>Medical Receivable</u></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Medical receivables are due under fee-for-service
contracts from third party payors, such as hospitals, government sponsored healthcare programs, patient&#146;s legal counsel and
directly from patients. Substantially all the revenue relates to patients residing in Florida. The carrying amount of the medical
receivable is reduced by an allowance that reflects management&#146;s best estimate of the amounts that will not be collected.
The Company continuously monitors collections from its clients and maintains an allowance for bad debts based upon the Company&#146;s
historical collection experience. The Company determines allowances for contractual adjustments and uncollectible accounts based
on specific agings, specific payor collection issues that have been identified and based on payor classifications and historical
experience at each site.</p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><u>Management and Other Fees Receivable</u></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><u></u></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company's receivables from the related and
non-related professional corporations (PC's) substantially consist of fees outstanding under management agreements. Payment of
the outstanding fees is dependent on collection by the PC's of fees from third party medical reimbursement organizations, principally
insurance companies and health management organizations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Payment of the management fee receivables from
the PC&#146;s may be impaired by the inability of the PC&#146;s to collect in a timely manner their medical fees from the third
party payors, particularly insurance carriers covering automobile no-fault and workers compensation claims due to longer payment
cycles and rigorous informational requirements and certain other disallowed claims. Approximately 59% and 55% of the PCs&#146;
net revenues for the three months ended March 31, 2016 and 2015, respectively, were derived from no-fault and personal injury protection
claims. Approximately 60% and 54% of the PCs&#146; net revenues for the nine months ended March 31, 2016 and 2015, respectively,
were derived from no-fault and personal injury protection claims. The Company considers the aging of its accounts receivable in
determining the amount of allowance for doubtful accounts. The Company generally takes all legally available steps to collect its
receivables. Credit losses associated with the receivables are provided for in the condensed consolidated financial statements
and have historically been within management's expectations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Net revenues from management and other fees
charged to the related PCs accounted for approximately 10.2% and 11% of the consolidated net revenues for the three months ended
March 31, 2016 and 2015, respectively. Net revenues from management and other fees charged to the related PCs accounted for approximately
10.3% and 10.6% of the consolidated net revenues for the nine months ended March 31, 2016 and 2015, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Tallahassee Magnetic Resonance Imaging, PA,
Stand Up MRI of Boca Raton, PA and Stand Up MRI &#38; Diagnostic Center, PA (all related medical practices) entered into a guaranty
agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which have arisen under
each individual management agreement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&#146;s patient fee revenue, net
of contractual allowances and discounts less the provision for bad debts for the three and nine months ended March 31, 2016 and
2015 are summarized in the following tables.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="text-align: center; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">For the Three Months Ended <br />March 31,</td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 60%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Commercial Insurance/ Managed Care</td><td style="width: 6%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 11%; text-align: right; font-size: 11pt">1,245</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 11%; text-align: right; font-size: 11pt">1,091</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Medicare/Medicaid</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">332</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">292</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Workers' Compensation/Personal Injury</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">5,453</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">4,513</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Other</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1,665</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1,388</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Patient Fee Revenue, net of contractual allowances and discounts</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">8,695</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">7,284</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Provision for Bad Debts</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(3,830</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(3,201</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Net Patient Fee for Revenue</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,865</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,083</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="text-align: center; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">For the Nine Months Ended <br />March 31,</td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 60%; text-align: left; padding-left: 0pt; font-size: 11pt">Commercial Insurance/ Managed Care</td><td style="width: 6%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 11%; text-align: right; font-size: 11pt">3,438</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 11%; text-align: right; font-size: 11pt">3,245</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="padding-left: 0pt; font-size: 11pt">Medicare/Medicaid</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">874</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">896</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; font-size: 11pt">Workers' Compensation/Personal Injury</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">15,649</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">11,354</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="padding-bottom: 1pt; font-size: 11pt">Other</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">4,635</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">5,205</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Patient Fee Revenue, net of contractual allowances and discounts</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">24,596</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">20,700</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; font-size: 11pt">Provision for Bad Debts</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(10,608</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(9,244</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; font-size: 11pt">Net Patient Fee for Revenue</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">13,988</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">11,456</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5066-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5162-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6887613504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 4 - INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">NOTE 4 - INVENTORIES</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 4 - INVENTORIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Inventories included in the accompanying condensed consolidated balance
sheet consist of the following:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="text-align: center; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">March 31, <br />2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">June 30, <br />2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 56%; text-align: left; text-indent: -0.25in; padding-left: 0.25in; font-size: 11pt">Purchased parts, components and supplies</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">2,033</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">2,043</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; font-size: 11pt">Work-in-process</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">201</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">149</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; font-size: 11pt">Total Inventories</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,234</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,192</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6720903840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock', window );">NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 5 &#150; COSTS AND ESTIMATED EARNINGS
ON UNCOMPLETED CONTRACTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left">Information relating
to uncompleted contracts is as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">March 31, 2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">June 30, 2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 56%; text-align: left; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Costs incurred on uncompleted contracts</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">2,310</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">1,862</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Estimated earnings</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1,622</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1,371</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Subtotal</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">3,932</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">3,233</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Less: Billings to date</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">3,908</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">2,693</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Total Costs and estimated earnings in excess of billings on uncompleted contracts</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">24</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">540</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>



<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left">Included in the accompanying
condensed consolidated balance sheets under the following captions:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">March 31, 2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">June 30, 2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 56%; text-align: left; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Costs and estimated earnings in excess of billings on uncompleted contracts</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">279</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">682</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Less: Billings in excess of costs and estimated earnings on uncompleted contracts</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">255</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">142</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Total Costs and estimated earnings in excess of billings on uncompleted contracts</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">24</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">540</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>



<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs And EstimatedEarningsOn Uncompleted Contracts And Customer Advances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6887688336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 6 - OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">NOTE 6 - OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; text-align: center; margin-bottom: 0">&#160;</p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 6 &#150; OTHER INTANGIBLE ASSETS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Other intangible assets, net of accumulated
amortization, in the accompanying condensed consolidated balance sheet consist of the following:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 11pt">March 31, 2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 11pt">June 30, 2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 56%; text-align: left; padding-left: 8.85pt; font-size: 11pt">Capitalized software development costs</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">7,005</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">7,005</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 8.85pt; font-size: 11pt">Patents and copyrights</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">4,612</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">4,547</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="padding-left: 8.85pt; font-size: 11pt">Non-compete</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">4,100</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">4,100</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 8.85pt; font-size: 11pt">Customer relationships</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">3,800</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">3,800</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 8.85pt; font-size: 11pt">Gross Other intangible assets</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">19,517</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">19,452</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 8.85pt; font-size: 11pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">11,451</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">10,502</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 8.85pt; font-size: 11pt">Other Intangible Assets</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,066</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,950</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of patents
and copyrights for the three months ended March 31, 2016 and 2015 amounted to $47 and $46, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of capitalized
software development costs for the three months ended March 31, 2016 and 2015 amounted to $65 and $81, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of non-compete
for the three months ended March 31, 2016 and 2015 amounted to $146 and $146, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of customer
relationships for the three months ended March 31, 2016 and 2015 amounted to $47 and $47, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of patents
and copyrights for the nine months ended March 31, 2016 and 2015 amounted to $141 and $137, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of capitalized
software development costs for the nine months ended March 31, 2016 and 2015 amounted to $227 and $246, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of non-compete
for the nine months ended March 31, 2016 and 2015 amounted to $439 and $439, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">Amortization of customer
relationships for the nine months ended March 31, 2016 and 2015 amounted to $142 and $142, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final.  May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6720947136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 7 - OTHER CURRENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">NOTE 7 - OTHER CURRENT LIABILITIES</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;NOTE 7 &#150; OTHER CURRENT LIABILITIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Other current liabilities in the accompanying
condensed consolidated balance sheet consist of the following:&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">March 31, 2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">June 30, 2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 56%; text-align: left; text-indent: -8.95pt; padding-left: 8.95pt; font-size: 11pt">Accrued salaries, commissions and payroll taxes</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">903</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">992</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Accrued interest</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">117</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">117</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Litigation accruals</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">493</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">521</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Sales tax payable</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">2,565</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">2,539</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Legal and other professional fees</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">307</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">344</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Accounting fees</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">193</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">235</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Self-funded health insurance reserve</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">434</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">510</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Interest and penalty - sales tax</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">2,644</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">2,509</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt; font-size: 11pt">Other</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">982</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">486</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: right; padding-bottom: 2.5pt; padding-left: 5.4pt; font-size: 11pt">Total Other Current Liabilities</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,638</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,253</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6604700512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 8 - SEGMENT AND RELATED INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">NOTE 8 - SEGMENT AND RELATED INFORMATION</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 8 - SEGMENT AND RELATED INFORMATION</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company operates in two industry segments
- manufacturing and the servicing of medical equipment and management of diagnostic imaging centers.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The accounting policies of the segments are
the same as those described in the summary of significant accounting policies as disclosed in the Company&#146;s 10-K as of June
30, 2015. All inter-segment sales are market-based. The Company evaluates performance based on income or loss from operations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Summarized financial information concerning
the Company's reportable segments is shown in the following table:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Medical</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Equipment</p></td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Management</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">of</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Diagnostic</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Imaging</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Centers</p></td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; font-size: 11pt"><font style="font-family: Arial, Helvetica, Sans-Serif">Totals</font></td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt">For the three months ended March 31, 2016</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 46%; text-align: left; padding-left: 5.4pt; font-size: 11pt">Net revenues from external customers</td><td style="width: 5%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 11%; text-align: right; font-size: 11pt">2,454</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 5%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 11%; text-align: right; font-size: 11pt">16,165</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 5%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 11%; text-align: right; font-size: 11pt">18,619</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Inter-segment net revenues</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">546</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">546</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">(Loss) income from operations</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">(207</td><td style="text-align: left; font-size: 11pt">)</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">4,304</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">4,097</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Depreciation and amortization</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">79</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">751</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">830</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Capital expenditures</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">31</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">117</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">148</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="padding-left: 5.4pt; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt">For the three months ended March 31, 2015</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Net revenues from external customers</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">2,486</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">14,610</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">17,096</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Inter-segment net revenues</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">502</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">502</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">(Loss) income from operations</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">(367</td><td style="text-align: left; font-size: 11pt">)</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">3,033</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">2,666</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Depreciation and amortization</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">78</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">811</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">889</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Capital expenditures</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">111</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">111</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="padding-left: 5.4pt; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt">For the nine months ended March 31, 2016</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Net revenues from external customers</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">7,833</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">46,766</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">54,599</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Inter-segment net revenues</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">1,594</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">1,594</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Income from operations</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">18</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">11,919</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">11,937</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Depreciation and amortization</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">242</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">2,265</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">2,507</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Capital expenditures</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">390</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">209</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">599</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="padding-left: 5.4pt; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt">For the nine months ended March 31, 2015</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Net revenues from external customers</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">9,177</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">42,996</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">52,173</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Inter-segment net revenues</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">1,504</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">1,504</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Income from operations</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">457</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">9,246</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">9,703</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Depreciation and amortization</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">229</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">2,436</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">2,665</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Capital expenditures</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">178</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">55</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">233</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8981-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9038-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 33<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8971-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8595-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8380-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 35<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8984-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9031-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8538-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8864-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8924-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6887798672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 9&#150; SUPPLEMENTAL CASH FLOW INFORMATION</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During the nine months ended March 31, 2016
and March 31, 2015, the Company paid $280 and $406 for interest, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During the nine months ended March 31, 2016
and March 31, 2015, the Company paid $235 and $99 for income taxes, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6632725584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 10 - COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">NOTE 10 - COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 10 &#150; COMMITMENTS AND CONTINGENCIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 10pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><u>Litigation</u></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company is subject to legal proceedings
and claims arising from the ordinary course of its business, including personal injury, customer contract and employment claims.
In the opinion of management, the aggregate liability, if any, with respect to such actions, will not have a material adverse effect
on the consolidated financial position or results of operations of the Company.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">There were no material changes in litigation
from that reported in our Form 10-K for the fiscal year ended June 30, 2015 with the exception of the case with Dr. Shapiro. The
case was settled for $258,400 plus interest on February 18. 2016.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Other Matters</u></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company is also delinquent in filing sales
tax returns for certain states, for which the Company has transacted business. As of March 31, 2016, the Company has recorded tax
obligations of approximately $2,565 plus interest and penalties of approximately $2,644. The Company is in the process of determining
the regulatory requirements in order to become compliant.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company maintains a self-funded health insurance
program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims
to $100 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company
considers historical and projected medical utilization data when estimating its health insurance program liability and related
expense. As of March 31, 2016 and June 30, 2015, the Company had approximately $434 and $510, respectively, in reserve for its
self-funded health insurance programs. The reserves are included in &#147;Other current liabilities&#148; in the condensed consolidated
balance sheets.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company regularly analyzes its reserves
for incurred but not reported claims, and for reported but not paid claims related to its reinsurance and self-funded insurance
programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing these reserves
such as assessing historical paid claims, average lags between the claims&#146; incurred date, reported dates and paid dates,
and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded
in the periods covered by this report.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In March 2016, the Company signed a 2nd amendment
with Signature Bank to extend the terms of the revolving loan to September 2018. As of March 31, 2016, the Company has not been
advanced any money under this revolving loan.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25287-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6887752464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 11 - INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">NOTE 11 - INCOME TAXES</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0">NOTE 11 - INCOME TAXES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">ASC topic 740 prescribes a recognition threshold
and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken
in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon
examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit
recognized and measured pursuant to the interpretation are referred to as &#147;unrecognized benefits&#148;. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it
represents an enterprise&#146;s potential future obligation to the taxing authority for a tax position that was not recognized
as a result of applying the provisions of ASC topic 740.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In accordance with ASC topic 740, interest costs
related to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &#147;Interest expense,
net&#148;. Penalties if incurred would be recognized as a component of &#147;Selling, general and administrative&#148; expenses.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company files corporate income tax returns
in the United States (federal) and in various state and local jurisdictions. In most instances, the Company is no longer subject
to federal, state and local income tax examinations by tax authorities for years prior to 2009.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company recorded a deferred tax asset of
$8,423 and a deferred tax liability of $510 as of March 31, 2016, primarily relating to net operating loss carryforwards of approximately
$122,926 available to offset future taxable income through 2034. The net operating losses begin to expire in 2019 for federal tax
purposes and in 2015 for state income tax purposes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The ultimate realization of deferred tax assets
is dependent on the generation of future taxable income during the periods in which those temporary differences become deductible.
The Company considers projected future taxable income and tax planning strategies in making this assessment. At present, the Company
does have a sufficient history of income and anticipates profitability in the coming years and has concluded that it is more-likely-than-not
that the Company will be able to realize a portion of its tax benefits in the near future and therefore a valuation allowance was
established for the partial value of the deferred tax asset.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A valuation allowance will be maintained until
sufficient positive evidence exists to support the reversal of the remainder of the valuation. Should the Company continue to remain
profitable in future periods with supportable trends, the valuation allowance will be reversed accordingly.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="margin: 0pt">&#160;&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6605787872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 12 - SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">NOTE 12 - SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">MARCH 31, 2016 and 2015</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Amounts and shares in thousands,
except per share amounts)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">(UNAUDITED)</p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 12- SUBSEQUENT EVENTS</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On May 2, 2016, the Company repaid the balance
of the Class A Stockholders capital contribution in the amount of $1,125. As a result, the Company&#146;s subsidiary, HMCA, owns
a 100% interest in Imperial Management Services.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6866009936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract', window );"><strong>Note 2 - Summary Of Significant Accounting Policies Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>


<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><u>Principles of Consolidation</u></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The unaudited condensed consolidated financial statements include
the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships (collectively the &#147;Company&#148;).
All significant intercompany accounts and transactions have been eliminated in consolidation.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left">(Amounts and shares in
thousands, except per share amounts) (UNAUDITED)</p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><u>Earnings Per Share</u></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Basic earnings per share (&#147;EPS&#148;)
is computed based on weighted average number of shares common stock and stock equivalents outstanding, net of common stock. In
accordance with ASC topic 260-10, &#147;Participating Securities and the Two-Class method&#148;, the Company used the Two-Class
method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for
the three and nine months ended March 31, 2016 and March 31, 2015.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;</p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">Diluted EPS reflects the potential dilution
from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares
outstanding during the period. For the three and nine months ended March 31, 2016 and March 31, 2015, diluted EPS for common shareholders
includes 128 shares upon conversion of Class C Common.&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Three months ended <br />March 31, 2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Three months ended <br />March 31, 2015</td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt"><u></u></td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="font-size: 11pt"><p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Basic</u></p>
        <p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Numerator:</u></p></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; width: 33%; font-size: 11pt">Net income available to&#160;common stockholders</td><td style="width: 3%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">3,005</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,810</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">50</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,019</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1,888</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">33</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"><u>Denominator:</u></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.50</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.46</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.13</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">0.33</p></td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.09</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="font-size: 11pt"></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="font-size: 11pt"><p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Diluted</u></p>
        <p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Denominator:</u></p></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">6,050</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">383</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">6,050</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">383</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Convertible Class C Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Total denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.45</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.13</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.09</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&#160;</p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Nine months ended <br />March 31, 2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Nine months ended <br />March 31, 2015</td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt"><u></u></td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="font-size: 11pt"><p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Basic</u></p>
        <p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Numerator:</u></p></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; width: 33%; font-size: 11pt">Net income available to&#160;common stockholders</td><td style="width: 3%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">9,360</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,752</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">155</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">7,212</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,743</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">119</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"><u>Denominator:</u></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.55</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.45</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.40</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.19</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.11</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="font-size: 11pt"></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="font-size: 11pt"><p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Diluted</u></p>
        <p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Denominator:</u></p></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">6,050</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">383</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">6,050</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">383</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Convertible Class C Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Total denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.42</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.40</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.09</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u>Recent Accounting Pronouncements </u></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In March 2016, the FASB issued ASU No. 2016-09,
&#147;Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting&#148;. This update
includes provisions intended to simplify various aspects of accounting for share-based compensation. ASU No. 2016-09 will take
effect for public companies for the annual periods beginning after December 15, 2016. The Company is currently assessing the potential
impact of ASU No. 2016-09 on the Company&#146;s consolidated condensed financial statements.</p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In November 2015, the FASB issued ASU No. 2015-17,
Balance Sheet Classification of Deferred Taxes, which will require entities to present deferred tax assets and deferred tax liabilities
as non-current in a classified balance sheet. The ASU simplified the current guidance, which requires entities to separately present
deferred tax assets and deferred tax liabilities as current and non-current in a classified balance sheet. This standard is effective
for annual periods and interim periods within those fiscal years, beginning after December 15, 2016 but permits entities to early
adopt at the beginning of any interim or annual period. During the quarter ended December 31, 2015, the Company elected to early
adopt ASU 2015-17 and applied the change retrospectively to all periods present. As a result, the Company presented all deferred
assets and liabilities as non-current in its consolidated balance sheet. The adoption of this ASU did not result in a reclassification
of the Company&#146;s net deferred tax assets and liabilities as of June 30, 2015. As of March 31, 2016, there was no impact on
the Company&#146;s results of operations as a result of the adoption of ASU No. 2015-17</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The FASB has issued ASU No. 2014-09, <i>Revenue
from Contracts with Customers</i>. This ASU supercedes the revenue recognition requirements in Accounting Standards Codification
605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity
recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the company expects to be entitled in exchange for those goods or services. This ASU is effective for annual reporting
periods beginning after December 15, 2017, as deferred including interim periods within the reporting period and should be applied
retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the
ASU recognized at the date of initial application. The Company is currently evaluating the effect that this ASU will have on its
condensed consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has
it determined the effect of the standard on it ongoing financial reporting.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In July 2015, the FASB issued Accounting Standards
Update No. 2015-11, &#147;<i>Simplifying the Measurement of Inventory</i>&#148; (&#147;ASU 2015-11&#148;). ASU 2015-11 requires
an entity to measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices
in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement
is unchanged for inventory measured using last-in, first-out (&#147;LIFO&#148;) or the retail inventory method. It is effective
for annual reporting periods beginning after December 15, 2016. The amendments should be applied prospectively with earlier application
permitted as of the beginning of an interim or annual reporting period.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">FASB, the Emerging Issues Task Force and the
SEC have issued certain other accounting standards, updates, and regulations as of March 31, 2016 that will become effective in
subsequent periods; however, management does not believe that any of those updates would have significantly affected our financial
accounting measures or disclosures had they been in effect during 2016 or 2015, and it does not believe that any of those pronouncements
will have a significant impact on our condensed consolidated financial statements at the time they become effective.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><u style="text-decoration: none"></u></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><u>Reclassifications</u></p>

<p style="font: 11pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><u style="text-decoration: none">&#160;</u></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Certain prior year amounts have been reclassified
to conform to the current year presentation. The reclassifications did not have any effect on reported consolidated net income
for any periods presented.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=d3e5614-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6721570144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left">(Amounts and shares in thousands,
except per share amounts) (UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><u>Earnings Per Share</u></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Three months ended <br />March 31, 2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Three months ended <br />March 31, 2015</td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt"><u></u></td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="font-size: 11pt"><p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Basic</u></p>
        <p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Numerator:</u></p></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; width: 33%; font-size: 11pt">Net income available to&#160;common stockholders</td><td style="width: 3%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">3,005</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,810</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">50</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,019</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1,888</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">33</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"><u>Denominator:</u></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.50</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.46</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.13</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt"><p style="margin-top: 0; margin-bottom: 0"></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">0.33</p></td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.09</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="font-size: 11pt"></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="font-size: 11pt"><p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Diluted</u></p>
        <p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Denominator:</u></p></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">6,050</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">383</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">6,050</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">383</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Convertible Class C Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Total denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.45</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.13</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.09</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Nine months ended <br />March 31, 2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="11" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Nine months ended <br />March 31, 2015</td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt"><u></u></td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Total</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Common Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Class C Common Stock</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="font-size: 11pt"><p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Basic</u></p>
        <p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Numerator:</u></p></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; width: 33%; font-size: 11pt">Net income available to&#160;common stockholders</td><td style="width: 3%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">9,360</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,752</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">155</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">7,212</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,743</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 7%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">119</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt"><u>Denominator:</u></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,050</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Basic income per common share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.55</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.45</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.40</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.19</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.11</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="font-size: 11pt"></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="font-size: 11pt"><p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Diluted</u></p>
        <p style="margin-top: 0; margin-bottom: 0; font-size: 11pt"><u>Denominator:</u></p></td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Weighted average shares outstanding</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">6,050</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">383</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">6,050</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">383</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Convertible Class C Stock</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">128</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Total denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">6,178</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">383</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt; font-size: 11pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.42</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.40</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">1.09</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">0.31</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6730610688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $) (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock', window );">Receivables - net</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left">(Amounts in thousands)
(UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Receivables, net is comprised of the following
at March 31, 2016:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Gross <br />Receivable</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Allowance for <br />doubtful accounts</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Net</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Accounts receivable</td><td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,614</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">288</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,326</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Accounts receivable - related party</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">30</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">30</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Medical receivable</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">36,164</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">26,067</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">10,097</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Management and other fees receivable</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">28,873</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">12,972</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">15,901</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Management and other fees receivable - related medical practices ("PC&#146;s")</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,462</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">403</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,059</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Receivables, net is comprised of the following
at June 30, 2015:</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Gross <br />Receivable</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Allowance for <br />doubtful accounts</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">Net</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Accounts receivable</td><td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,153</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">362</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="width: 5%; padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">3,791</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Accounts receivable - related party</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Medical receivable</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">24,541</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">15,459</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">9,082</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Management and other fees receivable</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">27,330</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">13,272</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">14,058</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; font-size: 11pt">Management and other fees receivable -&#160;&#160;related medical practices ("PC&#146;s")</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">3,910</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">403</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">3,507</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock', window );">Patient fee revenue - net</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left">(Amounts in thousands) (UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&#146;s patient fee revenue, net
of contractual allowances and discounts less the provision for bad debts for the three and nine months ended March 31, 2016 and
2015 are summarized in the following tables.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="text-align: center; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">For the Three Months Ended <br />March 31,</td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 60%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Commercial Insurance/ Managed Care</td><td style="width: 6%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 11%; text-align: right; font-size: 11pt">1,245</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 11%; text-align: right; font-size: 11pt">1,091</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Medicare/Medicaid</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">332</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">292</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Workers' Compensation/Personal Injury</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">5,453</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">4,513</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Other</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1,665</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1,388</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Patient Fee Revenue, net of contractual allowances and discounts</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">8,695</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">7,284</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Provision for Bad Debts</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(3,830</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(3,201</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Net Patient Fee for Revenue</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,865</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">4,083</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="text-align: center; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">For the Nine Months Ended <br />March 31,</td></tr>
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 60%; text-align: left; padding-left: 0pt; font-size: 11pt">Commercial Insurance/ Managed Care</td><td style="width: 6%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 11%; text-align: right; font-size: 11pt">3,438</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 11%; text-align: right; font-size: 11pt">3,245</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="padding-left: 0pt; font-size: 11pt">Medicare/Medicaid</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">874</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">896</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; font-size: 11pt">Workers' Compensation/Personal Injury</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">15,649</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">11,354</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="padding-bottom: 1pt; font-size: 11pt">Other</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">4,635</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">5,205</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; font-size: 11pt">Patient Fee Revenue, net of contractual allowances and discounts</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">24,596</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">20,700</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; font-size: 11pt">Provision for Bad Debts</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(10,608</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">(9,244</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; font-size: 11pt">Net Patient Fee for Revenue</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">13,988</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">11,456</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of credit losses for current financing receivables (such as trade and accounts receivable), including a rollforward of the balance.  An alternative caption includes allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=SL6953423-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of patient service revenue (net of contractual allowances and discounts), by major payor source of revenue for health care organizations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 55<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68073389&amp;loc=SL9156489-173031<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052803&amp;loc=SL9156464-115641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6720846032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 4 - INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left">(Amounts in thousands) (UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Inventories included in the accompanying condensed consolidated balance
sheet consist of the following:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="text-align: center; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">March 31, <br />2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">June 30, <br />2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 56%; text-align: left; text-indent: -0.25in; padding-left: 0.25in; font-size: 11pt">Purchased parts, components and supplies</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">2,033</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">2,043</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; font-size: 11pt">Work-in-process</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">201</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">149</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; font-size: 11pt">Total Inventories</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,234</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">2,192</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6720855024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CustomerAdvancesTableTextBlock', window );">Information relating to uncompleted contracts</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left">(Amounts in thousands)
(UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left">Information relating
to uncompleted contracts is as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">March 31, 2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">June 30, 2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 56%; text-align: left; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Costs incurred on uncompleted contracts</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">2,310</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">1,862</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Estimated earnings</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1,622</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">1,371</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Subtotal</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">3,932</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">3,233</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Less: Billings to date</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">3,908</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">2,693</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Total Costs and estimated earnings in excess of billings on uncompleted contracts</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">24</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">540</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>



<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets', window );">Included in the accompanying condensed consolidated balance sheets</a></td>
<td class="text"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left">(Amounts in thousands) (UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&#160;Included in
the accompanying condensed consolidated balance sheets under the following captions:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">March 31, 2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">June 30, 2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 56%; text-align: left; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Costs and estimated earnings in excess of billings on uncompleted contracts</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">279</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">682</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Less: Billings in excess of costs and estimated earnings on uncompleted contracts</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">255</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">142</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; font-size: 11pt">Total Costs and estimated earnings in excess of billings on uncompleted contracts</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">24</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">540</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>



<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerAdvancesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Table of total customer advances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerAdvancesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Table of balance sheet items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6887695696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 6 - OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Other intangible assets - net</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left">(Amounts in thousands)
(UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; text-align: center; margin-bottom: 0"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Other intangible assets, net of accumulated
amortization, in the accompanying condensed consolidated balance sheet consist of the following:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 11pt">March 31, 2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-size: 11pt">June 30, 2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 56%; text-align: left; padding-left: 8.85pt; font-size: 11pt">Capitalized software development costs</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">7,005</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">7,005</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 8.85pt; font-size: 11pt">Patents and copyrights</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">4,612</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">4,547</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="padding-left: 8.85pt; font-size: 11pt">Non-compete</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">4,100</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">4,100</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 8.85pt; font-size: 11pt">Customer relationships</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">3,800</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">3,800</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 8.85pt; font-size: 11pt">Gross Other intangible assets</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">19,517</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">19,452</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 8.85pt; font-size: 11pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">11,451</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">10,502</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 8.85pt; font-size: 11pt">Other Intangible Assets</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,066</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,950</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6887695408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 7 - OTHER CURRENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Other current liabilities</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left">(Amounts in thousands) (UNAUDITED)</p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Other current liabilities in the accompanying
condensed consolidated balance sheet consist of the following:&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; font-size: 11pt">
    <td style="text-align: right; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">March 31, 2016</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid; font-size: 11pt">June 30, 2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 56%; text-align: left; text-indent: -8.95pt; padding-left: 8.95pt; font-size: 11pt">Accrued salaries, commissions and payroll taxes</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">903</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 8%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 12%; text-align: right; font-size: 11pt">992</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Accrued interest</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">117</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">117</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Litigation accruals</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">493</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">521</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Sales tax payable</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">2,565</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">2,539</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Legal and other professional fees</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">307</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">344</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Accounting fees</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">193</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">235</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Self-funded health insurance reserve</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">434</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">510</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Interest and penalty - sales tax</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">2,644</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">2,509</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt; font-size: 11pt">Other</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">982</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt">486</td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: right; padding-bottom: 2.5pt; padding-left: 5.4pt; font-size: 11pt">Total Other Current Liabilities</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,638</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 2.5pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-size: 11pt">$</td><td style="border-bottom: Black 2.5pt double; text-align: right; font-size: 11pt">8,253</td><td style="padding-bottom: 2.5pt; text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0">&#160;&#160;&#160;&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6720943696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 8 - SEGMENT AND RELATED INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Segment information</a></td>
<td class="text"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left">(Amounts  in
thousands) (UNAUDITED)</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Summarized financial information concerning
the Company's reportable segments is shown in the following table:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Medical</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Equipment</p></td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right; font-size: 11pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Management</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">of</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Diagnostic</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Imaging</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">Centers</p></td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 11pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; font-size: 11pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; font-size: 11pt"><font style="font-family: Arial, Helvetica, Sans-Serif">Totals</font></td><td style="padding-bottom: 1pt; text-align: left; font-size: 11pt"></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt">For the three months ended March 31, 2016</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="width: 46%; text-align: left; padding-left: 5.4pt; font-size: 11pt">Net revenues from external customers</td><td style="width: 5%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 11%; text-align: right; font-size: 11pt">2,454</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 5%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 11%; text-align: right; font-size: 11pt">16,165</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td><td style="width: 5%; font-size: 11pt">&#160;</td>
    <td style="width: 1%; text-align: left; font-size: 11pt">$</td><td style="width: 11%; text-align: right; font-size: 11pt">18,619</td><td style="width: 1%; text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Inter-segment net revenues</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">546</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">546</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">(Loss) income from operations</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">(207</td><td style="text-align: left; font-size: 11pt">)</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">4,304</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">4,097</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Depreciation and amortization</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">79</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">751</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">830</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Capital expenditures</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">31</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">117</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">148</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="padding-left: 5.4pt; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt">For the three months ended March 31, 2015</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Net revenues from external customers</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">2,486</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">14,610</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">17,096</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Inter-segment net revenues</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">502</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">502</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">(Loss) income from operations</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">(367</td><td style="text-align: left; font-size: 11pt">)</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">3,033</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">2,666</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Depreciation and amortization</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">78</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">811</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">889</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Capital expenditures</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">111</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">111</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="padding-left: 5.4pt; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt">For the nine months ended March 31, 2016</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Net revenues from external customers</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">7,833</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">46,766</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">54,599</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Inter-segment net revenues</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">1,594</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">1,594</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Income from operations</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">18</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">11,919</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">11,937</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Depreciation and amortization</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">242</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">2,265</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">2,507</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Capital expenditures</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">390</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">209</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">599</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="padding-left: 5.4pt; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-decoration: underline; padding-left: 5.4pt; font-size: 11pt">For the nine months ended March 31, 2015</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">&#160;</td><td style="text-align: right; font-size: 11pt">&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Net revenues from external customers</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">9,177</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">42,996</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">52,173</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Inter-segment net revenues</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">1,504</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">&#151;&#160;&#160;</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">1,504</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Income from operations</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">457</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">9,246</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">9,703</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White; font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Depreciation and amortization</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">229</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">2,436</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">2,665</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-size: 11pt">
    <td style="text-align: left; padding-left: 5.4pt; font-size: 11pt">Capital expenditures</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">178</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">55</td><td style="text-align: left; font-size: 11pt">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td style="text-align: left; font-size: 11pt">$</td><td style="text-align: right; font-size: 11pt">233</td><td style="text-align: left; font-size: 11pt">&#160;</td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6730605664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 3,005<span></span>
</td>
<td class="nump">$ 2,019<span></span>
</td>
<td class="nump">$ 9,360<span></span>
</td>
<td class="nump">$ 7,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Income Per Common Share</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 1.55<span></span>
</td>
<td class="nump">$ 1.19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 2,810<span></span>
</td>
<td class="nump">$ 1,888<span></span>
</td>
<td class="nump">$ 8,752<span></span>
</td>
<td class="nump">$ 6,743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Income Per Common Share</a></td>
<td class="nump">$ 0.46<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="nump">$ 1.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Convertible Class C Stock</a></td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total Denominator for diluted earnings per share</a></td>
<td class="nump">6,178,000<span></span>
</td>
<td class="nump">6,178,000<span></span>
</td>
<td class="nump">6,178,000<span></span>
</td>
<td class="nump">6,178,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Income Per Share</a></td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 1.42<span></span>
</td>
<td class="nump">$ 1.09<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Class C Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Income Per Common Share</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total Denominator for diluted earnings per share</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Income Per Share</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6717456768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Receivables, Net - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">$ 4,326<span></span>
</td>
<td class="nump">$ 3,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="nump">10,097<span></span>
</td>
<td class="nump">9,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFees_NonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">15,901<span></span>
</td>
<td class="nump">14,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC's")</a></td>
<td class="nump">4,059<span></span>
</td>
<td class="nump">3,507<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember', window );">Gross Receivabe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">4,614<span></span>
</td>
<td class="nump">4,153<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="nump">36,164<span></span>
</td>
<td class="nump">24,541<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFees_NonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">28,873<span></span>
</td>
<td class="nump">27,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC's")</a></td>
<td class="nump">4,462<span></span>
</td>
<td class="nump">3,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AllowanceForDoubtfulAccountsCurrentMember', window );">Allowance for Doubtful Accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="nump">26,067<span></span>
</td>
<td class="nump">15,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFees_NonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">12,972<span></span>
</td>
<td class="nump">13,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC's")</a></td>
<td class="nump">$ 403<span></span>
</td>
<td class="nump">$ 403<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from service and repair fees of Non Related MRI scanner customers; net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFees_NonRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management of, and other fees receivable from MRI Centers owned by non-related parties, - net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFees_NonRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management of, and other fees receivable from MRI Centers owned by related medical practices - net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical receivable from management of specific centers - net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AllowanceForDoubtfulAccountsCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AllowanceForDoubtfulAccountsCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6730646736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Patient Fees Revenue - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenue', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 8,695<span></span>
</td>
<td class="nump">$ 7,284<span></span>
</td>
<td class="nump">$ 24,596<span></span>
</td>
<td class="nump">$ 20,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts', window );">Provision for bad debts for patient fee</a></td>
<td class="num">(3,830)<span></span>
</td>
<td class="num">(3,201)<span></span>
</td>
<td class="num">(10,608)<span></span>
</td>
<td class="num">(9,244)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts', window );">Net patient fee revenue</a></td>
<td class="nump">4,865<span></span>
</td>
<td class="nump">4,083<span></span>
</td>
<td class="nump">13,988<span></span>
</td>
<td class="nump">11,456<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember', window );">Commercial Insurance / Managed Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenue', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">1,245<span></span>
</td>
<td class="nump">1,091<span></span>
</td>
<td class="nump">3,438<span></span>
</td>
<td class="nump">3,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember', window );">Medicare/Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenue', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">332<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="nump">874<span></span>
</td>
<td class="nump">896<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember', window );">Workers Compensation/Personal Injury</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenue', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">5,453<span></span>
</td>
<td class="nump">4,513<span></span>
</td>
<td class="nump">15,649<span></span>
</td>
<td class="nump">11,354<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenue', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 1,665<span></span>
</td>
<td class="nump">$ 1,388<span></span>
</td>
<td class="nump">$ 4,635<span></span>
</td>
<td class="nump">$ 5,205<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationPatientServiceRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=d3e8184-115640<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=d3e8195-115640<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052803&amp;loc=SL9156464-115641<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationPatientServiceRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of patient service revenue, net of contractual allowances and discounts, less the related provision for bad debts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the provision for bad debts related to patient service revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6888916896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 4 - INVENTORIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInventorySupplies', window );">Purchased parts, components and supplies</a></td>
<td class="nump">$ 2,033<span></span>
</td>
<td class="nump">$ 2,043<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">Total inventories</a></td>
<td class="nump">$ 2,234<span></span>
</td>
<td class="nump">$ 2,192<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1),(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventorySupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Inventory<br> -URI http://asc.fasb.org/extlink&amp;oid=6516093<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventorySupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6881208544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Information relating to uncompleted contracts -  (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsIncurredOnUncompletedContracts', window );">Costs incurred on uncompleted contracts</a></td>
<td class="nump">$ 2,310<span></span>
</td>
<td class="nump">$ 1,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_EstimatedEarnings', window );">Estimated earnings</a></td>
<td class="nump">1,622<span></span>
</td>
<td class="nump">1,371<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts', window );">Subtotal</a></td>
<td class="nump">3,932<span></span>
</td>
<td class="nump">3,233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerAdvancesAndDeposits', window );">Less: Billings to date</a></td>
<td class="nump">3,908<span></span>
</td>
<td class="nump">2,693<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear', window );">Total Costs and estimated earnings in excess of billings on uncompleted contracts</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 540<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsIncurredOnUncompletedContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred on uncompleted contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsIncurredOnUncompletedContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EstimatedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EstimatedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The calculation of the subtotal of costs, estimated earnings, and billings on uncompleted contracts plus costs incurred on uncompleted contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable reflecting the cost incurred on uncompleted contracts in excess of related billings which is expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57795-111642<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57807-111642<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerAdvancesAndDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refundable consideration, usually cash, held by the entity pending satisfactory completion of the entity's obligations or pending the closing of a contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerAdvancesAndDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6888864208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Balance Sheet Items -  (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms', window );">Costs and estimated earnings in excess of billings on uncompleted contracts</a></td>
<td class="nump">$ 279<span></span>
</td>
<td class="nump">$ 682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BillingsInExcessOfCostCurrent', window );">Less: Billings in excess of costs and estimated earnings on uncompleted contracts</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear', window );">Total Costs and estimated earnings in excess of billings on uncompleted contracts</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 540<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BillingsInExcessOfCostCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability attributable to (i) billings in excess of costs under the percentage of completion contract accounting method representing the difference between contractually invoiced amounts (billings) and revenue recognized based, for example, on costs incurred to estimated total costs at period end or (ii) contractually invoiced amounts (billings) in excess of costs incurred and accumulated under the completed contract accounting method that are expected to be realized within one year or one operating cycle, whichever is longer, from the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57788-111642<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57807-111642<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57795-111642<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BillingsInExcessOfCostCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable reflecting the cost incurred on uncompleted contracts in excess of related billings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68054760&amp;loc=d3e55302-109406<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57795-111642<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57807-111642<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable reflecting the cost incurred on uncompleted contracts in excess of related billings which is expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57795-111642<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57807-111642<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6730468576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 6 - OTHER INTANGIBLE ASSETS - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Other intangible assets</a></td>
<td class="nump">$ 19,494<span></span>
</td>
<td class="nump">$ 19,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">11,451<span></span>
</td>
<td class="nump">10,502<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other Intangible Assets - net</a></td>
<td class="nump">8,066<span></span>
</td>
<td class="nump">8,950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Capitalized software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Other intangible assets</a></td>
<td class="nump">7,005<span></span>
</td>
<td class="nump">7,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents and copyrights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Other intangible assets</a></td>
<td class="nump">4,612<span></span>
</td>
<td class="nump">4,547<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Other intangible assets</a></td>
<td class="nump">4,100<span></span>
</td>
<td class="nump">4,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Other intangible assets</a></td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6730564256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 7 - OTHER CURRENT LIABILITIES -  (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued salaries, commissions and payroll taxes</a></td>
<td class="nump">$ 903<span></span>
</td>
<td class="nump">$ 992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Litigation accruals</a></td>
<td class="nump">493<span></span>
</td>
<td class="nump">521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales tax payable</a></td>
<td class="nump">2,565<span></span>
</td>
<td class="nump">2,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal and other professional fees</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Accounting fees</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">434<span></span>
</td>
<td class="nump">510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Interest and penalty - sales tax</a></td>
<td class="nump">2,644<span></span>
</td>
<td class="nump">2,509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">982<span></span>
</td>
<td class="nump">486<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total Other current liabilities</a></td>
<td class="nump">$ 8,638<span></span>
</td>
<td class="nump">$ 8,253<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=28361426&amp;loc=d3e1243-112600<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6717030448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 8 - SEGMENT AND RELATED INFORMATION - Segment Information - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net revenues from external customers</a></td>
<td class="nump">$ 18,619<span></span>
</td>
<td class="nump">$ 17,096<span></span>
</td>
<td class="nump">$ 54,599<span></span>
</td>
<td class="nump">$ 52,173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Inter-segment net revenues</a></td>
<td class="nump">546<span></span>
</td>
<td class="nump">502<span></span>
</td>
<td class="nump">1,594<span></span>
</td>
<td class="nump">1,504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income from operations</a></td>
<td class="nump">4,097<span></span>
</td>
<td class="nump">2,666<span></span>
</td>
<td class="nump">11,937<span></span>
</td>
<td class="nump">9,703<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">830<span></span>
</td>
<td class="nump">889<span></span>
</td>
<td class="nump">2,507<span></span>
</td>
<td class="nump">2,665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">599<span></span>
</td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember', window );">Medical Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net revenues from external customers</a></td>
<td class="nump">2,454<span></span>
</td>
<td class="nump">2,486<span></span>
</td>
<td class="nump">7,833<span></span>
</td>
<td class="nump">9,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Inter-segment net revenues</a></td>
<td class="nump">546<span></span>
</td>
<td class="nump">502<span></span>
</td>
<td class="nump">1,594<span></span>
</td>
<td class="nump">1,504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income from operations</a></td>
<td class="num">(207)<span></span>
</td>
<td class="num">(367)<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="nump">229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">390<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember', window );">Management Of Diagnostic Imaging Centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net revenues from external customers</a></td>
<td class="nump">16,165<span></span>
</td>
<td class="nump">14,610<span></span>
</td>
<td class="nump">46,766<span></span>
</td>
<td class="nump">42,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income from operations</a></td>
<td class="nump">4,304<span></span>
</td>
<td class="nump">3,033<span></span>
</td>
<td class="nump">11,919<span></span>
</td>
<td class="nump">9,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">751<span></span>
</td>
<td class="nump">$ 811<span></span>
</td>
<td class="nump">2,265<span></span>
</td>
<td class="nump">2,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="nump">$ 117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 209<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4613673-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6887718720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION - (Details Narrative)<br></strong></div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_Note9ControllingAndNoncontrollingInterestsAbstract', window );"><strong>Note 1 - Description Of Business And Basis Of Presentation - Details Narrative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent', window );">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM (percent).</a></td>
<td class="nump">24.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent', window );">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM (percent).</a></td>
<td class="nump">45.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent', window );">The ownership interest of the original investors of HDM after reorganization of newly expanded HDM (percent).</a></td>
<td class="nump">30.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name, &amp;#8221;Health Management Company of America&amp;#8221;.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_Note9ControllingAndNoncontrollingInterestsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_Note9ControllingAndNoncontrollingInterestsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name, &amp;#8221;Health Management Company of America&amp;#8221;.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name, &amp;#8221;Health Management Company of America&amp;#8221;.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6881350304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Details Narrative) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Shares included upon conversion of Class C Common to calculate a diluted EPS</a></td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6888733184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract', window );"><strong>Note 3 - Accounts Receivable Medical Receivable And Management And Other Fees Receivable - Details Narrative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims', window );">Net revenues derived from no-fault and personal injury protection claims</a></td>
<td class="nump">59.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">54.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs', window );">Net revenues from management and other fees charged to related PCs</a></td>
<td class="nump">10.20%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">10.30%<span></span>
</td>
<td class="nump">10.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Approximate per cent ofthePCs net revenues derived from no-fault and personal injury protection claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net revenues from Management and other fees charged to related PCs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6720109632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 6 - OTHER INTANGIBLE ASSETS - (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents and copyrights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Capitalized software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">439<span></span>
</td>
<td class="nump">439<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6617397680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION ($)- (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract', window );"><strong>Note 9 - Supplemental Cash Flow Information - Details Narrative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="nump">$ 280<span></span>
</td>
<td class="nump">$ 406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income Taxes Paid</a></td>
<td class="nump">$ 235<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6888907056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 10 - COMMITMENTS AND CONTINGENCIES - (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent', window );">Recorded tax obligations</a></td>
<td class="nump">$ 2,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Tax interest and penalties</a></td>
<td class="nump">2,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance', window );">Maximum limit for individual claims under stop-loss umbrella policy for health insurance</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">$ 434<span></span>
</td>
<td class="nump">$ 510<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6881411664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 11 - INCOME TAXES - (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred income tax asset</a></td>
<td class="nump">$ 8,423<span></span>
</td>
<td class="nump">$ 8,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent', window );">Deferred income tax liability</a></td>
<td class="nump">510<span></span>
</td>
<td class="nump">$ 510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net deferred operating loss carryforwards</a></td>
<td class="nump">$ 122,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.4.0.3</span><table class="report" border="0" cellspacing="2" id="idp6717495568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 12 - SUBSEQUENT EVENTS - (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>May. 02, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_Note9ControllingAndNoncontrollingInterestsAbstract', window );"><strong>Note 1 - Description Of Business And Basis Of Presentation - Details Narrative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_OwnershipInterestOfImperialInHdm', window );">Company's (HMCA) ownership interest of Imperial</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_RepaymentOfBalanceOfClassStockholdersCapitalContribution', window );">Repayment of balance of Class A Stockholders capital contribution</a></td>
<td class="nump">$ 1,125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_Note9ControllingAndNoncontrollingInterestsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_Note9ControllingAndNoncontrollingInterestsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestOfImperialInHdm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>On May 2, 2016, the Company repaid the balance of the Class A Stockholders capital contribution in the amount of $1,125,000. As a result, the Company's subsidiary, HMCA, owns 100% interest in Imperial Management Services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestOfImperialInHdm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RepaymentOfBalanceOfClassStockholdersCapitalContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>On May 2, 2016, the Company repaid the balance of the Class A Stockholders capital contribution in the amount of $1,125,000. As a result, the Company's subsidiary, HMCA, owns 100% interest in Imperial Management Services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RepaymentOfBalanceOfClassStockholdersCapitalContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>52
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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ML@SGJ*;JGBR%LHL1[.U?1GXP[;SF'44$>_LWSDC-OED%_6LV_@]02P,$%
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MT6 _QHGJ;T[N,_7FMI$PDX-]76IG0LV^U6F5O.EE1@48Q2-6D$F1J+4G +@
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MG4EN6.C=W%!@&78<Y*MFR9-*9@*1$Z:09MEW\T+A9X#W B2-59GB9U$@,^A
MH(:.L513F!KD_5!.I@9852&K0C<QG&K*4\/S5%-6:IUZX>D$,J#S/_03@ZJF
M5#4\537%JO9.L".J0C<Q_FH*8,,#6%.VILKQRTVHRJPTDF,(UI3!GQ?8FQN*
MU\RSP[T(1*FT,.D8@C5EL.$9K"E?4U!:<$-EWAF1."R(UPI'4Q)+=07$" J4
MH)8G* 1L-)8=G\4G528\7X@1%"A!+4]0H'#4R,^6(E3Y5* $Q!@*E*&69RA
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M_7(:G] PZ:YF(S--,7*RY@!I2X;E J!^<= C$T+2)=R$CMFX#'U<"G+E9-+
M_"*[G /DZ#!5 "2M(:LJD7*2R<)DS,^E!6&THTLP8EH6V# MRL*RH"4Q# J*
MF;ET((BV<PEF;0VS0($2AHD](94(24;Q$BB;&LM(BWF[3$ :[>XRM%OK.&E
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MR_,#55SHK"QB[-64!0Y."@VOAMA!*6[^GD'B>,HVV2WP)MK.A0 M"SKS:J%
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M".]];-*52HG3W>V!3*^T^ )02P,$%     @ ;WVJ2'N04SRD 0  L0,  !@
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M2&A="#_YV*0KE1*'P^V!+*^T^@M02P,$%     @ ;WVJ2"_7P=*C 0  L0,
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ME3>M"P52Y&3F55R"LEPK9* ^XH?-X;0+B AXXS#818R"][/6[R%YKHXX"Q9
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M]>]G3@34+H1W/C;I2J7$Z6YZ(/,K+3X!4$L#!!0    ( &]]JDC,/0O%HP$
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M7.$BC[5G4^2Z=X(K>#;(]E(R\^\(0@\'O,*7P@MO6A<*I,C)Q*NX!&6Y5LA
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MGBHN=%86L?9BR@(')X6&%T/LH!0W?TX@<3QFF^Q:>!5MYT*!E@6=>;50H*U
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M8M1 RT;A7O7T#',+MX&PUL+&+ZI'Z[2\0C"2[#V=7,5S2G_R;(9M [(9D"V
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MM#)AMPG$;A.(G280VR<P4,YU-6W/PXFZ\P[LUG A3VF=3NW/4)P+9^U[L,Z
MH3T7I_SA'/G5_6YS)6?ZD[3GLNF\-\;[T^AP=#PQQFF?=K]5]KT+)<?IIJ(G
M+BY3,6_CR7R\X>SZ^*%A^K5C]P]02P,$%     @ ;WVJ2((\TUBU @  UPH
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M?""A$PEVBX!P"1(I0;QN\V -XM2  %1%2%6[J@J4*,Q"(RS48PE665.7A58
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M<R]S:&5E=#(X+GAM;(V62W.;,!#'OPK#O4%/'A[LF02[TQXZD\FA/1-;MID
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MF3ME&3!HM>WN;=7^-_,#+<;[I;'<7.4_4$L#!!0    ( &]]JDBFMC(?^ $
M -H%   9    >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;'V478^C(!2&_XKQ
M!PP*?G0::S+C9K-[L<ED+G:OJ6(U@^("K;/_?D%L!QKJC7R][SG/ :&8&?\0
M'2$R^!SH* YA)^6T!T#4'1FP>&(3&=5*R_B I1KR$Q 3)[A93 ,%,(HR,.!^
M#,MBF7OC9<'.DO8C>>.!. \#YO]>"67S(8S#Z\1[?^JDG@!E 6Z^IA_(*'HV
M!IRTA_ EWE>Y5BR"WSV9A=4/-/N1L0\]^-D<PD@C$$IJJ2-@U5Q(12C5@53B
MOVO,KY3::/>OT;\OU2KZ(Q:D8O1/W\A.P49AT) 6GZE\9_,/LI:0ZH UHV+Y
M!O592#9<+6$PX$_3]N/2SF9E%ZTVOP&N!G@SQ,FF :T&=&< AFRIZQN6N"PX
MFP-NSF+"^LCC/5([5P=BF>1FNU1E0LU>2IC$!;CH0*L&+II71^-35+8"?04!
M"N!& 7T4F:& EC_.D#\ \@5 )@!RRKB#S$T91C,:#8HCGZBR1?$N@WZ49 ,E
M<5"0FR4U*(F=)8/0)ZH<$<H?;&NZ@9(Z*(D7);6RH&?D1W%$$#TXH&P#)7-0
M4B]*YJ!$.R^*+8+9\P.4? ,E=U R[[^2VUD2[Y]B2](DNN, UC6<\(G\POS4
MCR(X,JEN]'+]6L8D49&B)U5:IQ[:VX"25NINKFLV;X\92#9=7]+;<U[^!U!+
M P04    " !O?:I(6C87:\L!  "_!   &0   'AL+W=O<FMS:&5E=',O<VAE
M970S,2YX;6Q]E-N.FS 0AE_%X@'6G)-&!*E+5;47E59[T5X[9 AH;4QM)VS?
MOCX0:E9N;K ]_/_XF\&XFKEXDSV 0N^,CO(8]4I-!XQEVP,C\HE/,.HW'1>,
M*+T4%RPG >1L38SB-(Y+S,@P1G5E8R^BKOA5T6&$%X'DE3$B_CP#Y?,Q2J)[
MX'6X],H$<%WAU7<>&(QRX",2T!VCS\FA*8S""GX.,$MOC@S[B?,WL_A^/D:Q
M00 *K3(9B!YNT "E)I'>^/>2\]^6QNC/[]F_VFHU_8E(:#C]-9Q5KV'C")VA
M(U>J7OG\#982+&'+J;1/U%ZEXNQNB1 C[VX<1CO.[LT^7FQA0[H8TM60Y \-
MV6+(/ABP([-U?2&*U)7@,Q+N6TS$?/+DD.G.M4C:H'#MTI5)';W5:;ZK\,TD
M6C2IU3QO-"%%XRNR9)5@#;!2I"&*TE&DGC\ILW""+)0@<PDR'^#3EG'GJG"2
MT56Q"VH:7U/NTS!'_H CW[1SO]VD<""Y#U(4(4WC:Y+\/R#% Y!B U(&.U+X
M('FP(;ZDR.,/'-@[:Q.YP \B+L,HT8DK?6SM&>LX5Z SQ4\Z5:]ODW5!H5-F
MNC,ENQ_,+12?[M?%>F?5?P%02P,$%     @ ;WVJ2-0*?M(Z @  Q0<  !D
M  !X;"]W;W)K<VAE971S+W-H965T,S(N>&ULC971CIP@%(9?Q?@ *RCJ.'%,
MNC9->]%DLQ?M->,PHUD4"\RX??N".%8FZ.Z-"/SG/]^!Y) /C+^)FA#IO;>T
M$P>_EK+?!X&H:M)B\<1ZTJF=,^,MEFK*+X'H.<&G,:BE00A $K2XZ?PB']=>
M>)&SJZ1-1UZX)ZYMB_G?9T+9</"A?U]X;2ZUU M!D0=SW*EI22<:UGF<G _^
M%[@O8:@EH^)70P:Q^/<T_)&Q-SWY<3KX0#,02BJI+; :;J0DE&HGE?G/9/H_
MIPY<_M_=OXWE*OPC%J1D]'=SDK6B!;YW(F=\I?*5#=_)5$.L#2M&Q?CUJJN0
MK+V'^%Z+W\W8=.,XF)T43&'N@' *".< B#8#HBD@>@@(#-E8UU<L<9%S-GC<
M7$:/]9W#?:1.KO+$N,C-<:G*A%J]%2'*\N"FC29-.&J>+8U+42X5$9PE@0*8
M*4(7160HPF6&&-@Y4D-A--VH@1G*D$M5/JCBT T3;<!$%@RTT\0&)EJF@<BM
M*BT5B,$*#-J 019,Z(1!BS0[D"1.%DN4+<[80HDW4&(+)7(;)!L&R=8M3[4D
M"\P4@-A9RZK(0DDW4%(+!;D-=AL&NT_4LEM@H@0Z+Z^T1#%*W2C9!DIFH:P<
MANYHJPYZ\\-J)M%$"H%35:ZK;!QG3[KC6 TG3E8LMAH*_$Q'@<MF$>T>*YHZ
MRKK*X 2+AMOC"_F)^:7IA'=D4O7NL=&>&9-$>8$G=4JU>E/G"25GJ7]3?7SF
ME3$3R?K[HSF_W,4_4$L#!!0    ( &]]JDC1I$_P:0(  ),(   9    >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;'V6S8[;(!#'7\7R ZP-^#-R(C6NJO90
M:;6']DP2DEAKFQ1(LGW[@K%=6(U]"0;^,_,;( /5DXMW>65,!1]=V\MM>%7J
MMHDB>;RRCLH7?F.]GCEST5&EN^(2R9M@]#08=6V$XSB+.MKTX:X:QE[%KN)W
MU38]>Q6!O'<=%7_WK.7/;8C":>"MN5R5&8AV533;G9J.];+A?2#8>1M^09L:
M82,9%+\:]I3.=V#@#YR_F\Z/TS:,#0-KV5$9%U0W#U:SMC6>=.0_H]/_,8VA
M^SUY_S:DJ_$/5+*:M[^;D[IJVC@,3NQ,[ZUZX\_O;,PA-0Z/O)7#;W"\2\6[
MR20,.OIAVZ8?VJ>=R<EH!AO@T0#/!BA9-2"C ?ED$%FR(:^O5-%=)?@S$'8S
M;M3L.=H0O7+'0 Z#PBZ7SDSJT<<.IWD5/8RC48,'S=[30(K:51 T2R(-,%-@
MB"*S%-BQ1UD).R"0 V(=$"^-PH?,;1I6TP^:,B:0IO8T)89!DA60Q ,I_2"I
M!4F<( CED*9>TG@@Z0I(ZH)D,0B2.D&2DH @KB;%"WN;K8!D'@@"03(G"$ZS
M%"3Q163AE.0K*+F'@D&4W(E"8GAS/$V2P"#%"DCA@8 +OR_<$["P.:X&DQ0&
M*5= 2@\D 4%*]Y004%.[FA3%,(BIJHLD9M)! 8_ ?A3U$R\,XZO2>.&D(+ N
M3CA>T2,9C(/<<E& !ZKV1$F1+<" Y7&"P=[:9&!Y&T4V3I$1L C6ODK_C3[A
M1,[U<:,7]I.*2]/+X,"5OHF&:^/,N6+:5_RB,[SJ%\+<:=E9F<_<I&[O3-M1
M_#8] >9WR.X?4$L#!!0    ( &]]JDCCX]7OLP,  'H0   9    >&PO=V]R
M:W-H965T<R]S:&5E=#,T+GAM;(V837.;,!"&_PKC>P,2$H*,XYD$Z+2'SF1Z
M:,_$EFTF@%S <?KOBT X6KH07X(1SZ[VU<>NE/5%U:_-4<K6>2^+JGE8'=OV
M=.^ZS?8HRZRY4R=9=5_VJBZSMGNM#VYSJF6VZXW*PJ6>%[AEEE>KS;IO>ZXW
M:W5NB[R2S[73G,LRJ_\^R4)='E9D-3;\S _'5C>XF[5[M=OEI:R:7%5.+?</
MJT=RGY)0(SWQ*Y>7QOKMZ.!?E'K5+]]W#RM/QR +N6VUBZQ[O,E8%H7VU/7\
MQSC]Z%,;VK]'[U][N5WX+UDC8U7\SG?ML8O66SD[N<_.1?M37;Y)HX%KAUM5
M-/U?9WMN6E6.)BNGS-Z'9U[US\OP)?2,&6Y C0&]&ES[P0U\8^!_&+!% V8,
MV*T]<&/ )SVX@_9^Y)*LS3;K6EV<>ICN4Z97%;GGW=QLG:9OK(<)Z<:NZ5K?
M-C00:_=-.S(,[9DGFPE1)+$1<B7<+H!K%!2+PO1 [2BP#F*;"$,TAD^=I#-.
M0)@^%J8_#)8/!FL2A1BD#$PUC$08D BC8D )+PHP*K$ISGB$^DH!18GP<6%L
M01@#PB;=\$$8 \$$&!,#QJ,8D]@,X1'#H!1"'L,E\05)W)8D/%02MWIA7B10
M339$@P 5GM@0(9&/NDIM*A+>S$0%"ZH">Y]1M)>GP.HE]%'E,6!"=,(3FZ'<
MPR4%<'0X+DDL2!)@H@@J2=C#RT)4$F (ZB>QF?^VDU%D,]2?F:-P05 (!%'<
M0;3@(%I*,V9$(CM*QM%=%$,HQ)>N#8G0$FP/B@U%1 A<E"[,LZKTQT^3C(&6
MLPR$9M(,@&;SS(2:2S0$+:&C,')#JC'0T-$7BN^F&%+^M!Z/TFR*H.LC!0SC
M<Q.&%N51%[TAV1C(+!]T4F/(H/$F@*$,G=,40C2:$;54PHE_0[HA=DGU428&
MS%R^@8XB=&FDT).8.9>0I?I-0 &?.P&0I7I)^ U9AX Z%Q KWX.Q 1@+""H\
M 1@+!%Y;4XC1R#HL07E+A9,$MVQ2NYHQW\.S*J!\#\^8":"Z(\'T(#B*L[&(
MLCEM2Q64B%LVJEW7!)^L5W,L!5 XMZA!A:3X&D@AQ?PY84N5E(1+F]4<N TT
M#K3 H 1 U,,/T@#BTZ.,:UVL2ED?^BMMXVS5N6IUQ%;K]=K\2/7%;-+^1.YC
M@K0G^IK=7^0^W&_6I^P@?V3U(:\:YT6UW76PO[OME6IE%[1WUXWW46:[ZTLA
M]ZW^*?1$#%?CX:55I_&F?_UWP^8?4$L#!!0    ( &]]JD@E[(K3G@$   ,$
M   9    >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;'U3RX[;(!3]%>0/&&SR
M;.18:J:JVD6ET2S:-;&O8S3@ZP*)IW]?'HX;*FLVAGLY+\"4(^HWTP%8\JYD
M;XY99^UPH-34'2ANGG" WJVTJ!6WKM07:@8-O DD)2G+\RU57/1958;>BZY*
MO%HI>GC1Q%R5XOK/"22.QZS([HU7<>FL;]"JI#.O$0IZ([ G&MIC]KDXG#8>
M$0 _!8SF84Y\]C/BFR^^-\<L]Q% 0FV] G?##9Y!2B_DC']/FO\L/?%Q?E?_
M&G;KTI^Y@6>4OT1C.Q<VST@#+;]*^XKC-YBV$!+6*$WXDOIJ+*H[)2.*O\=1
M]&$<X\H^GVC+!#81V$PHUB%X- HQOW#+JU+C2'0\VH'[&RP.S!U$34QHZKA[
M%]2X[JUBNW5);UYHPK" .:68S8RA3G\V84LFVVC"$H'MLL!J26 5!5:)P"Y-
M&3&G%+-?-EE_8+).!#XMFB28?;YLLOG 9),(%(LF*8;]9T(?+GC@%_C!]47T
MAIS1NG\E7&R+:,$IY4].JG,O<BXDM-9/=VZNXT\:"XO#_<G-[[[Z"U!+ P04
M    " !O?:I(<Z#O?>\!  !V!0  &0   'AL+W=O<FMS:&5E=',O<VAE970S
M-BYX;6R-5-N.FS 0_16+#UAS[:*((&U(JO:ATFH?VF<'AHO6QM1VPO;OZPLA
M9$73O&#/<,[,F;$]V<C%NVP!%/I@M)=;KU5JV& LRQ88D4]\@%[_J;E@1&E3
M-%@. DAE28SBT/>_8$:ZWLLSZWL5><9/BG8]O HD3XP1\6<'E(];+_ NCK>N
M:95QX#S#,Z_J&/2RXST24&^]EV!SB W" GYV,,K%'AGM1\[?C?&]VGJ^D0 4
M2F4B$+V<H0!*32"=^/<4\YK2$)?[2_2OMEJM_D@D%)S^ZBK5:K&^ARJHR8FJ
M-SY^@ZF$Q 0L.97VB\J35)Q=*!YBY,.M76_7T?U)_8FV3@@G0C@3YCSKA&@B
M1%="?)<03X3XT0S)1$@^9<"N=MNY/5$DSP0?D7"G/1!SJ8)-HL^F1-(ZA3L0
MW3NIO><\3*,,GTV@"1-:S&Z)29_7(/LE))@16 N8581K*J8,X5+%6H)BB4C3
M50W_#7+X1Y ;F=&:S,@U*UIF2-;Y\1U^?-/L^%9CXEKA,+WK9)CZOK\&*QZ#
M[1^#'>[ 7'%X<:L8B,:^9XE*?NJ5*6_AG4?&2VANY2?_+M@4P8I_KT>,FPC7
M\'DVD 9^$-%TO41'KO1;L!>WYER!UNT_:?VM'H*S0:%69OML"G-SP1F*#Y<I
M-X_:_"]02P,$%     @ ;WVJ2%AR%P0- @  / 8  !D   !X;"]W;W)K<VAE
M971S+W-H965T,S<N>&ULC55=;YLP%/TK%C^@YC.E$4%J2*;M85+5A^W9(4Y
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M+/*,5<T36WB!<5*YX9JA]0/F-Y=GOWM[^>Y\<CW_3DQ^_WYZ\\<2UJY LC2
MMGHW.3(#TPA0#DF)MX'WDW7"N%O*.W?AEH[O+(CSPO8N#-9" E<$CU**"+7B
M?> M95C>&=C740*V3L1:VXF)X8";VQUE*3,3DOJE03@&K,'%?6H0$XU 3\I:
M/<D(+%FYK+ 5:( W$'5E_IG!.&+L@(X'RC0)8-4Q^3Y3ENA).]CGR8(1<73E
M( _>RQAY^AC0]D*\K/$PE%DB8#\_!F0S%@R7'7:-+6 Q\6,5CY1&CI/X'A3<
MG\N>3&DHV<B[AVVQX[9O YV]5]'&6<C?? />' I.^<UKL<V^W++3_+#Z;>;'
M5>\Q/V:;H1KX4>"Y2SJ#:.B3L4,'8\H"<%]CLKNWEUDZ0M>3'R>S]Y-YA;&P
M3!:QB!PR[*K4^UPI*V1R,G"4>?;$P07]5OWX%1QLE,KPC-:7-HYC*<+J*8'#
MYWA>\$!JD%9:@O]!*KYB>Q_="&4%^/#BUEF25HCHKTVVUOXV:274VX9OL5NK
MIF+9<LU;QS&S"N/V<GXS%^/9N9C\X6HRFY>IRN:O7AK4Y\8D\\[14341G_O<
M'L9-"=XR'^Q\9EU'A><_N8U^I1,&PHGT&C$DP.P%9'B73P@I(ENLI"\Q&H/C
MG>7:]2G$$[L?*P1T)1?7F&FIQ3=1;DC)@YF=75Y,RGX-R:(WJ/PO-Y)5;(7W
MP^I33U[E'44QH9(GK#:LU&)':I;C&F!.)6Q8BOS^U7<WSB=U^D$EFAI^6J?A
MZZ<I&0VR#OSL&SR;>RZ<>^ALGR=.G<A="..Y*XSR*(V#]D'Q@9^DN[I'/AU_
M!-*M '4TP^XPRKGK)?C<EZREY]B]6E[]48#C#4CR_>,IQB-W!J<"+L=P+#]6
M.QRX-[>2G./ESPFS:\1>!M!SX8(-[*>/X.?X%P5A-LA"H'O%[:,(TJ6=^J7/
M)5@M"Y?M53KI:W0X_EP9IN4 E$OF!O&HX;W5G&6@$W[AQ %8X=)C(0:HC=*I
M*IW%(R UVN[R&$0)_X9H-[9$'COIWM*>M#]MIT(Q<QZ.HF."UQ"I%?JUZ')4
M''^&Z4A#=YP'SW#,JF&<[4NQ70S& FT'@UTE(/C1N21?K#+^4J6$V'.+JT)Z
M*?Q)1(XR_--P[ _[&]<'ZN^ _1H4]:-FF]L@#(,'"@Z4/&<1W'KNJEHMG*/N
M<F\3^I).3%XTUGI=I\ECD-#2^SZ1@]=_ON]:PO!=BJUZ#"LIF1Z8-$1+OTSJ
M0[2U T'RG<J5ZV-$!G?$$?BG/(ZW'K4/SBYO)J(-H\XG\[/KZ=7-]'(F+M^(
MT_?SZ6PR9S/R=#R?SO'3J^O)?#*[&=.H(Y3(+TJJ69U^\D#!K5F@+?]?X]N(
M;//__GKK[^4(OKF<C:_%V>7UU>4U/67A?//WI_/I^71\/9W,!4(P%S>7,&IV
MCM;R.?XVOWPW/1_?P!]OIK/Q[&PZ?B?FL/#D M:?BXOQ]=G;?(0"O2IQ-%YS
M*!$_40$.8(-8JRO;PIC,)A8@ ?A[%/CXQ#'@<S9^?SZ%-8^%0LOG_WD&7<YE
MM C=C0Z'GB:1ZV,8:')W)Y%QI?AMXCT*Y0C: )Q$=;YQ_$>!)RH$1R!!?QN_
M6*AP"ISN<.7X2C%9,"]^:TAQ^&3I.BL?Q!;8%>[:62$'+"0>TP@L_Y4>%21@
MHBJ8FJ#(T8 WYQ8/#HPWH #[&XT\'8<$T/'LKQ H"X$(4F,4IW\K'2^^%X;+
M94:$8,!X#0=AX1"%WIY?-,44-&3H@A0C\8)""E8%!Q('NTA*#FT?/=R[8+T_
M@-01(,<\C M81%N9[N<I !SCS@  Y0VAA,)U1:?7['R;BC?D'H)RZ[26L:]0
MQH[KTU1+%^8%I#^ (Q'=NYML5AC?ZS>'WZKI;0*"D!FZ0#@*'Z(^"<)(#3'G
M[;::K6\KIM7H\.4#4 E,$@?C$ P_$AJ@!HCVYYH4K9I]W @D^H.XE30J\-%G
M9=6-F[ R_9W PB'#XH")]OF7*O0QRV>H^_S7)IG%1,8KE"%^S%1#X)W%@I_@
M^9UDZ:J@^!(M+_HMC>-82ED (J/,I+UWX/#=2NF##0!:BD/<-'&XI+C?@PLP
M*K\/, C?@*Q E&<R=1."V>EN,!J#%B"AWEV+;#TW2T>PD*HT)V+"]?E4:17\
M!H8)O+0GXH_!ZER @FRW</?7<H5!80JB-O[0%&."$=;W'DE@/(HEZG"R@;UD
M*?5YX77R -P%0:SU,"BFD E6O:6*O2N>>N^[:7PL,L\QV\$L&T05VIO6E*<(
M-N!#\QG,6- FT!W#SC]"0KIL2Y$) 9LA$S8)0];^BS!Q/)#8-! 8#>#R)8;:
M\5H?X0&H,+BQ,7C(RHBO<+9L&MX)C$P\%7A"6./[4'*@!!0_'!F.ZTDZ3_GP
M.&P SA320L/@DHA$RYND/9/%TBO$]TX,^W\$6,AKH!.DE[WCB_I'O*B7Y*'E
M(N^#)G*-N$M"=?^74MH6%*9%OF*U8<0T4Z)8QEG(<P9.)^%9C1I-=75(OXO$
MV/<3BGSAA0S>3&GV_1W,[\$3R*K(,>M; *,S8NU6V)BE-R8+-PK-4L28-' '
M#)/Y^PO0]G]$-3N?_C";OIF>C6<W8GQV=OE^=C.=_2"NP%8X0U.BQB)ZQE3_
M^L;-$U%[E<D(# RD[*6E\RZ!7"D9-+N1&>'H6V"87V$V4[ V60)KYV?0C\IS
M>P"_P7MLH!8$;"2W( E<)]2W/1C(5.J1)(KGL>T%1Q,7^_R+XNS/?SUN6F.0
M0)&[\MT[.+.HYE"H*VV3P44J.G3 F5<R/),HTG/7L#\E+A<F=IIBHJ]S,6Y#
M(1@5_$GO>3-Z'7W^97(U!Z LT((( 1E#MT[$!^Q!1W8<%=GQ$SIN&%!@?LA?
MY2&?T&]&<@H8@&GXQXC=9X^!10:*HZ 4Q_,SD"T;@+HS:#7:<&P__W*%P6)@
M"I:@<Q30V74;8OGF(6CPO=A: I<N/_\U;^V29Y<;:/% 5BJ.MR E")/?UB&,
M0C:;C>>JF5RZAP#L<$R8)J-+V6RNI8J&5<P&RUI/D_XT*/<1R#(=;P-2HEA&
MUB,1*S8!!A/P$! 0J);((<;OY"?@.1?=^%!M(5+*$A4DCP=^BS(T YL&>8*G
MC$('2O'(V@D_ )5!RR^D26MB&,O@!K%,2,$2I.2MLKKY8HS8*<X1(\I@2&%0
M_K^EA$$DVIVA9N=DP]?#!C;R.6--ZX8@RP%4_LC2L??L3E!4)9^)/<=9*@"<
MK-& ",)75A;#!,0[KD?1C@)]U$[%"]&U6ZT^_.S80S#X7HA^B_YHM4?PLVT/
MAT,<U+7.I1^09,$E?BJ>?GV#;Y!P8+=@+OZ_.^P6_U9P*T"1\4U*P)JM)H'2
M:O8&]*/=I1]=]:--/UHC2[/X,P',0$.@SOC$4B*3QC;C'EGA\_^J'XJ(RVQ)
MXJ4MYWE@MT^&:C'U6PKY-AST^KG-I[N>E7B_],D_&J>-[.X *3JT3_H=9*X^
M[NW$[K3QKX%]TL--MMNCOS^OM9L$2UNCN]>BO_@,--MMA?Q_:5Z#S7?,S;=&
MFN6NY8*2#8UP7ACX\/M"&4_@5;&892\$I?2;\?Q4WT^,Y^_%+&C2MXW6R+;8
MYJ'+"!"E#<5RQD?BZ(8T_$E[>/P*PS)A\%&F=R\3';0E$Z9Q2JKF2H5Z,RC1
MB;^Y=U%TH^&72?6-OMTCQ<6G!^^D79C7O7L4'\%X T-6.-&&]"4JOFSOB'S"
M68-UW,* NUG<J\"421$['Z0E*>C&^03)K0>[8[O.E9FOY[!KPRHO HM.AWN=
M.[ #@>T6[-2@(F,G[,8P8MPT5PV]YB@"%S!5HEK=6[!)9T&65A'4(.=H??Y+
ME#>;,VNZTK5&)I@AE<CI2L.)-7S0;[1/;"N7Y,1G@ Q?'1]+T__HZM46*NZ&
M*%4!! HDD0E"J0OD9&/V&C^6)KZJW _S<^->R'(PF.0W=*(?1F+$0D%#1B^#
M2>4AC'+<BN(7;>_IIU>)2]:J!E=!&N5 C3#HXU (4T%M/15J&)/E"J,U])0=
MN!A8A:><<(EL(W5 V**819X+<7(=7-*?H27.#E^4"Q4 D78RK;A-R#%<HR-E
M(@6>]QXM9QF X^C$'$XU+SR(QQ4@13#!U,U,QC\EX ]([=ZG '0K ]W2X\!'
M 0"DL&+4DFF_N'?\%4:KXS @&:'<N8 ,9(TC15B0"8!#%=;)+ZU&J""S)K1E
M$+] [P*-$8&Y,UK!J;0;=9YBI#MN;.DN*4[$0#&[A'*1.X ZLF_( W31ZMBT
M "D\7 BKC.G#8L2*PCT4Z/<#H663;Q46UA$KO#3(8OQ.AE<=<31W6Q WA T2
M1_?P8%DD]5 UZ7PJ=H;.TJ1K\CQU8C4I/+HYJ9%SF;*8JT,66>])"1D M=%Q
M%7.E=#3K7E":;!H2UR4$C[0 +S4!$"@X3MF&$0C'Z -Z1RJ="B-\\\D9QP04
M1 NP,QR\%N?\^PP^+03@W+*6C&QU"Z&COIJ:!=>*8H<DB6\E612I" %NLC (
M F*/LJ;Y-/R'N \> +>A;0;]EX&,B!%O)1RNCY*G5;%X%BX*+/$0)-Z2-V4$
M2%#1T<+H;":A$6 T-KEFG$:"S*9HX07\Y[VSY BVBL6J/6CGD_89:&5&4G O
MB#<YX\@B)!'<3CZTHYF= ']*K$K)QMC%E!.&/T^")IILN<,,MJ5B 7"^84\4
M_50A.2-ZE,D %H@ "\9U+1W+5:*'GC9#VOKVKKBHEC.\?12VC.$ E\+P;7&_
M1C(-:Z)'S4!6*BQK(K1=T=#QPKFXGIQ-IC^.3]]-;'$Q.9^>C=\9G]&5Z<5X
M-OZ!XISTY^7-V\FU>#.9F _7Q7&OC1*G'3?:-6 U*\":?RE<>P:'Q3]1<+B+
M-]_/(ZM5CSZ#?AQX5#'.T*6H%>N2NP!3AT$26*5"A%?6#Z#Y09?JY&+B5G"'
MK:JZN1>B9P_:/8RK4#2E9W<[@\J1^?371XR\M- 3Q)]6N;X./P<7;T!3@V,Y
M.$'/K66W1B?67L5R")$]/"&_NV./3M@MMT>M]G[/;TM:/OKFZ@QT]S?'M./>
M .?NM;KT5ZL_>@8-<@;%TTG0[G<)81V*>IV,VGN2 /!/) !7O)($G9[=[[49
M<[W^B"(=K6%G;PJ<V-TNN=Q=N\,40 0-ORX%NO:(PGM,@:[=;YV8ON-WZ$MH
MZ\:A' M_037@'#0@@^R>;LX7^+7K+V%X^-@4*0XS>HHSL ]!5P(E/[#E!"(
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MH*8MG["%$P=.)-7TW>F:,^ 3>@5$X/@XTF@*VT(%O9\ZY/(OZ5NJA'1)70G
M@Y"/:48*[<M<KL[H;U.&&[Y41]R,_U"5 JA?-?.K->B+*#(:?I[T6M1V@B*\
MW/QE$0 [<IGG/7R#W>;H"#JZZP>?FUBU<S>LQ5+Y06XVBEGG>['0/8RR=R,J
MK2"S-^V<3/8'?VYQ Z:T8WYFQ^D^EABKOI6^O'.YAOA6ZN7_+)<VVA3&:F(-
MQPR'8/O[AN=^ )75 +/8;R!S\M,1#.&N[%@O"!AWJ%N<+@<#BX%KE;"^%=4/
M]@8MBYPG[%$56:4[RXJD>5M6MA\3F\M<#CV7<\&YW6!3><9\*$7ZHC],Q(]
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M!]XO1,?,+#G<UGSP"0W!:D#:#LB%\PB&C6J0I6"OB *IF[@C[%=UO,,<*0N
M2@EV+3>JMAT]=.4OIWIJC^Y;V80OHRA^_7]02P$"% ,4    " !O?:I(F9/Y
M]\P!  #3&@  $P              @ $     6T-O;G1E;G1?5'EP97-=+GAM
M;%!+ 0(4 Q0    ( &]]JDA(=07NQ0   "L"   +              "  ?T!
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( &]]JDAYY7JTL0$  !L:   :
M          "  >L"  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( &]]JDCKJR[V$@,  +(+   0              "  =0$  !D;V-0
M<F]P<R]A<' N>&UL4$L! A0#%     @ ;WVJ2'2H(%8^ 0  :0,  !$
M         ( !% @  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ ;WVJ
M2)E<G",0!@  G"<  !,              ( !@0D  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " !O?:I(W[Q$%U0"  #:"@  #0
M@ '"#P  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( &]]JDAGCO)''00  ( .
M   /              "  4$2  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" !O?:I(TA:)Z;,"  "^"@  &               @ &+%@  >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ ;WVJ2)W%O*+:!   +!D  !@
M             ( !=!D  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4
M Q0    ( &]]JDB[ %G^"@,  &,/   8              "  80>  !X;"]W
M;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !O?:I(PZ<GQ04'  "1
M*   &               @ '$(0  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL
M4$L! A0#%     @ ;WVJ2,P>DC!&!   3A0  !@              ( !_R@
M 'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( &]]JDAI,PQC
MI@$  +$#   8              "  7LM  !X;"]W;W)K<VAE971S+W-H965T
M-BYX;6Q02P$"% ,4    " !O?:I(H=7YBZ8!  "Q P  &
M@ %7+P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ ;WVJ
M2-9M3E.B 0  L0,  !@              ( !,S$  'AL+W=O<FMS:&5E=',O
M<VAE970X+GAM;%!+ 0(4 Q0    ( &]]JDA[D%,\I $  +$#   8
M      "  0LS  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &]]JDC]]VFLHP$  +$#   9              "
M 4X\  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ ;WVJ
M2)O*,I:C 0  L0,  !D              ( !*#X  'AL+W=O<FMS:&5E=',O
M<VAE970Q-2YX;6Q02P$"% ,4    " !O?:I(3CSMU:(!  "Q P  &0
M        @ $"0   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0
M   ( &]]JDB*>>P>I $  +$#   9              "  =M!  !X;"]W;W)K
M<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ ;WVJ2/V=K?C. 0  X 0
M !D              ( !MD,  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q0
M2P$"% ,4    " !O?:I(RG R9:8!  "Q P  &0              @ &[10
M>&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( &]]JD@*\"81
ML0$  !8$   9              "  9A'  !X;"]W;W)K<VAE971S+W-H965T
M,C N>&UL4$L! A0#%     @ ;WVJ2%]F^]6G 0  L ,  !D
M ( !@$D  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " !O
M?:I(_& <4K,!   6!   &0              @ %>2P  >&PO=V]R:W-H965T
M<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( &]]JDB)!"S,IP$  + #   9
M          "  4A-  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#
M%     @ ;WVJ2+P&_I2G 0  L ,  !D              ( !)D\  'AL+W=O
M<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " !O?:I("1>S(Z4!  "Q
M P  &0              @ $$40  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM
M;%!+ 0(4 Q0    ( &]]JDA_CQ=W>0,  /D0   9              "  >!2
M  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ ;WVJ2((\
MTUBU @  UPH  !D              ( !D%8  'AL+W=O<FMS:&5E=',O<VAE
M970R-RYX;6Q02P$"% ,4    " !O?:I(Y?U0E_0"  !""P  &0
M    @ %\60  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    (
M &]]JD@9 FJ[S $  ,4$   9              "  :=<  !X;"]W;W)K<VAE
M971S+W-H965T,CDN>&UL4$L! A0#%     @ ;WVJ2*:V,A_X 0  V@4  !D
M             ( !JEX  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"
M% ,4    " !O?:I(6C87:\L!  "_!   &0              @ '98   >&PO
M=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( &]]JDC4"G[2.@(
M ,4'   9              "  =MB  !X;"]W;W)K<VAE971S+W-H965T,S(N
M>&UL4$L! A0#%     @ ;WVJ2-&D3_!I @  DP@  !D              ( !
M3&4  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " !O?:I(
MX^/5[[,#  !Z$   &0              @ 'L9P  >&PO=V]R:W-H965T<R]S
M:&5E=#,T+GAM;%!+ 0(4 Q0    ( &]]JD@E[(K3G@$   ,$   9
M      "  =9K  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%
M  @ ;WVJ2'.@[WWO 0  =@4  !D              ( !JVT  'AL+W=O<FMS
M:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " !O?:I(6'(7! T"   \!@
M&0              @ '1;P  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+
M 0(4 Q0    ( &]]JDBC?V]<:@(  *((   9              "  15R  !X
M;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ ;WVJ2'B?CR?>
M 0  R00  !D              ( !MG0  'AL+W=O<FMS:&5E=',O<VAE970S
M.2YX;6Q02P$"% ,4    " !O?:I('PQ]?\T!  #@!   &0
M@ '+=@  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( &]]
MJDA_*VG0QP$  * $   9              "  <]X  !X;"]W;W)K<VAE971S
M+W-H965T-#$N>&UL4$L! A0#%     @ ;WVJ2!7SO_.; 0  GP,  !D
M         ( !S7H  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4
M    " !O?:I(WR//I0DL  "ZTP  %               @ &??   >&PO<VAA
D<F5D4W1R:6YG<RYX;6Q02P4&     #, ,P#7#0  VJ@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.4.0.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>88</ContextCount>
  <ElementCount>181</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>18</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/BalanceSheets</Role>
      <ShortName>Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/StatementsOfIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/StatementsOfCashFlows</Role>
      <ShortName>Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (USD $)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd</Role>
      <ShortName>NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (USD $)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (USD $)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (USD $)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd</Role>
      <ShortName>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - NOTE 4 - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note4-Inventories</Role>
      <ShortName>NOTE 4 - INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts</Role>
      <ShortName>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note6-OtherIntangibleAssets</Role>
      <ShortName>NOTE 6 - OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7-OtherCurrentLiabilities</Role>
      <ShortName>NOTE 7 - OTHER CURRENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - NOTE 8 - SEGMENT AND RELATED INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note8-SegmentAndRelatedInformation</Role>
      <ShortName>NOTE 8 - SEGMENT AND RELATED INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note9-SupplementalCashFlowInformation</Role>
      <ShortName>NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - NOTE 10 - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note10-CommitmentsAndContingencies</Role>
      <ShortName>NOTE 10 - COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - NOTE 11 - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note11-IncomeTaxes</Role>
      <ShortName>NOTE 11 - INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - NOTE 12 - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note12-SubsequentEvents</Role>
      <ShortName>NOTE 12 - SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables</Role>
      <ShortName>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - NOTE 4 - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note4-InventoriesTables</Role>
      <ShortName>NOTE 4 - INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note4-Inventories</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables</Role>
      <ShortName>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note6-OtherIntangibleAssetsTables</Role>
      <ShortName>NOTE 6 - OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note6-OtherIntangibleAssets</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables</Role>
      <ShortName>NOTE 7 - OTHER CURRENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note7-OtherCurrentLiabilities</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - NOTE 8 - SEGMENT AND RELATED INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note8-SegmentAndRelatedInformationTables</Role>
      <ShortName>NOTE 8 - SEGMENT AND RELATED INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note8-SegmentAndRelatedInformation</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Receivables, Net - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details</Role>
      <ShortName>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Receivables, Net - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Patient Fees Revenue - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details</Role>
      <ShortName>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Patient Fees Revenue - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - NOTE 4 - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note4-InventoriesDetails</Role>
      <ShortName>NOTE 4 - INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note4-InventoriesTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Information relating to uncompleted contracts -  (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details</Role>
      <ShortName>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Information relating to uncompleted contracts -  (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Balance Sheet Items -  (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details</Role>
      <ShortName>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Balance Sheet Items -  (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note6-OtherIntangibleAssets-Details</Role>
      <ShortName>NOTE 6 - OTHER INTANGIBLE ASSETS - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note6-OtherIntangibleAssetsTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES -  (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7-OtherCurrentLiabilities-Details</Role>
      <ShortName>NOTE 7 - OTHER CURRENT LIABILITIES -  (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - NOTE 8 - SEGMENT AND RELATED INFORMATION - Segment Information - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note8-SegmentAndRelatedInformation-SegmentInformation-Details</Role>
      <ShortName>NOTE 8 - SEGMENT AND RELATED INFORMATION - Segment Information - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION - (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative</Role>
      <ShortName>NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative</Role>
      <ShortName>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative</Role>
      <ShortName>NOTE 6 - OTHER INTANGIBLE ASSETS - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note6-OtherIntangibleAssetsTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION ($)- (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note9-SupplementalCashFlowInformation-DetailsNarrative</Role>
      <ShortName>NOTE 9 - SUPPLEMENTAL CASH FLOW INFORMATION ($)- (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note9-SupplementalCashFlowInformation</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - NOTE 10 - COMMITMENTS AND CONTINGENCIES - (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note10-CommitmentsAndContingencies-DetailsNarrative</Role>
      <ShortName>NOTE 10 - COMMITMENTS AND CONTINGENCIES - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note10-CommitmentsAndContingencies</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - NOTE 11 - INCOME TAXES - (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note11-IncomeTaxes-DetailsNarrative</Role>
      <ShortName>NOTE 11 - INCOME TAXES - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note11-IncomeTaxes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="fonr-20160331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - NOTE 12 - SUBSEQUENT EVENTS - (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note12-SubsequentEvents-DetailsNarrative</Role>
      <ShortName>NOTE 12 - SUBSEQUENT EVENTS - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note12-SubsequentEvents</ParentRole>
      <Position>42</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>fonr-20160331.xml</File>
    <File>fonr-20160331.xsd</File>
    <File>fonr-20160331_cal.xml</File>
    <File>fonr-20160331_def.xml</File>
    <File>fonr-20160331_lab.xml</File>
    <File>fonr-20160331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>58
<FILENAME>0000355019-16-000049-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000355019-16-000049-xbrl.zip
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M:&*YH ^H0BB^?VGI#-;,E];_;K)WOP:/+*SYY_=+AX^#]GXY;,'G*23)E<R
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M)QUWCOL)>Z;&;XYC8-X/YNP/[#O7&5/&-L9JO=YH)@#--E]Q4&9"9UWKU0N
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MNT7&[>V8U[!'MLQI+&P)B4'-#]>V9WKS#6RLYK9V=JW;!#)F@V%7$.<V8$L
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M& S9RWFR34X$J2:%L0C,%[/71U)+,9C42/)BN]8B52*!@W^C\9#GI@Y#1C8
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M#@<"L19RAA'L8:B28R\*L.,<M]0'H"^ZY>M>L*7)^3E7A.J;6T;/.H#G\$V
M Q'9]XDM89FQS_'I4HL_8,!.;CG,=P431& ]<T7LP1[O 9O(W5(7'"[D;DJ!
MFW G<?%AX:;@KN#A1F_+#3/"H!>7,@XY_/WD<"<MA#(DV7*/Y,04,QC4?_>!
MZBN,Z25ZD</SE7O)L5T,]M#(<0\5^4AZR $S?:$ZTIG[X$"/@0T:S'/<>:3'
M(W^<_!@-&-E#6O3 3Q<Q.TD+M::P8 *EB?(X%;."',CI @&QG%>A*,>HN[E-
M2U'W 9[^XAW?4!3H!1DN^12%AG,7X'+*^1A8U.*2[J(^DQ$$_HSC@L+185[
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MO[Z\'ORS_^GS=85\N;X:7(*\19]QM?&E/^S_QN5/Q';@H]N'WZ_OR<WU=7R
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M=G[9R#$T4<$^ (O1Q^8[\;:*H-3YY4?Y$I5]6I.6$)//<T6HS[FB30;6@\;
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MA@_]X6^#3Y^O27\TNMY))OMJJ Z$#%YA"H0FT/I$YVH_+)JJC\?^U+=PO^&
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MC?1@YACP.#J@&K=YZ?N!I#"Z7#KYTXD]*2VO1EJVFHVFB NUM%HR#H2V$WY
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M[/H/4I"U5?VO]'Z4BZ3HDX^[!5FJ0YEK;]P,#-AE0.VMRYO)FF99,DAU0QD
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M"-T^6ZD52,[7PF3N(W3 D(<E?&H ;_#@@-+X^,?F6G- B5:(,B&_$NT=Q1E
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M#R_L5+_=SG3MDA-2PL2VT%;&; 3 W,5T6E]<YEPXKR%1/2ER?O=A$("MP!B
MXPB7TV.XZY !\\(XI& N-4\(1]W)C4+"N%:B-'X0G: $7XF_^QQW7W:H/CA>
M=VHG1D[+HM[J@:EE)[4%T(-:3X!'QR.Q'G&?J"O%<CU=X;(FFU8V3K"WPD_(
MHF??5!= _!L[!M"SX[&@(F YD4483!$+-<B/IR@GO&B;".@*.$=OB9(S5%L
MK:@[+* I5GKOIU."KX(WE'(@Z-Q.R38?!X_(FYY/:4^MB31CTZ=)E(R7(4MR
MDU@9A2_=\96,G"%8O54,,V<NA "*4>N)<)LDB.*D*R(N4?0JG=/$;!P]=(;I
MFFSQ<P3:3!93Z6[44 !CF*,;K(2:21O L9&'VCD]O@!&R)W\QK!D'50 A3[M
M>$N(40@YF*/:<7.D&".1#&.4MO ZA8G:3_B:I1<?6   0AX<T,SB$PMJ!!!Z
M)_8=OK#)IY6\B9YI7WEY"+_R\+QLJ-]W](+\)?KR^LWY)PA7%_'PE]?O:$'O
M'OC/C^B9=CL P%\IP-^F/W9-G<-K(TGN6O4AYNI\PVUTWN-R3C[ETJ8@4]=W
M_#%Y'F'V9BHN48PQ8MT($P% TBA&)?X+2R'3*@;?PXE>T0&Y>!;\\E<HQDU'
M=/;!=C8D*@P^5!6.Z$.A8B^(  H"/#F9B6]H0F5D(]<2KY6N_W?ILA9!6SH$
M(67W!,KQG6>TRV=N,A5,:UCDRG6>_8"<!N,:%KN=.\_TE.2_THA]B4$;:]/&
MO.9Q]*GTYSOYY:DS=[W73X=/?Y;FB%E)_Y ;-X7)$DW0. B9:_DI'IOCN3XJ
MX7;<!/&@G6@6(B3-R2=F6$*L5ECP^D';"@ EG]2KX@C0IDG:-%X]2H(NHTAO
MS!R;<H<B$LJRS!&6IF$PE\BS2-!+0N'Q*H642</5/1PQ+VKL/RNWT&B8V?57
MCG=<VD\ZU9+5',0KT"Z/=D/94NL8X-1\:>P8Y,=YDEAC_<-71JKA,RJ;_T7Q
M/4:V>]:R\_ID6B1;,M7LT@F0B:O(-.[&G& CWG\-,/X@N70<$(I]EV"!X@"K
M]6:"4/14N/R'MM/ D'6E,ZBX"JBAV$+?I*S50;A"BQ"-W>0"I5^PP5Y+6)TS
MU+-O4C_(:078-UH,=:&AX4WY <ET#PG]7B!_XD;+L/U1@@Y2OPZ2N]-4X71:
M&-G81@$L0'D/H$K(!22I@39 F_;:@EIKI-D9:Q '4!6@C2AFI*F@XJ2Z:$N\
M24W.NZ+5,L6HP+>6+7YWK]M'CH&LV$+7': @60FC\T8]]$WHH2#9M,BTV6?H
M=D%2MWI?D-1E1>],+Z<*W$<K9U:+ '8 "I*55>&XI9U;1XJA"J69-2V&W>W.
M P7)O2H<B#U$":*(#!0KNY<M!MH ;=IC"RHM5OKDS^ ^)V@*T*;55@1JE1PS
M$/(04F_K!QB6/."7>VL=.4Q#-FVA4Q%0JZPFI"1\AAM!D(<01VC:[#?<=K)0
MJ4*M8I.!D^V<_@)])(<.5RA[4;'4#$ U;0KU6G=F$E9 #9/?)+HVNP-=+%OJ
M-B!ZUX+/;Y9.ZVC1N70!U":[%/,";;I!F^[7)N$>)6@*T$9\*P*U27[.I"VK
M ^A1LJY-:K+-[^)@Z\AA:D0ZN%6N6Y=T['1M$KH50FU2(*%IL]_0S=JD88*?
ML/&:-&B%O46-@0)>0C]*DQKDX3?%.$,'(["AAL6O4-MF;Z"+I4D5+E5O@F2
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MJ;@^ZJP649&9K65EMYP,SVJ '3?R.Y[^ -,.'@(_)Q&B-?>"2;27O9$UG(O
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M/0I:BF=0]E3]#_7TF"A\_"]02P,$%     @ ;WVJ2"6PKQ&M#P  'L   !4
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M^Q+<7IJ16Q!8=)B_)9*;8-K]HV$Q<RXTS<C*#PHZ<51PX9B_75/[-VDOT:C
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M\[.SQNEOMSU[^@"6C@D]2M 4G"2U:"N\>HVKJZM3]MNDZ%[)YWO?3=YQ<9K
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M44=1T )>EY,B+LG2^DC>AWRB9Q51N!5R O/>;",<T-YLX0"2R1W,+,?W2$_
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M<QTBZ9L;U\UH.$0)A;^\G#DTD\Q9VRK++7J0,(>W6HKC]+ YZ+ F"W&M'B:
M6A/%.5\/0YVA'1ETQY\FZ'F%-X$(SE\DQT#HP8OW#-\#:<*?AO? G$'2*S +
M ,0OVE3/NA7H!:>DZ&E<YI3;0/&XUR\S9VCIP(R@]VN7@)B]R5R"Y3WP,\+=
MKEH\5L=ULR%D%8K'Y:&@F15:4J?4/@GF3N@&!W?*I/HV9O(8>I"N/3WRSRW<
MX#D W@RL _FTP;><F"*/:0/Q&;B&81I)K<T?'6]F1$T8FVW$H!/8+IIN877I
M.3+D<Y7,E#-W\#W34(C-A>.L3NF,>@K< "=/V!QKGC7B@V-_B1]/UB=PB((
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MKY2]:[#RP10RH.1G%S"E>HI>5)7:^C.H+H4P*E5M4,I9P8 8-<\KX,U@$/H
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MDQ<%O_ <JCG[%W*RA45VU]5*0I\^K8-I96?7@GUP[';763V9PFD!N7E1QS-
MJ\A/%17.MEY(O.)688YW/TA%X8PO#M4L=G@)4O;M*DXN/1]**YB._AXL%2GZ
M;:^@8X_0B?P2>XG%#DT0*D@)HR6/GL_K;*3\K\V^5^'H(/L[O\4(9X]-M;3]
MAJ<6=:L1JH80#?!LVKG?RG[*2'7_U.HU\Z;+Y74Q5'L9O<6O7<TK0MFV @:'
MWB%:MX&DL>85IF"WO*3@MGXSZ-*-PZH-NFNH],KITR[SA4 &D3LL$(%*P9!!
M*N^[;EH&-I/WN[5@5[JZK:"G'=Q3.2JH;"?,%@\+,KJ[(I._S"=W"RP+QF#&
M;,47+A=Q:-[IK%'U#1N-BG6TE$A0@4352]UJ@O+=^="4Q6Q4*BT4X\!):>&2
MJ]N\OBG)!EH>KBAI6!SF-&BP8E"L$2RI?CWO1)$W?[P,R1[BYG5(79S77D9O
MD7=7\XK(NZV P>%WB-9=L8GUJA4^YQ ^>[:A<$XW>K(O.E@Y>B_J:5==J>^I
M)Q\<D>XZ-@^DZC(Q#J3)+K:?JMH&51-QKQ,^J\*5>9^6$@VJK.HU FIM6EOH
M9;AMM4#2[.=;BAMH$.YDM&$\;B5K<,@>R8#NH+8MF.'PH_<TI5!^AKV-4I$N
M.2<W)G99>?I-D'-0OYHM9V$8'+!MM%3RZ"2/V*?=<^' V8+RH@$?:<0"D9#9
M-?+7013 DD\6O% [X%R9^QW/VQA4'=]=.-%@L96Z:JX,9SXC3X*=@].K","!
MSV)7]SI.KN+M8[;:AODE(8878V?I]RQ@L_+5@X!F>C2X<U#2<6L>!\+JZ]V.
MR^+#[C"X["S@VI@R:&>XGJ^X]S$GQX$5'IB*:[0:-J:TE+VOF^A55=9+JF1H
M/(U9MSIJIG?CV>T$!T:$PC=QFEZS!AG'419$6S;6RJ6>.$HO*7.#-*_3)!&>
M_RG82U>U35Z9Y7'B!Y&7[*897:?Z>D^6$Q'#JM0GZC&\_'+W&E(?7/X?P9M0
MO(:XQ!#T(7LUL'B1RFLPOM0:5;]]3:MB%?X5$C0CBUXO%1^"*@]"L"#CA>D$
M*P@"OS:WKZ'L%R%&5:LH4<@0(<6DFXJ6G)((4AQP85XQSC>9A%YVEV*A[[<@
M?H/:U3KX!F(T,&K24'_-GQR@OI*T7^- E/M(WGJP/CAVZ/!$G.%IYU?7+?IL
M_;@O-;CL:J@A=A1B276!2W[''\,7,:J221&:8NK/3%OI9BYI1%>!O2]JJ/OO
M1T:5U3Z@D*(9&>SZV5=2RT##@26F'U,>.J)Y];@@Z'DIOJ98;>%=?HO+KREZ
M*87T*;)HDV9[7^Q2I=P4+[67TVMTVM7,2M3:5@@:G]55<S-ZX0@*ZD&R8K++
M:QD0D(U@P^7D=*I9D3+&"Y.)ET1,K32O1'GII<'28+>!MD_86-4MPT=+B,8?
MV;2K(XE_1TIX8DPDKXD&S#B!=!6$V\Q8L-%(/228:BK;X"1)T0*JJE\=4O);
M_*#ZD09/STS3T0N;%C_1N^WZD2:SE5(YT.:U6LKH$X"=S"O#LI4 -&#MHG4=
MPKD,(H40X2:%#'Q%(@TFRX[H6INTM10$8&XRT0'.)A'8 =V@=R.D<S>-%=2\
MD#GL'\U68R]]O@[CSTW'W^TL_=X UZQ\]1XW,ST:(#HHJ236YBQ0L N8".<B
M?\OY_A,'V/CMGNDS7T_TJ7^Y^Y12?QH5Y]%&RRQX$==YV2'815#/,^..AM:F
MSRVEH %Q9]65XS5[-*]**3-L$KX7\9T-W1B6=S^@:1>-4KI5CP#1ZJZX4A*\
M&]\L8WC@&V</\3V%-@I"6EG+>8B/XV)._]@^'5)?+['< 4[]3#2=JB=#ZQVU
M]%@X=YCD#^.5.T4/AL_A+] )ZJ#P)Y+''2GR0HCGYD;[Z^]7=,-,"?@..APP
M6L/MLZ):H^']6SGZ[&4.JI<[B(4<#;:;=506IDH<XH17B>=$![O+QX,,]5PM
M=+T=Q;:I69RQUA'U"@<V<WV,4ZK;/6E2\(LZ@P67W$!]H-F*7TO"T/VCER0>
M<Z?,,%G8()TEX] +UJ;=MY8R>DU7Z6)>)8FEC0 T#JN+UNI\FG&2@%^"Q)&[
M+(Z&451'P[BBXK*FJVT"5[73)(C%O723]2:,=S3/[9DS"XTK#BVE]+O&T\G$
MZK)/*Q%HH-Q-;\W52P!9@.".T+!8)TH+D/.*[C@ S:+DA'HIO:+B9SDN3E.:
M-<W:6O#WG#K8SJQ:,J$;,QK@MM6X#MFO<@%?LWA!_,8F-.5)"Y?"[RA ,FM1
M3<Z/I[-)( U>(%')^6WI6(>%J]D8.U)5/L0@-2JKS+PEX5E1R"<I6+Y*O^:!
M0JD,$)H+ %23]Z8:(UP[S["PU*AOQV.) 3$052V51=HXHVD)=5CQ!345IM'D
ME048Z6QU&?#\N5GT"5:G-B'-J#^6]\LXOYPV(H=%9WOC[>!UEX=EO>"(MNCK
MKO$I69H%:UY6C<H,*@@6*!<-@>ZC$,Y^C\AV+[^XV0AMZ N'.R/V-+7PKR//
ML/#7J&_'=XD!/X!5975G<R4%5H3->1EAO^F\?Q/;L#C3&V&'6I4'/]JT^JJK
MK9RH6*,JU9]<;I.$5Z3D$R>L<.0'D&$+36@KYHKN<TP]]\#S?)M)#;-\'2M^
MJ-K4UI\X1P[*?-7A)O!8*.&2.]!6")*E*(N!CNM1&@F(IUD.:FM.8(OEJ*_R
MA:FOJRM3X5[4E[$\-?=VG=:F"CX<"U,U,]Q6I203?I^J5]BT+$4V@@PK],15
M!&)X*'6]=B.,CA_!4&\VRV&P5YGQ0].NN'[ SZ/1DK/$BM7Q-LWB-4U&_@O?
M)G-?X% 8!UZ,,AC2L.14X\*/1X/&RO*1)".>I,,*P$\1K%]1O\M*O99W6!A:
MS+$C4<.('XQFI943PODB967I<FE;Y/S2EC-K$\/.([]!!(+!WVI<J\G^EQ<"
MV'371P%?P.A?B[NME_%UEH)J F6^D*^C"/SP=5%?27+>4I%SC_H^'_=36(:7
MU48 SO-U.@2[<Z.K6=-.;]W1+J>C(*CA*VK>'N&XJ%40 C@[&.H :XL4-&NS
MG55O.BY:2' ]+MICU4)OQ\]N/<2CY3^V04*9]:PK9CO(Y84+Z2;L4WYIE^&E
MM1'0:]7#UH95CLTZ<Z-!;VN5E8U;ILVS!SNV;,ZWD<QBVI=S(L7L-,J8(0$+
MFZR;M0Y\@R+49(85F'4FO'@T:*I+J>((9#%MA&4=P7UH.'ALP3KH'S;8?Q$Q
MK%EO8PR[98RP6A840_P7$K]>!Y$7+8\0OUH%(8"R@Z$.D+9(0>-Q.ZO>%+\6
M$O#%K_=T(\>9V8JGH]LS"<SD_5X1;%>Z>CNPGA8-ZAH45.\$EN0\*3I.DO@S
MWT> .'/I;0*X S'DR2WQ8Q@\8;J8:E[8>15 #XO\]#:(XB3(=@TUO9TXAX@]
M'4S119\6-C2X=-=5+6J:BKK> #U>O*1:GSLX5N%E0QV)R^TNWF;0F[2WNM7L
M=6/IK;J$H_)%H8D&^L'AU$))93>5<X&?.Q6 CC^&\DTQ**;AX.U+M$.-GHJZ
MIJ&S(!P<4"[:60?-J';J3L1H5![%%R?JG^/0IPD2?+G'I0<'MEAG'(?--+Z(
MR;-9[\;)\ZJ87V";/(.AH\B''[!\^N*%T&%%!8SZ'J[A=;43T>O-ZAV,J]RZ
MWH(?C=OMH+3A1@Z1@L_@RZ?+,'_AOY2D8L;PB'7B)-FQ3L<KN;1Z6PKO\*@U
MF-,,UQICKSC=<-0M,B_); ZWC>+:I1P=-LDYN:1/0019?!!5B!XP4 W;$[=I
MOY5O1:M.(O_P-C55Q[6UZ@2.6[JT9X_%<T5N$]2.BL-@Z5#VUL+0:\':1L4K
MI6:-U&A&OT85#:=YP$GD'.@*NE]NTR"B:7I%TV42;/(BH8JI#_0UNV1Z_&QX
M.1WD] G&SF:6,=I:"!KH=M5<B=YF#Q-RP1SEU60QOI_.'Z:S.S*[)I>?%M.[
MR6)!1G=7Y'*TF"[@T_G]9#&Y>Q@!%0ZT+X*G*%@%2TCJ: UQ5^9>:RNV,JA2
M4M&)$PV"6ZFKA>T'!MO%I]O;T?U? 9R+Z<>[Z?5T/+I[(*/Q>/;I[F%Z]Y',
M9S?3\72RP('7TJF3AE%?2]GORJ)1U>JZHD*&!F-FW=0UQ8(2W8A^$WM1RC<3
M'Q+/I\S/\Q72DLI70;H,XW2;T":7UU%6G[@[R-PR,CL)0H/=0[37NLMOF+N4
M?G%![B?CR?2'T>7-Y"VYG5PQKWE3^DP,^[>CN]''R>T$_"G[<_;P_>2>7$\F
M96[RU:?%%?GGKW'TE+R\TV[_:AK+@E@X^CT%U*AZ]<2/D1P-@IMU-)7GVI$]
M"SIWK#&KR>O:60:&F=6'VN@Q \W)(_Z.><3IW0_,P<WNCQ A&A(8A ^/Y8Z0
M%Q8WPYDB0&>NWM(8W$TH,AF:60:'3SL]]>5>LY@4K&3/>R(H\0*;<'@A/WF>
MWT^LK=()E/72"R9/=7SQO8'S!"^E0/$19>. ^_$-TGK6WS//.IXM'D0@.5D\
M3&]'#Q/VV^C^CDW*%V1V1S[=C6>W\YL)?#Z>W3W<C\8/2&;I'^/8_QR$(3._
M?D[#.;)L*://(*"3>>6HH)6 P8%_B-9U=.<R^'[37@H18C"'K4[6-P6R;86@
M0[4UV&TGX<O"M9/;_@-SVV*:/[U[&-U]G,(,?[183+ X9IE-GXJ]CF3KA4W+
MJ%:.GI/,FU2O)9>;R-$ KUE'Y52MY.#N,^=!YRIKU4>XGM0O5R25BW&EC_8]
M31;>:W*EQW[( )D 1WY!FNR!(ST!38\YB5E:5_Y_"E<^_G1_#VNX-]/1Y?1F
M^H!F+VQ!GV"R?$\W<!EI]-3@R<WDO>[/-BA=V9$UT**!8X."RAV,@IP4].@\
M=]T@]\C6B7-(H#G&L YL:.'7,EK]%]C_GWPL-JCN)S=\D6%Z=SV[O\64I++=
M;,0ECUX(.8IPF'@26M> V['VBLL6QE2 Z<"'!YGNRBI.LL1*BK/C).=&YS)S
M\\IZ[SMB8PZ5.WO?:?%MC*IG4;OPH@%K2X6UOO1;GDLUG]_P_?[1#1F/%M^3
MZYO9C_C<Z3A>KX-,],6(KU6SL8-&RTJLW.!76\KH%;M=S*L N(T /"CNH+7F
M7N5<AC@04):">7'6R?A&5]Q2"#I0V]UR*PE?%JS=LK3?\TVUV]OI _AHL;4&
M&V?3NX^3.SPIKE/81Z0/WFN+)"P+1\^EF)M4KY5=-I&CP5^SCIK[E!@'82R8
M/:;&KN8L+!O+P#AKR,(RTV-&FIM?N^!I6,RS3<C#Z"]8W-AB^YC2?VR9XYZ\
M.$W43>3]3L[M2E<GY'I:-(!J4%"=>.?D1-"C\UEU@QK7),WT0X+*OOYH(D8+
M*S<G)0X;72XF__$)UALGD#5ZJHS1Q7:]]I+=;&4](]5P>O@@2;TE[QUF:I&G
MUTW,X) \7'==5JHX&">DDMF*E.02W0GF_!<<3I)-D5*FD,]K'7+5=LT37QM+
MO]/<9N6KDUHS_>#H;*&D>NUUP*:XFU"43Z\(P(&R/.UU3I/%LY=0-Z U<O6)
M-4<3RG!K8$&#.#<]ZZ#+N:#:!^%\.+!V1S^7_'D21^S7I=@-$H:Y@:^]F'ZK
MOW4SLEH#KIT,-'CMJ+CN$')MC*[(P@%GYMOC1!3480J'7IKRX(*7H/!_VJ9\
ML;-4E\*4/-A:3*_9FAV-K*1PMI2!!LX=%=? N<*+!+^+Y3/UMR&=K>K#S*67
M!LM1Y%\%X3:C_@.DZ#7.T;M*ZW4&?YC)E?E]-U'8KAP\S(PO)?+86SE.J!]D
M-W&:TO0Z3HKRI*5R GEV:3O4=Q<\3 <X]$7H^T)7J6A<_M%,L156.2<117)K
MUM[>>_I"HRU=\->9?D^],'L>LQX\2YZ\*/B%CUPM^T07D</TAN[&Z_M!>WD(
M>T!G(]33+ED  ?V*4I((H3C[0%% H=L8T,0^#+;=C-+CV,Z+-YAQTMM4=>4(
M2\"FN@7U,^0V?#EQ]%==P$GU?<$ *_G@SLY=1Q4DJSA9<]\GKMB&Y8DL)MM]
MU0"RS,L&G A&TV@9;GTHKP]+).N-%T%QX'$<^31*>=4"N<Q,_4LO!-L6SU2]
M ?- 6;U![U!S"U!V%80#K@=JKTEOXN*@5GWV3(E7$@H(%E+AMT(L>11R2<H%
MXQN]JX>^V>0U/Q+>>B!WEC34F-[25-/P[B@&\TC?SH1Z-^"G3.'NI;R"A2<J
M6*",3^O'9N5Y\\K)V990[R)R&,QW-UX/_O;R\/:"SK;HN\-21,TDW'-CZPIR
M<GJYN_5^BI,\E$LO=\4I2GFJLFV'Z"YXT*6+SB_"NH#16NK@H=+133$=_@[V
M$X&![D>YHYG(-89%2OT^<HF@Y_M.[-O$.KV4BQ)A X+<;5EC@3OYCL -2X%(
MRO=>O"#DU]RQJ1?[9,UF8ZY7W)VP17ZDP=,S"Y1'S'E[3Y3I_DB3V8KOA*2S
M;9:R*,-G@..FZ5JLE8">6]1A0.JFOK[AKV@4KX-(-'TNF#4\E\QF(""2Q'N9
M S6Y=MO,)><(:1/:U=0WE3PI YM^8]$7$>W]\3O9Y EVKIQ XR@3M_EREQ^S
MR3-[-RGSY;/5G#V<LOC'7V36,S2'2>WYF,TQ7D'M),XA(M$,1<>Q0SU_"PP9
MGT^.(?>#C FGQS4NR:U]Q3VW&)E,(O YMJX&U-OV 6Y"+8].A,6!Q!=B",TS
M(#;,&:9-7K#'<4G:Z3(R25)\3=BDJ'IENVB4TOC4.#"=L$GR23JOF,VOM6#S
M=$U> <Q,\M\?V/L<O0;:\/X0>?@:]RC6F+,N"-"2OP&U]13<J38Q<O/V&BUH
M\A(L8:T&+O(.DFM*U2T+-S8\K=E%:</M@N7;S(=HL5OJ!TLOW!NA-(Y"@:P=
MS/K57[FD)*4LI4%>N1>QH1G"L;S^(P?*71S=PU8K]>=>4K\XO14CM@9JJ[;2
M;H4 7N<EYJNW*R9CZ+X#>M7MVH-+6B=1-X>]<N8=TCN:C<(P_LQWX_5M?)A,
MC,U_)(NZ((- BXDL!A8EK:4/V.0/(E^]F8]_F[Y!<JF5/@%-YI;) 4:N]=[0
M-)TG\4L <[;K.+GT_"OZJ"1 '%5RGQ/Z([Z*<D!Y!+&]]J\,IF*VF/)X!BGG
MBVE&-FI:(XZ>PGU)D0+'R^&5!LW:.S(1]XEGN\)EB.HIT2PG6=53TF+9DY\]
M2++9L&$^/8.-C$T<%57;4LF. U2%53_&R<_3B/45-D280&4B'N2*-ZW"VLO=
M*I1H0&55KPXJH#D/HO.-H!IHJ:-0F4W@@_29\IP<F-"[MX65L^= KG&@::FU
M?DTQ.'W^,=QZ-8UX>H>OO^E*%Z<ZL?5[SYF;$=7[R^P\@W?WEHJJ>PZ,$_;'
M.2N)HUY3DI5[U'3&:8AZ0XU1P0(C"@4.1)C44LY>YG3%'L3)JC(]<G_( :=H
MQWS>91"&YJOTYN$V[>B'^GIRCU6?^GR5I2I1?3P6QPC=O\&:>GS\X3C"^/JA
M%SCA33=Q&AA71ZP<O1:5:E:]4E/*3#ZX9W?7L8XF6*?XCN1XA?0W.)J!!%NB
MCTQ>(=B=K>R=:I:PJ/@I\=;IY'5#EU!B(+ZDXS@,^1\_!MES$,TB^E<VG)G>
MWNF>UV^QM!._MFJEM1,]#(>[[\M,_0Q.Q."P=D.5: S.65&N#I2">\P[<)<X
M_818S%_4_M6!3?(4K0Y/5@8\^RWMU&UPNI667-K:_%2SL./X:UBLR.A-\$*5
M"U,_)K%Q<:^9K4_OZ6I$&;1-/-A0ZZBO<DDS?$<,)]S00W"T7&[76[XW.5K#
M00VQ>]/^%1D%(8%I@Z&.P#5(01/J=E9=DQZ44Q.O1#[84G?5F#N:L:$EW$(2
M:7X25;_0W<R';YF[A<[ZHX7J7?&(3MK*0Y,++_1@%;X6]J@)BUKBGB\@MBA<
M2Q;54*+Q#E;U-!X B$DJJ?G.Z3I(8>M>A&(;;\<>&9+,>\6S?YI1]M8R>437
MCBT3<;_[IS:%:ZY,0XD&6U;U3-@*)!,.\'#?J1[IMH.HB:GW#(]& Y1,#R,'
M&G YJ:G,)QG-DZ@AY &K%R)Q4LS_\D5(-JH'*=QAY.2M&KEZ/1GO9D+EV+N=
M!0W6W/14]A^ "T9"&!6;$H)[C[7F2;RB?.3V0DA_=8JYC$P#Q%X-!FAB, ,'
M&I@YJ:DND3UY82G5>%/BYGG'7P+J6-^ZBZ/E 1"L2<"#1ZUI[N"LL'\A2-7I
M;#AK!#7/\(!T0</5-$JW">P)WM.4)B_4-"1H27L=;RW*5@99#1T:(%F44^N_
MA*OSU3:"TGG//+^<S14D)TD$*PX8&4+31@_GP(=@ZF#W9HU,:*#GJJE:OU%,
M4,5Z!V6N+]N1<U@3$=$>(@PN6&])=NWFK6:>WK'7I+Z".Q,#MFTE%V6UJ[@#
M+;7S9[=H!XU1R!;4F]34IQET*M)WRA @\S)^U'"V@5I=+)@:+;/@A:LDRZ69
M:A@XLN)+)&BKN-*/<C:RYQNF/$%E=4&>AKNCYH62/0FBDG(FS73G]N19O50<
M?Z6O;!R%2>HRKPR(8^24QIB2,/9?]SD>UI4J@R/_#@TF:@II ZCS5)9SC$K
MP & ?8G$:]8&D*P61%OF,*3GB"/SX;MFQI[+CSD:4JLPUL"%!FC.JFIJL$-A
M(NZ'XH(8!_RNZ":ARX"KQ'X/*;_V+G+)Q7%C[1.";8PI@]"%#UMDTD)GI6!6
MB97/*UWS:WK,,?<V 8N!(5$W\H-LRUYB?BKC<IO=Q=E?:3;W M_P<MS9>\T
M;VE4):';D1>-MVRIL'+.4;"SN&W/?Z*3;E"*[%N>)1[SS%^YH+S_(%^#*6ZC
MKYG<64IO)]"ZFUB<)FLO8G H'J:W,J=@@L@%.2>EJV#);$4NMVD0098XDTR@
M4FX*G\YAC3C*A(\%GLP+PI3<>0D,_X>O'1NP_/UZZ<T^1VQZ\QQL%L$O<'7&
MFH4<@1?N2P7)DBA08'&IKL\=(*<W/!]B9H'H+D)P8/H S96EIF=*XEQ4D0X%
M)QYRB:148RJ72;P5(V0SJ;A4< >8(OHYW('3]OC.R?=7M^2KC5#@Z[<GPGSQ
M)O*>/ +E[BNZ7<>)J!*T-V8<)YM8Q.*SU6C-;&4O=74'!DRD_M_[:TL?Z>>Y
MO?6I/E]CT0?[>"B./MNCI>Y]7#RMW,-+SP,"^<0OLK_[ZUD2/ 61%T+=EI2)
M3T_2O]L]!UU_[O*:6O??-@_YLOIK!\O<^R?<V!=+\;QP$)?/>R[K:4?OE*==
M'<1V.0&ZS:9C&:3DLHA;5(+\*LCMAN%D6<@!R.37%\B+/>"Z'2]<\N-7Q"O*
MWD_FBQ/Y=+66M+YH[OY[.:,J)E2VN?DQI??FOX__2BSEQKN*QN&KCVZ/=N[_
M#9O'%T7+2R7GU:K:?"F@%%3!GV(W'[0H$_:W,G!'LWRG[(K%="_4AUV,NWCE
M;4-X26R(2F,^BOVT37;SA%F\A &%>89@K:W3=*C$_E:_CF+Z?B7L('$X>LQ1
M;+#NNOM"K-CUBN)S+EEFL0G9;$ "X9!#+J63)1=_^AX QNI=Q)B-E4]0&20O
MS;YLPGY+64.@OI.Y.KRW$M0/TK\52(_H$SQ6%UX=PXCF!).UL1+[4DB%H"HO
MPCX?(]G^+>\6JK<L&^+4)J9>CT,X&5 Y 6'E&-P]MU)3.>=08H*P_NCE0"Q;
M:!<7O!!V/H'QTN?K,/X\W=^?VB9B/U!@KQMK!QM>V6/K+&UPY![-!&WT_2V+
ME<MB"<@E()B4))\BH#YV80!CUD*59)@B /KL@_+W@^/,HI3Q],2&T6#! 22#
M/4#%"BL4:E3]9_(I*JII>P4)(DSH]#(DY'$R,D<#C8:#WR['5MN)0'1@O_'@
M:AM^-'#LH+3F;L,X@55;.-H?/X:RH@22^4/1WR:O'K\H%2[>X:?4 FYXL7DB
M3KXU]5I7*8-XPW8F:KVEFP@T\.VFM[*]Q8 ;J,<83W?_Q:WW&JRWZYM@'637
M<3*-_. E\+<L%.7+2Y\BGR:++-Z$<9I^6C^R27GHS>,P6.Z*#?CBE+ NQCVN
M_-[F*J=X+:5K^XXG?'#\G\HB]?8^_@@2PC/X!=-!\12Y%DK@"'I"4O:@<W@2
MV<I'D0U_%N>J'U#',39<R<U)UO_%HD5Q& [.4(S9]&S'E/_L);YIH:F5A'X/
M&K0VK7K>P)E]\+[076?=FJDOI>3G8*(GPE&]+/,/<97I,!G2:%(0#C5 GRS]
M@:_9/*;T'UM8%Y_ Q5=ICWN>2@[//D]V&GWOKYWR?A2>X3*X#.J;L[%J#(,[
MDS9:JC=?K3=>M/MM2K[Z_G8\^KHA;?E$D(*+S7?\0/CJT@MAL)VM>/(,3\%Y
MCD,V6J?R\ KO2I"YHYZA.U!6;Q \U-P"FET%X8#L@=JK<WHICM\1(03NL[!&
MI"R5#8WB)-2R)'>($5)-LN&%YV_I^I$F2GM;J?_NQ\O>&I4]:[O.C^*X90^I
MJNIK[FNR@08)7E0+^'9W<;?\SJ%Y:AS8FTBOKJ'NFWH;>BH.LO#EB(3UQD#N
MU;-.>)_OT8-<<GL_)>G2BR)>BD66CO@CKR/ :+WBAG8^#_/C[6.VVH90[I4_
M%P<8Y*D=%L[=<U,AU<$!$3HV[+"PZ'P,;+!PN,#'EX>,R^TNWK(AS!#4*Y!H
MH,>%!3=E39=S\[3Y"F<15/:=,2\NB(5(8,1L^2&&27(UT=LPY#KPX&HR=X65
MN8 ,E I>4C"+X&F0-HO7S 4L^31&+L2)-#-_["74U&@.3,A:S5UCS11.LI*"
M5^9)^P2XB6 ?IO5@72/RE7M#]9?),<KZK8X/]#6[#&N'58XM&QL6CFV8_KYK
M2*#7/(.4'D**IW#J_#DD?]!@F#K!'>;X,."D<,>[S(<9@$$W&>H]Q*;C)/QK
M>?YC#LK"X7A]DW:3A;"I#S)$#X$\+3J+^8E'<RKU>4&ZEH=N-OD#A@>);NY1
MFJ,&C<AH%H 9#L[:-[@!7I"*A0)^P"9F6;@KH^.)1G+;:.U!?![)<MPB$?\M
M&85IG)]S3.6=G2RR+Q/S4R8!8*MP, Q6,$?+G[,1V@X"J/KHR,]\FN,**SDR
ML+CHJJ:.P*P<#D+SBKCY-)MX P[J2ARB-(M"@:LE3.K57_Y$N>AVD)%XN%H_
MJ%KM  N4AEVMX+S="R7_MF7^]>*,?'A_\?LS/O;*73:XXB!+MDNHN^;S+Y:R
M, @4)*B6&Z@-V>P3/_">(N9\@R5A"'J"^3FH [L9>2%61L7>$7F4Q;/>$BB"
M4"ME\-EC]"4M8K*.$]!$A(A,=7#K3UPI7BFAJ*W9KK9)Q&LDO-U7/"JV6F X
M"D-^D@9N?Q8W67[U^3E8/I//E.FRS8*0M05<),=5R.UIH\#78!FOY\ 7'&$Q
M$IY+/OSN[8??[/<VV1.XELYV);#+'G%18BPU[)C^[O=O_^4W4OP95\)0=D*0
ME.5^\_[M^]_HQ,K7H5:B$ W-M&8:N:.F>*TY?(*41/%G\D@Y51SY6[C"G3SN
MA!'[[!*1/L5U\=;TC/QO;[WYXS_]RX</%W_4O4@!_OU++)$/XORFLF;#-(+E
M:JX=LXI-K'P:I7R&E<9AX(.7EAN3BV=*-=/*KH)P.<$#K3"&%_D>; K4K*]3
M^R'DT[4V9,C$R:Y>1U_]%EN[J*HI83X/W@@5![A8S%TP$8]Q#?&^6\U@:\7R
M.PG U6H=M5>S&?CTBU_/NTF"%)9RH$NE8@N-3<? W;\4\[1J:0 U>O@I9L,(
M 6Q T=<S\2WX\NPY2/SS#=^7W23@XS-^+3";NWF16"6 )V60(U2*!:JS.V7A
MH/EFZG[A]_>[.&I8-G!E_!+@9M1:398N@>2LOC)4W\2%W=FQC!X@/N&Q011'
MY[59_IEH?JQ;MGNC9ZNK(CZ:BO!(VF?867)GQ0H31[VM0"%[$43**'!Q+K>;
MV"_5P6FPEC87+#)[Y5$!6ST$#I.)$!M',>@$WJ5AA,'K8KZ48T'(H'ATRW1U
M(?,I*5_"9O]/V:P[M=U-R0*CI\1;D\\!^]BS'!R2!#RH(B*HXE)@NAS+(TDB
M.!.'E#9Q!M$5 W9^%=G.<&2)L?_SQ?OW9^_?OX=B3[+@$^]3P.!I1'+.DF"(
M'OF.X%IX:!I!6@XTR%OR(RC.VG0#2QI\RRA(<[.KBU@,^FG DV@9"9MI\&[)
M3R F\4]T6>ZL8B%'K*&P^:-'/C_3B%"Q!,K3@;+4_++WBHLU'.$(^-T%*1UD
MX4#ZP,D_ML$&7ILI2-"2(>MI-AT5/R[;D^;4R$9YH=Y^R#*UR)X"96,HZIG:
MH3YR5J=ZT(>#%0O-ED5(AGFDY#9!CA/\#'QKGZJ386Q&@X[ZMDSR2I?V<AFG
M>OFXBCBB:LRCV**D1V_8X/;*-P#Y(+X4798-K_-Q6KE'[U2E'GM TD"%$;&B
MIXL5S941;XWI/.TK(YX*$]Q0^1H6_!T;G+N)$%>;-FBIO>V92'HB& 9IA2_V
MR@)<K7\Z"W]-)?@UE>#75((O,I7@O^[]3E^D\SV"Q;\ZXU^=\:_.^+^&,SZX
MM MN)ZC75IF'1*S5=N0#=UQ_J#LNJ.$K.N.^8@:G<*V:D:/76\,2(K#_\\79
MQ8??PT;%6S*"K16FZS;,*D_^+4/G]C$-&(R3W1F!VC-GT#52<O'^?;4?VZ[,
M' 1F<P\V6/BYNWBS8SW_.3.E"YA)<4&K44_EB+=@X YP6;"8MP4&67^HGGT6
M!Z--#64D1=9037HJ#54<X4Z! U8(>;]&M8$S3^*7(!4QW*7G7]%'3;*MC@A;
MXQ@U5)M%DO*-F$?/)SY0DRWLT,)'^4UQC(2YU"64Y5]!6?Z4/5[TJ$%\W_"E
MJU"U^(%6_#I4GQBNS<<G=0G(3ERX@-A&94.J<77'J7RZ,\TO*-^ U^*77?*)
MPOZL)R2@) D3*ER32(,1)T)3W3'0X=*#%]M'?NR1GX]5#NVQ]W<9\$HUAF(+
M\W";=BE T,]CD6&R3YMU:5ZE,33WE:G4"?[F)YG/\G2DTHE,,:]_E-H92RB0
M#=-0GH?&66_AQSCY&08@I@Z-4EEIOKQM;8B&'?EPP:V=TG6\2&Y29B<Y/Q$"
M!KKE652&'IMO\:@0]%S^N**W; Z[7DI.!*<Z(Y)NT)=<BP:4+]&]W+).NJ2!
M4>,%=2=\IS<R@9,-^!;TJE2(WK)%N?KK+I$.#>:2*O;[?[2$.%^_1C]K"^SI
MAV^$AE>/\X6[O.:!7BV4O(LC/M_]P0NW5/=^ZS2(7K)1-5UI/Q:&<,HSPFG/
MR#1-M[3O;-'B[JW2&@/DCF>[42;6%WCEF9A--EF/NXOEV2#VV76<L(%(KH'H
M&NI D8C:]5B6U&%0EOM;(B23LFC8$Q7"P>^Q43^7S^?>$ ?(1Z!!C:@Y /5)
MX6[=.*J^*'VYV9'_TS;=%R&X< /3,9Z$&F-'-= %>LP%Y8\D\ID*&JN/)?ES
MSTC^9"(?/?S@/(I\]:4VC-A:'D0H<5;5,K;S11!!/M@P+PNABB-?VC"J3H.H
M$8RJZ6OU\=<M20=ZX>)J0KAZ"I+688DMB+:L_\Z*7*%+RD84FG=GJ6[^IV O
MW18[><T2+TZ8I_"2W10*P!@*B1OFW4/J@PA(*%Z#X;K?KT"MK\6>P5XSLE>-
M/'+=BB$@Q_C9_A,AZHR4;Q ^,PTA\$WO6P?M6Z+URSX,_ZT?]T7"N[N5AZ/7
M 9I?5NK$-X,#H%DW8]I$B7@X5Y!0+Z575/R<1C",3Z/)ZY*FZ6PE-[>TFU:&
MOMY9'J[.?+@9FM[*A9&O<K%?0[H!2(:?0C9LZ4GIL NGJV*/!BIYE3;#VJ"5
M 75CZ_1T;,T2*YIVFHNL&QFRN#55E0=U:QE4=6PPR9T'=&@:C1^\W"__BRTP
MM[;3LJ)N0KO&CBTICJKNI0R[;:@:F=\J-O=V]?(>SDRH6]&DJV/[%;>N27XT
M#<>!)?="&_;#G)E1-V23SJTZI)1#AM]PTT1UM9L''$/:&A?JMC0JZQJ>#GQ;
MDMFR3Q$DMU&_=,.J6_MI&%$WH4U?QU;,10QX':WSZ-_-Q6KY43>K@]I=(Q^,
MOK86'9CK&'<4@;JMW33O&"B=52XF'J[->1) ^CR7^?67NT\IU..?Y2=S1W "
MW=BOW;D1M70'I74)CB"#Y$+@2/-7((>U]=>D$$7VLG"UKZ@0T[5]-=SXV]>F
M=,OV+42A;=_K  [0=&U?#3?^]K4IW;)]"U'#MR]H"8>CV0_(B'CQ0GY<FKV!
M)('+4LQ9B"Z,"+9BNNFK)#) 8T(> _^E).",>-#40H9(9!PJ%6WY3/UM2&>K
M_"#2G":+9R^AEUX:+)GM5T$(M4S,MP0>* I1'S[4 B5;3,J#K9A<(ARB(5SF
M&>%2.4"D7/(W<5L0B"9<]G\.CHOB!AVY_-(&"'9>E"WOJ+*MJ0L1Q;D'G.V:
M,0,"II98W6;H_AC'_F<VNV_7Q(YBD+9V6^WM#9]+DSL&O&_G C&"H#:;9.:S
M3Y(M]4OS_C9H:"\/)2P.,,.&C_ITF\-#2BZOM.!!BBASQ2(5.BL55YNS?VEQ
M$:@\+W]#T[0I^^:(8A'AYIC6U.$CZXR!<%*6?D:D_+R@1%%9%QY!JO54V%/(
M$+E!_PTJ# P_51G"6L7)]?+X(=/NE8PM@RFS9"ZN:TDA#63)+ZV_I.,X#/D?
M<*U,$,TB^E?J)3K/>+*'(?*7I[=1?Z) EQHW^-GDZR *,GH#E6;JP>C')$ZU
MPV<3#Z*V=E:UWF2"\9QSJH'U&>'< [49WR5;;",_V;F=Z;<R(&HM-SWUE?T%
M&T%T[/^*;A*Z#'B\Q'YG?@6. [)8?@VG]'[QZH78VO A:K16ZM;;KLQ\1@IV
M,3,I"?CO>8<*DNCN8/TU.PV=!&I04/[HAOW&/LX_8O_ %7OLD_\/4$L#!!0
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M4RJA%_XT6RK(+N]F.];;P#UNA6@:VF".T,I_3@O>7?@!]X@'<W'*)VZ6W).
MR2_*2M4(7OF%%'FE)CY>]>&L1X0/A_)061I-G=E?^'_N_ BQ3_X?4$L! A0#
M%     @ ;WVJ2.&@?<_$@0  '*\( !$              ( !     &9O;G(M
M,C Q-C S,S$N>&UL4$L! A0#%     @ ;WVJ2 ()]G:Y#0  .X   !$
M         ( !\X$  &9O;G(M,C Q-C S,S$N>'-D4$L! A0#%     @ ;WVJ
M2"6PKQ&M#P  'L   !4              ( !VX\  &9O;G(M,C Q-C S,S%?
M8V%L+GAM;%!+ 0(4 Q0    ( &]]JDC!1J1I;A<  "Q5 0 5
M  "  ;N?  !F;VYR+3(P,38P,S,Q7V1E9BYX;6Q02P$"% ,4    " !O?:I(
M^G/#:[ ^   S* , %0              @ %<MP  9F]N<BTR,#$V,#,S,5]L
M86(N>&UL4$L! A0#%     @ ;WVJ2'C*U[#0*0  3G4" !4
M ( !/_8  &9O;G(M,C Q-C S,S%?<')E+GAM;%!+!08     !@ & (H!  !"
%( $    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
